
<html lang="en"     class="pb-page"  data-request-id="4d726c9c-dff3-48e8-8479-e22fe77ef063"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2014.57.issue-16;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm5001425"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases" /></meta><meta name="dc.Creator" content="Sina  Ghaemmaghami" /></meta><meta name="dc.Creator" content="Miranda  Russo" /></meta><meta name="dc.Creator" content="Adam R.  Renslo" /></meta><meta name="dc.Description" content="Creutzfeldt–Jakob disease (CJD) is a rare but invariably fatal neurodegenerative disease caused by misfolding of an endogenous protein into an alternative pathogenic conformation. The details of pr..." /></meta><meta name="Description" content="Creutzfeldt–Jakob disease (CJD) is a rare but invariably fatal neurodegenerative disease caused by misfolding of an endogenous protein into an alternative pathogenic conformation. The details of pr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 24, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5001425" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5001425" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5001425" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5001425" /></link>
        
    
    

<title>Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5001425" /></meta><meta property="og:title" content="Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0006.jpeg" /></meta><meta property="og:description" content="Creutzfeldt–Jakob disease (CJD) is a rare but invariably fatal neurodegenerative disease caused by misfolding of an endogenous protein into an alternative pathogenic conformation. The details of protein misfolding and aggregation are not well understood nor are the mechanism(s) by which the aggregated protein confers cellular toxicity. While there is as yet no clear consensus about how best to intervene therapeutically in CJD, prion infections can be propagated in cell culture and in experimental animals, affording both in vitro and in vivo models of disease. Here we review recent lead discovery efforts for CJD, with a focus on our own efforts to optimize 2-aminothiazole analogues for anti-prion potency in cells and for brain exposure in mice. The compounds that emerged from this effort were found to be efficacious in multiple animal models of prion disease even as they revealed new challenges for the field, including the emergence of resistant prion strains." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5001425"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5001425">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5001425&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5001425&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5001425&amp;href=/doi/10.1021/jm5001425" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6919-6929</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401841p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm5004733" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sina++Ghaemmaghami">Sina Ghaemmaghami</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miranda++Russo">Miranda Russo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+R.++Renslo">Adam R. Renslo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Biology, University of Rochester, 326 Hutchison Hall, Rochester, New York 14627, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmaceutical Chemistry and The Small Molecule Discovery Center, University of California, San Francisco, Byers Hall 503D, 1700 4th Street, San Francisco, California 94158, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-415-514-9698. E-mail: <a href="/cdn-cgi/l/email-protection#b2d3d6d3df9cc0d7dcc1deddf2c7d1c1d49cd7d6c7"><span class="__cf_email__" data-cfemail="4a2b2e2b2764382f243926250a3f29392c642f2e3f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5001425&amp;href=/doi/10.1021%2Fjm5001425" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6919–6929</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 24, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 January 2014</li><li><span class="item_label"><b>Published</b> online</span>24 April 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 August 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5001425" title="DOI URL">https://doi.org/10.1021/jm5001425</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5001425"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2554</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5001425" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sina&quot;,&quot;last_name&quot;:&quot;Ghaemmaghami&quot;},{&quot;first_name&quot;:&quot;Miranda&quot;,&quot;last_name&quot;:&quot;Russo&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;R. Renslo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;6919-6929&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5001425&quot;},&quot;abstract&quot;:&quot;Creutzfeldt–Jakob disease (CJD) is a rare but invariably fatal neurodegenerative disease caused by misfolding of an endogenous protein into an alternative pathogenic conformation. The details of protein misfolding and aggregation are not well understood nor are the mechanism(s) by which the aggregated protein confers cellular toxicity. While there is as yet no clear consensus about how best to intervene therapeutically in CJD, prion infections can be propagated in cell culture and in experimental animals, affording both in vitro and in vivo models of disease. Here we review recent lead discovery efforts for CJD, with a focus on our own efforts to optimize 2-aminothiazole analogues for anti-prion potency in cells and for brain exposure in mice. The compounds that emerged from this effort were found to be efficacious in multiple animal models of prion disease even as they revealed new challenges for the field, including the emergence of resistant prion strains.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001425" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001425&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001425" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001425&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001425" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5001425&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001425&amp;href=/doi/10.1021/jm5001425" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5001425" /></input><a href="/doi/pdf/10.1021/jm5001425" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5001425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5001425%26sid%3Dliteratum%253Aachs%26pmid%3D24762293%26genre%3Darticle%26aulast%3DGhaemmaghami%26date%3D2014%26atitle%3DSuccesses%2Band%2BChallenges%2Bin%2BPhenotype-Based%2BLead%2BDiscovery%2Bfor%2BPrion%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D16%26spage%3D6919%26epage%3D6929%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jmcmar.2014.57.issue-16/production/jmcmar.2014.57.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0006.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Creutzfeldt–Jakob disease (CJD) is a rare but invariably fatal neurodegenerative disease caused by misfolding of an endogenous protein into an alternative pathogenic conformation. The details of protein misfolding and aggregation are not well understood nor are the mechanism(s) by which the aggregated protein confers cellular toxicity. While there is as yet no clear consensus about how best to intervene therapeutically in CJD, prion infections can be propagated in cell culture and in experimental animals, affording both in vitro and in vivo models of disease. Here we review recent lead discovery efforts for CJD, with a focus on our own efforts to optimize 2-aminothiazole analogues for anti-prion potency in cells and for brain exposure in mice. The compounds that emerged from this effort were found to be efficacious in multiple animal models of prion disease even as they revealed new challenges for the field, including the emergence of resistant prion strains.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Prion diseases are a group of fatal neurodegenerative disorders characterized by neuronal loss, vacuolation, and the accumulation of amyloid protein aggregates in the central nervous system.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> They include Creutzfeldt–Jakob disease (CJD) in humans, scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, and chronic wasting disease (CWD) in cervids. In humans, prion diseases such as CJD result in widespread neurological abnormalities including dementia and ataxia.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The symptomatic phase of the disease, characterized by rapidly progressive neurodegeneration, typically occurs after a long latent incubation period.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The initiation and progression of disease are thought to occur through the conformational conversion of an endogenous membrane-bound protein, PrP<sup>C</sup>, to an aggregated conformation termed PrP<sup>Sc</sup>.<a onclick="showRef(event, 'ref1 ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref7">(1, 2, 7)</a> Endogenous PrP<sup>C</sup> is localized to the plasma membrane via an glycophosphatidylinositol anchor in the unstructured N-terminal domain (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A). The structure of human PrP<sup>C</sup> has been determined by NMR,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and X-ray structures of antibody-bound mouse PrP<sup>C</sup> have appeared recently.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Pathogenic PrP<sup>Sc</sup> on the other hand forms a fibrillar aggregate (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) that has so far thwarted attempts to determine atomic-resolution structures. However, solid-state NMR has revealed the β solenoid structure of the Het-S prion from the filamentous fungus <i>Podospora anserine</i>, and this fold provides one possible model for PrP<sup>Sc</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Once formed, PrP<sup>Sc</sup> can template its own formation in a chain reaction that utilizes the cellular pool of PrP<sup>C</sup> as substrate (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C). PrP<sup>C</sup> appears to be a nonessential protein, and although some neuroprotective functions have been ascribed to it, the deletion of PrP<sup>C</sup> does not cause any gross developmental and behavioral phenotypes in mice, goats, or cattle.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Thus, CJD and other prion disorders are thought to be gain-of-function diseases. Although the accumulation of PrP<sup>Sc</sup> in the central nervous system is believed to be the basis of neurodegeneration, the exact cellular mechanisms of its toxicity are poorly understood.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of prion propagation and potential points of therapeutic intervention. (A) The NMR structure of the folded domain of human PrP<sup>C</sup> is shown. (B) PrP<sup>Sc</sup> forms fibrillar aggregates as shown in the electron micrograph (bar indicates 1000 Å). The β solenoid structure of the fungal Het-S prion provides one possible model of the pathogenic fold. (C) A simplified model for the propagation of PrP<sup>Sc</sup> suggests several potential sites for therapeutic intervention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The self-replicating nature of PrP<sup>Sc</sup> accounts for its ability to be horizontally transmitted in the infectious forms of the disease. Given the potential public health implications of transmissible latent prions in the food and blood supply, there is significant interest in the development of effective drugs for prion diseases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, there are presently no effective therapeutics available. A number of approved drugs have been found to have anti-prion effects in cell culture experiments, and this has spurred efforts to repurpose these agents to treat CJD patients. Hence, the approved drugs flupirtine maleate,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> quinacrine,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and doxycycline<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) have been studied in placebo-controlled human clinical trials for CJD. Unfortunately, none of these trials could establish any improvement in survival compared to placebo, highlighting the need to develop new molecules designed specifically to treat CJD.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Approved drugs studied in human clinical trials for CJD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Historically, drug discovery efforts against prion diseases have been facilitated by the availability of robust cellular models that take advantage of the infectious nature of prion aggregates.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Exposure of cultured cells to prion-containing extracts results in intracellular accumulation of PrP<sup>Sc</sup>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These cells persistently maintain high levels of infectious prions upon subpassage (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Prion levels in infected cells can be readily quantified by fairly simple immunoassays. These assays commonly exploit the differential susceptibility of PrP<sup>C</sup> and PrP<sup>Sc</sup> to proteolysis. In a typical assay, cell lysates are treated with proteinase K to degrade PrP<sup>C</sup> and the remaining PrP<sup>Sc</sup> is quantified with anti-PrP antibodies (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). By comparing PrP<sup>Sc</sup> levels between treated and untreated cells, compounds that reduce prion load can be readily identified. These relatively convenient cell-based assays have been used extensively for identification of anti-prion compounds. However, it should be noted that protease-sensitive forms of PrP<sup>Sc</sup> have been described<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and the presence of these forms may be overlooked by protease-based assays.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell-based assay for identification of anti-prion compounds. (A) Neuroblastoma cell lines are exposed to PrP<sup>Sc</sup> to initiate the infection process. Once infected, cells continuously transmit PrP<sup>Sc</sup> to daughter cells upon passage. (B) Infected cells are exposed to test compounds at various concentrations and time durations. The effect of a compound on PrP<sup>Sc</sup> levels is quantified by treating cell lysates with proteinase K and quantifying the level of remaining PrP<sup>Sc</sup> by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Once a compound with anti-prion activity has been identified and optimized, its in vivo efficacy can be evaluated in mouse models of disease.<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a> Inoculation of mice with prion isolates results in neurologic disease and recapitulates typical symptoms and histopathologies associated with the specific prion strain. Prion infected mice have well-defined and predictable incubation periods that can range from several weeks to several months, depending on the prion strain. Thus, monitoring survival times of prion-infected mice in the presence or absence of a lead compound provides a convenient, if time-consuming, approach for evaluating drug efficacy in vivo. Alternatively, recent studies have indirectly measured neurological damage as an indicator of disease progression and treatment effectiveness. In these models, up-regulation of glial fibrillary acidic protein (GFAP), a widely used marker of neuronal damage, is detected in Tg(<i>Gfap</i>-luc) mice using bioluminescent imaging (BLI).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Importantly, this new BLI model can provide an indication of compound efficacy weeks before clinical symptoms of disease emerge.</div><div class="NLM_p">It is important to note that the above assays are inherently phenotypic in nature and do not provide information about the pathways or molecular targets that might be involved in anti-prion action of small molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C). A wide variety of possible molecular mechanisms can be envisioned for small molecule anti-prion agents. Thus, an anti-prion therapeutic might exert effects on disease via (1) influencing the expression or degradation of PrP<sup>C</sup>, (2) inhibiting the interaction of PrP<sup>C</sup> with PrP<sup>Sc</sup>, (3) inhibiting the conversion of PrP<sup>C</sup> to PrP<sup>Sc</sup> via binding to PrP<sup>C</sup> and/or to cellular factors involved in misfolding, (4) capping or promoting fragmentation of the growing PrP<sup>Sc</sup> fiber, (5) directly interacting with PrP<sup>Sc</sup> aggregates leading to their degradation, or (6) modulating other cellular pathways such as those involved in the clearance of misfolded protein.</div><div class="NLM_p">By 2010, a number of research groups had utilized cell-based assays to identify a striking variety of compounds with apparent anti-prion effects (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). These included the symmetrical biphenylmethylene <b>1</b> (GN8),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> phenothiazine antipsychotics, statins, tetracycline antibiotics, diaryl oxazoles and thiazoles (<b>2</b>), indole-3-glyoxylamides (<b>3</b>), and polyanionic or cationic dendrimers, among many other chemotypes described in recent comprehensive reviews.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> In an effort to explore anti-prion mechanisms, Kuwata and co-workers studied the binding of several distinct classes of anti-prion compounds to recombinant PrP<sup>C</sup> using SPR and NMR.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The anti-prion compounds studied were classified by the nature of their interaction with PrP<sup>C</sup> as (1) stoichiometric binders or “medical chaperones”, (2) nonspecific, superstoichiometric binders, (3) compounds that cause aggregation/precipitation of PrP<sup>C</sup>, or (4) noninteracting compounds that likely have a different target. One caveat with this important work is that the binding studies were conducted with a PrP<sup>C</sup> construct (PrP121–231) lacking N-terminal residues that have since been found to be important for the interaction of the tricyclic antipsychotic promazine with a cryptic small molecule binding site on PrP<sup>C</sup>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This recent finding that promazine binding induces the organization of otherwise unstructured N-terminal residues in PrP<sup>C</sup> must be taken into account when designing protein constructs for future biophysical studies of small molecule binding to PrP<sup>C</sup>.</div><div class="NLM_p">Despite considerable success in identifying new chemotypes, relatively few compounds have been evaluated in animal models, and those that have performed poorly. Quinacrine for example fails to significantly prolong survival in mice despite initial favorable effects on prion load in vivo. This failure has been attributed to a combination of low brain exposure due to P-glycoprotein (P-gp) mediated drug efflux and to the formation of quinacrine-resistant prion strains.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The antibiotics tetracycline and doxycycline were shown to extend survival in Syrian hamsters; however, in these studies drug was co-incubated with the infectious brain homogenate prior to the inoculation of animals.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The relevance of this study design to true therapeutic intervention is unclear, and the ultimate failure of doxycycline in human trials<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> casts further doubt on the experimental model. In another study, mice treated subcutaneously with analogue <b>1</b> lived ∼20 days longer than untreated controls, amounting to a ∼12% extension of survival.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Among in vivo efficacy studies published prior to 2013, the arylhydrazone <b>4</b> (compound <b>B</b>) is the only agent that produced a ≥50% extension of survival in treated animals compared to controls.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Notably, the year 2013 saw the disclosure of several new small molecules reported to exhibit promising effects in prion animal models. Among these was the compound <b>5</b> (GSK2606414),<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> an inhibitor of the kinase PERK, a key mediator of one branch of the unfolded protein response (UPR). The UPR is initiated in response to the accumulation of misfolded protein and PERK functions both to detect misfolded protein in the ER and to phosphorylate the translation initiation factor eIF2α, leading to repression of translation. In the context of neurodegenerative disease, repression of translation may contribute to a loss of synaptic function and neuronal death. Previously, genetic manipulation of the PERK pathway had been shown to be neuroprotective in mice, and in the more recent study similar effects were observed in mice treated with <b>5</b>.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> While the effects of <b>5</b> on survival were not examined in this work, modulation of the PERK pathway appears to merit further investigation, as this approach could conceivably be effective in multiple misfolding diseases.</div><div class="NLM_p">The other notable anti-prion small molecules disclosed in 2013 include the diarylpyrazole <b>6</b> (anle138b)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the 2-aminothiazole analogues <b>7</b> (IND24) and <b>8</b> (IND81).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> These compounds were identified in phenotypic assays of the variety described above, and optimized analogues were subsequently found to extend the survival of infected mice ∼2-fold (∼100%) compared to untreated controls. The molecular targets of these agents remain to be identified. In this review, we will detail the discovery, optimization, and in vivo evaluation of the 2-aminothiazole chemotype represented by compounds <b>7</b> and <b>8</b>. This work involved the efforts of a multidisciplinary team of scientists from multiple laboratories at University of California, San Francisco, the contributions of which are explicitly acknowledged here and in the primary references cited herein.</div><figure id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0008.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Small Molecules with Anti-Prion Activity<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compound <b>1</b> and <b>4</b>–<b>8</b> have demonstrated efficacy in animal models of prion disease.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Screening and Hit Profiling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Most anti-prion compounds have been discovered by ad hoc screening of small collections of known bioactive compounds. In fact, the only moderate-throughput cell-based screening effort published prior to 2010 was a screen of 2000 compounds utilizing a dot blot assay.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> This screen identified 17 anti-prion compounds that included naturally occurring polyphenols, phenothiazines, antihistamines, statins, and antimalarial compounds including quinacrine. Another screen of 10 000 compounds involved a cell-free assay to identify compounds that interfered with the interaction of PrP<sup>C</sup> and PrP<sup>Sc</sup>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> A number of these compounds were shown to be active in cell culture. However, the activity of the hits identified in these two screens was not recapitulated in vivo.</div><div class="NLM_p">In 2010, the Prusiner group sought to extend these studies by initiating a larger cell-based screen of 10 000 diverse leadlike compounds utilizing an ELISA-based assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In this screen, N2a cells infected with scrapie prions (ScN2a) were incubated with 5 μM test compound for 5 days (quinacrine was used as a positive control). Following proteolysis of cell lysates, the resulting change in protease-resistant prion levels was quantified by sandwich ELISA. Importantly, the cytotoxic effects of each compound were also analyzed in a parallel screen. Although the 96-well format prion assay was inherently heterogeneous in nature (drug incubation and signal readout were conducted in different plates), the screen was shown to have a high level of quantitative precision, reproducibility, and signal linearity.</div><div class="NLM_p">The ELISA screen identified 121 compounds that reduced PrP<sup>Sc</sup> levels by >50% at 5 μM without significant cellular toxicity (1.2% hit rate). The hit set was evaluated for nascent SAR and synthetic tractability. Four structural scaffolds were selected for follow-up studies, including quinazolines, 8-hydroxyquinolines, 2-arylbenzoxazoles, and 2-aminothiazoles.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The first three scaffolds were eventually deprioritized for reasons ranging from chemical instability to inscrutable SAR. This left the 2-aminothiazole series (henceforth denoted AMT), which demonstrated tractable SAR and was amenable to parallel synthesis using the classical Hantzsch thiazole synthesis. Of potential concern was that the parent 2-amino-4-arylthiazole ring system is known to be subject to P450-mediated oxidation leading to the production of electrophilic metabolites.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> We judged this risk was somewhat mitigated in our leads, which possessed electron-withdrawing heteroaryl substitution on the 2-amino function and thus would be less prone to oxidation. Although the potential oxidative liability of AMTs was never explicitly investigated, we found empirically that 2-pyridyl AMTs like <b>7</b> and <b>8</b> were generally well tolerated in mice over the long courses of therapy employed in the mouse infection models (see below).</div><div class="NLM_p">The early AMT analogues were further profiled in orthogonal assays. Thus, using an assay that exploits the propensity of PrP<sup>Sc</sup> to precipitate in the presence of phosphotungstic acid,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we demonstrated that early AMTs were able to clear both protease-sensitive and protease-resistant forms of PrP<sup>Sc</sup> aggregates. We also found that the compounds did not disaggregate PrP<sup>Sc</sup> in cell-free assays, nor did they alter the expression level of endogenous PrP<sup>C</sup>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This suggested that AMTs might act by interfering with the formation of new PrP<sup>Sc</sup> in the cell, either directly by interference in the misfolding/assembly process or indirectly by modulating endogenous cellular clearance mechanisms. A review of the literature raised other mechanistic hypotheses. For example, the 2-arylaminothiazole ring system is found in a number of pharmacological agents, including kinase inhibitors (e.g., dasatanib, VEGFR inhibitor <b>9</b>),<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> and in adenosine A<sub>1</sub> receptor antagonists (e.g., <b>10</b>).<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> However, as the SAR of anti-prion AMTs became better defined, action at kinases or adenosine receptors appeared increasingly unlikely. For example, AMTs bearing benzamide substituents as in compound <b>10</b> lacked anti-prion effect. Similarly, modification of the putative hinge-binding motif to ablate kinase inhibition did not diminish anti-prion activity.</div><div class="NLM_p">During the course of SAR studies, AMT analogues more closely related to our leads appeared in the literature (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), including compounds reported to induce autophagy (e.g., <b>11</b>)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and modulate γ-secretase activity (<b>12</b>).<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> Despite close structural resemblance, anti-prion AMTs do not appear to induce autophagy (S. Ghaemmaghami, unpublished data) nor do they inhibit γ-secretase activity (S. L. Wagner, personal communication). The molecular target(s) and mechanism of action of AMTs thus remain under active investigation. The recent finding<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> that flexible, unstructured regions of PrP<sup>C</sup> contribute to forming a cryptic small molecule binding site has encouraged further study of direct interactions between AMTs and PrP<sup>C</sup>.</div><figure id="cht2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0009.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Pharmacologic Agents Bearing the 2-Aminothiazole Ring System</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Structure–Activity Trends</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our structure–activity studies of the AMT chemotype have been described elsewhere<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> and are summarized briefly here (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). One confounding issue in our early SAR studies was the nonlinear dependence of EC<sub>50</sub> values on PrP<sup>C</sup> expression levels in different N2a cell lines. Thus, early SAR work using the original ScN2a assay led quickly to a number of analogues with low nanomolar potency. While encouraging, the high sensitivity of this assay to AMTs made it challenging to discern clear SAR trends. Concurrent with the early chemistry effort, the Prusiner lab had developed additional N2a cell lines for screening purposes, including the so-called “clone-3” cell line that overexpresses PrP<sup>C</sup>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Interestingly, we found that AMT analogues were generally much less potent (10- to 100-fold higher EC<sub>50</sub> values) when the clone-3 line was employed in the ScN2a assay. This effect was not limited to AMTs but was true of other anti-prion classes as well, including hydrazone <b>4</b>. Further improvements to the ELISA assay using the clone-3 cell line resulted in a very robust assay with good dynamic range and excellent precision.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The “ScN2a-cl3” assay thus supplanted the earlier assay and allowed for more subtle SAR trends to be discerned, at the cost of less impressive EC<sub>50</sub> values.</div><div class="NLM_p">Anti-prion AMTs comprise an 2-aminothiazole “B-ring” substituted on the 2-amino function with a small acyl “C-group” or aryl “C-ring” and at C-4 of the aminothiazole ring with an aryl or heteroaryl “A-ring” (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Replacement of the aminothiazole ring with other heterocycles was examined briefly but with unsatisfactory results. With regard to the C-ring, we found that only small acyl C-groups (e.g., acetamide, cyclopropylamide) were tolerated, while a wider variety of C-rings could be employed, pyridine and quinoline being favored. The 2-amino function could be further alkylated or acylated, indicating that a hydrogen-bond donor was not required at this position. With regard to the A-ring, both five- and six-membered heteroaryl rings were tolerated, and these could be appended to a second aromatic or aliphatic “A′-ring”. The dihedral angle of the A- to B-ring connection proved to be important, with coplanar (including fused) A/B-ring analogues generally active, while those with enforced orthogonal A/B-rings lacked the anti-prion effect.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">Given the coplanar and highly conjugated pharmacophore, it was unsurprising that poor aqueous solubility became an issue when formulating AMTs for oral dosing. This issue was addressed to some degree by the introduction of heteroaliphatic A′-rings (morpholine, piperazine) or by the introduction of ortho substituents in the A′-ring to enforce orthogonal disposition of the A′ and A-ring. Unlike with the A/B-ring connection, staggered A′-ring/A-ring dihedrals were accommodated without significant loss of anti-prion activity. Although notable improvements were made in terms of potency and druglike properties, the majority of efficacy studies performed to date have involved the relatively early analogues <b>7</b> and <b>8</b>, for which suitable oral formulations were eventually developed.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of anti-prion SAR for aminothiazole analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Structure–Brain Exposure Trends</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The team recognized early on that new anti-prion chemotypes should be evaluated as soon as feasible for brain exposure in animals. Indeed, the fact that many early AMT analogues exhibited good brain exposure in mice encouraged further work on the series. To maximize the number of AMTs that could be evaluated, pharmacokinetic studies were focused on determining brain exposure (AUC) in mice on oral dosing. It was expected that the most promising compounds would later be evaluated in full PK studies with both iv and po dosing to derive additional PK parameters. Bioanalysis was performed on whole brain homogenate, and the bound and unbound fractions were estimated later for select analogues using in vitro brain tissue binding assays.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> By use of this approach, the fraction unbound in mouse brain tissue was estimated at ∼8–9% for compounds <b>7</b> and <b>8</b>.</div><div class="NLM_p"> Among the first ∼100 AMT analogues synthesized, nearly a quarter were evaluated in PK studies. We selected analogues that covered a breadth of A- and C-ring chemotypes, intentionally including analogues with only modest potency in the ScN2a-cl3 assay. The goal was to derive structure–brain exposure relationships, and it was understood that these relationships would be unrelated to in vitro anti-prion SAR. In fact the first 27 AMTs evaluated exhibited brain exposure (AUC) values distributed over 4 orders of magnitude. While the presence of more than one hydrogen bond donor was associated with poor brain exposure, we unfortunately could not derive correlations with other properties such as molecular weight or polar surface area (PSA). It should be noted, however, that most of the compounds in this set already fall within recommended<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> PSA and MW ranges for brain-penetrant small molecules. Also, it is clear that the brain exposure values obtained vary as a result of differences in oral absorption, clearance, and metabolism, as well as from intrinsic differences in brain penetrance. Nevertheless, by prioritizing PK studies early in the discovery process, we identified a number of promising analogues.</div><div class="NLM_p">Some of the more promising AMT analogues from the first round of PK studies are presented above (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>). Of three quinoline C-ring analogues (<b>13</b>, <b>14</b>, and <b>15</b>) with submicromolar potency, analogue <b>13</b> bearing a pyridyl A-ring exhibited the highest brain AUC value. Also apparent is that seemingly small structural changes can have significant effects on brain exposure. Thus, in the case of regioisomeric analogues <b>16</b>/<b>17</b> and <b>8</b>/<b>19</b>, the 4-methyl congeners exhibited significantly higher brain exposure in vivo than the 5-methyl comparators. Other compounds exhibiting high brain exposure included the benzofuran <b>18</b>, phenylisoxazole <b>20</b>, and especially the biphenyl A-ring analogue <b>7</b>, which exhibited the highest brain AUC among the initial 27 AMTs evaluated. The ratio of brain AUC/EC<sub>50</sub> was used as a criterion for advancement into additional in vivo PK studies, and by this measure compounds <b>7</b>, <b>8</b>, <b>13</b>, <b>15</b>, <b>18</b>, and <b>20</b> merited further evaluation.</div><figure id="cht3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0010.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Select Early AMT Analogues Evaluated for Brain Exposure in Mice<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The EC<sub>50</sub> values shown are for the ScN2a-cl3 assay, while brain AUC values reflect analysis of total brain homogenate following a single oral dose of 40 mg/kg in mice.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></p></figure><div class="NLM_p">Animal models of prion disease typically require 100–200 days to evaluate efficacy, depending on the incubation time of the prion strain employed. Previous studies with quinacrine had established that the test article could be conveniently administered daily as part of a liquid rodent diet.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We used this formulation to evaluate AMT analogues <b>7</b>, <b>8</b>, <b>13</b>, <b>15</b>, <b>18</b>, and <b>20</b> in dose escalation studies. Mice received test article in their feed at approximate doses of 40, 80, 130, or 210 mg kg<sup>–1</sup> day<sup>–1</sup> for 3 days (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Plasma and brain samples were collected at the end of the last dosing cycle and analyzed as in the single-dose PK studies. Since only a single time point was evaluated in these dosing studies, the resulting concentrations must be regarded as pseudo-steady-state concentrations. Compounds <b>7</b> and <b>8</b> emerged from these studies as the most suitable for efficacy trials, both compounds achieving pseudo-steady-state brain concentrations in the micromolar range at the 40 mg kg<sup>–1</sup> day<sup>–1</sup> dose and showing linear exposure with escalating dose.</div><div class="NLM_p">Among other analogues, compounds <b>20</b> and <b>18</b> exhibited nonlinear exposure profiles while compounds <b>13</b> and <b>15</b> exhibited surprisingly poor exposure when dosed in the liquid diet. In general AMT analogues exhibited higher exposure in brain than in plasma, suggesting that the class is not subject to P-gp mediated efflux. Assuming a free fraction of ∼8%, compounds <b>7</b> and <b>8</b> were thus predicted to achieve free, steady-state concentrations in excess of their EC<sub>50</sub> values at doses of 80 mg kg<sup>–1</sup> day<sup>–1</sup> and higher (for <b>7</b>) or 130 mg kg<sup>–1</sup> day<sup>–1</sup> and higher (for <b>8</b>). Even at the highest dose of 210 mg kg<sup>–1</sup> day<sup>–1</sup>, mice receiving <b>7</b> or <b>8</b> exhibited no adverse clinical or behavioral effects, suggesting that the compounds would be well tolerated on prolonged dosing in an animal model of prion disease. Accordingly, compounds <b>7</b> and <b>8</b> became the focus of further PK and efficacy studies, as described below.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pseudo Steady-State Brain Concentrations of Selected AMTs after 3-Day Dosing in a Liquid Rodent Diet at Various Daily Doses<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a><sup>,</sup><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">brain concentration (μM) after 3 days at the indicated dose</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">40 mg kg<sup>–1</sup> day<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">80 mg kg<sup>–1</sup> day<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">130 mg kg<sup>–1</sup> day<sup>–1</sup></th><th class="colsep0 rowsep0" align="center">210 mg kg<sup>–1</sup> day<sup>–1</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">8.70 ± 1.46</td><td class="colsep0 rowsep0" align="left">19.3 ± 2.28</td><td class="colsep0 rowsep0" align="left">31.8 ± 5.46</td><td class="colsep0 rowsep0" align="left">37.4 ± 9.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">3.00 ± 0.52</td><td class="colsep0 rowsep0" align="left">7.45 ± 1.00</td><td class="colsep0 rowsep0" align="left">13.0 ± 2.81</td><td class="colsep0 rowsep0" align="left">19.3 ± 3.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.02 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.08 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.04 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.10 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">0.03 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.06 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">1.31 ± 0.39</td><td class="colsep0 rowsep0" align="left">2.70 ± 0.52</td><td class="colsep0 rowsep0" align="left">3.74 ± 0.41</td><td class="colsep0 rowsep0" align="left">3.23 ± 2.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">0.88 ± 0.68</td><td class="colsep0 rowsep0" align="left">5.39 ± 2.93</td><td class="colsep0 rowsep0" align="left">23.3 ± 13.2</td><td class="colsep0 rowsep0" align="left">12.6 ± 8.62</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Drug concentrations are for total brain homogenate.</p></div></div></div><div class="NLM_p">Having identified <b>7</b> and <b>8</b> as candidates for study in animal models of disease, we sought to determine their full PK profile compared to that of hydrazone <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The three compounds were evaluated head-to-head with iv and po dosing in female FVB mice. In nearly every respect, <b>7</b> appeared to be the superior compound. Compared to <b>4</b>, compound <b>7</b> achieved nearly 30-fold higher brain exposure following oral dosing and also exhibited a much longer half-life, lower clearance, a superior brain/plasma ratio, and greater bioavailability. Compound <b>8</b> was also superior to <b>4</b> in most respects and exhibited the highest volume of distribution of the three compounds. Although full toxicology studies were not conducted for any AMT analogues, we observed over the course of dozens of efficacy studies that compounds <b>7</b> and <b>8</b> produced no overt signs of toxicity in mice, even on prolonged dosing over many weeks at doses of 210 mg kg<sup>–1</sup> day<sup>–1</sup>. In contrast we found that hydrazone <b>4</b> exhibited lethal toxicity at a dose of 150 mg kg<sup>–1</sup> day<sup>–1</sup> and could only be employed in efficacy trials at doses of ≤110 mg kg<sup>–1</sup> day<sup>–1</sup>.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters for AMT Analogues and Compound <b>B</b> after a Single Dose of 1 mg/kg (iv) or 10 mg/kg (po)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">route/matrix<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">CL (L h<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">AUC (μM·h)<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><i>B</i>/<i>P</i> <a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)<a class="ref internalNav" href="#t2fn8" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">iv/pl</td><td class="colsep0 rowsep0" align="left">2.46</td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">2.16</td><td class="colsep0 rowsep0" align="left">2.49 ± 2.65</td><td class="colsep0 rowsep0" align="left">2.78 ± 1.09</td><td class="colsep0 rowsep0" align="left">2.60</td><td class="colsep0 rowsep0" align="left">40.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/pl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.65</td><td class="colsep0 rowsep0" align="left">1.66 ± 0.11</td><td class="colsep0 rowsep0" align="left">11.2 ± 1.31</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/br</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">2.45 ± 0.74</td><td class="colsep0 rowsep0" align="left">29.1 ± 1.24</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">iv/pl</td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">9.05</td><td class="colsep0 rowsep0" align="left">1.18</td><td class="colsep0 rowsep0" align="left">0.52 ± 0.28</td><td class="colsep0 rowsep0" align="left">0.30 ± 0.04</td><td class="colsep0 rowsep0" align="left">5.53</td><td class="colsep0 rowsep0" align="left">27.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/pl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.98</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.82 ± 0.39</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/br</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1.62 ± 0.54</td><td class="colsep0 rowsep0" align="left">4.54 ± 2.28</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">iv/pl</td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="left">4.56</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">1.76 ± 0.14</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">24.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/pl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.01</td><td class="colsep0 rowsep0" align="left">0.83 ± 0.38</td><td class="colsep0 rowsep0" align="left">2.06 ± 0.06</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">po/br</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">0.46 ± 0.16</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Route of administration and matrix analyzed (brain, br; plasma, pl).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Clearance.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Half-life.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Maximal concentration.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Brain exposure expressed as area under the drug concentration–time curve.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Brain/plasma AUC ratio.</p></div><div class="footnote" id="t2fn8"><sup>h</sup><p class="last">Bioavailability.</p></div></div></div><div class="NLM_p">Even as compound <b>7</b> became the focus of extensive in vivo evaluation (see below), further optimization of this promising lead continued.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Interestingly, we found that replacement of the terminal phenyl ring in <b>7</b> with heteroaromatic or heteroaliphatic rings produced analogues with clearly superior potency in the ScN2a-cl3 assay (Chart <a class="ref internalNav" href="#cht4" aria-label="4">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Thus, pyridyl (<b>21</b> and <b>22</b>), pyrazole (<b>24</b>), and morpholine (<b>26</b>) A′ ring congeners of <b>7</b> all exhibited EC<sub>50</sub> values below 100 nM, a greater than 10-fold improvement in potency compared to <b>7</b>. Compound <b>21</b> also exhibited excellent brain exposure in animals (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), yielding a greater than 20-fold improvement in brain AUC/EC<sub>50</sub> ratio for <b>21</b> compared to <b>7</b>. An attempted bioisosteric replacement of the aminothiazole ring in <b>21</b> with pyrazolylmethyl (analogue <b>23</b>) unfortunately led to an utter loss of anti-prion activity. Whether this effect is due to the pyrazole ring, the sp<sup>3</sup> linkage between B-ring and C-ring, or some combination of the two is unclear. More promising results were had with a series of cyclopropylamide C-group analogues, including compound <b>25</b>, the direct analogue of <b>7</b>. Analogue <b>25</b> exhibited potency and in vivo brain exposure superior to <b>7</b>, with a brain AUC/EC<sub>50</sub> ratio 10-fold higher than for <b>7</b>. The new generation of AMT analogues exemplified by <b>21</b> and <b>25</b> are only now being evaluated in animal efficacy models.</div><figure id="cht4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0011.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 4. Anti-Prion Activities (ScN2a-cl3 Assay) for Structural Analogues of <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Additional PK data for some of these analogues is provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Anti-Prion Activity and Select PK Parameters for AMT Analogues Related to <b>7</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">ScN2a-cl3 EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">brain <i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center">brain AUC (μM·h)</th><th class="colsep0 rowsep0" align="center">plasma AUC (μM·h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">1.29 ± 0.12</td><td class="colsep0 rowsep0" align="left">2.45 ± 0.74</td><td class="colsep0 rowsep0" align="left">9.78 ± 2.07</td><td class="colsep0 rowsep0" align="left">6.99 ± 0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">0.068 ± 0.013</td><td class="colsep0 rowsep0" align="left">2.46 ± 0.85</td><td class="colsep0 rowsep0" align="left">10.90 ± 1.75</td><td class="colsep0 rowsep0" align="left">15.60 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">0.087 ± 0.043</td><td class="colsep0 rowsep0" align="left">0.50 ± 0.005</td><td class="colsep0 rowsep0" align="left">1.68 ± 0.10</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">0.248 ± 0.067</td><td class="colsep0 rowsep0" align="left">4.34 ± 0.53</td><td class="colsep0 rowsep0" align="left">18.60 ± 3.75</td><td class="colsep0 rowsep0" align="left">12.70 ± 1.11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">The PK study involved a single oral dose of 10 mg/kg.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Efficacy in Animal Models</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The effects of compounds <b>7</b> and <b>8</b> in prion infected mice have been extensively studied, as recently reported.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Oral administration of either compound is found to significantly extend the survival of mice infected with various prion strains (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). For example, mice infected with the Rocky Mountain Laboratories (RML) scrapie strain and treated with <b>7</b> at 210 mg kg<sup>–1</sup> day<sup>–1</sup> survived for 204 ± 5 days, compared to 118 ± 1 days for vehicle-treated controls. Similarly, treatment with compound <b>7</b> under the same protocol extended survival from 126 ± 2 days to 214 ± 4 days in mice inoculated with the ME7 scrapie strain. In a chronic wasting disease (CWD) model involving transgenic mice expressing elk PrP<sup>C</sup>, compound <b>7</b> extended survival from 108 ± 3 days to 237 ± 0 days. When treatment with <b>7</b> was initiated 60 days postinoculation (rather than 1 dpi), significant lifespan extension was still observed in mice inoculated with RML or ME7 strains (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This finding is significant given that BLI imaging of these mice reveals that brain disease is already progressing by day 60. However, despite significant and reproducible extension of lifespan in scrapie and CWD animal models, AMT-treated mice eventually showed accumulation of PrP<sup>Sc</sup> in their brains and ultimately succumbed to disease. Most disappointingly, compound <b>7</b> proved to be entirely ineffective against human CJD prions in susceptible transgenic mice expressing human PrP<sup>C</sup>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kaplan–Meier survival curves for mice infected with ME7 (top) and RML prions (bottom) . The vehicle-treated cohort is shown as a solid black line. Treated cohorts received compound <b>7</b> from day 1 postinoculation (solid gray line) or from day 60 postinoculation (dashed gray line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The animal studies summarized above clearly demonstrate that the in vivo efficacy of AMTs is dependent on the specific prion strain employed and that even infections involving susceptible prion strains cannot be fully cured with the compounds. In a number of elegant experiments, the Prusiner lab demonstrated that the eventual failure of AMTs can be accounted for by treatment-induced selection of AMT-resistant prion strains.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> For example, prions isolated from the brains of terminal AMT-treated mice were resistant to AMTs, both in cell culture and in vivo. This result also helped to explain the initially surprising finding that a dose of 50 mg kg<sup>–1</sup> day<sup>–1</sup> of compound <b>7</b> provided comparable benefit as the higher dose of 210 mg kg<sup>–1</sup> day<sup>–1</sup> (K. Giles, manuscript in preparation). Efficacy is limited in both cases by the emergence of resistant prion strains, so greater drug concentrations at the higher dose provided no additional benefit.</div><div class="NLM_p">Another intriguing finding is that selective drug pressure must be continuously maintained in vivo in order to preserve the AMT-resistant strain. Thus, passage of AMT-resistant prions in naive, untreated mice returned prions that were once again susceptible to AMTs. This result may suggest that AMT treatment leads to the selection and proliferation of a resistant prion strain that is otherwise uncompetitive with AMT-sensitive strains. The ability of AMTs to induce the formation of drug resistant strains is reminiscent of similar effects observed with quinacrine and swainsonine.<a onclick="showRef(event, 'ref29 ref53'); return false;" href="javascript:void(0);" class="ref ref29 ref53">(29, 53)</a> Although quinacrine does not extend survival in animal models of disease, it does rapidly select for quinacrine resistant prions in vivo.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In cell culture experiments, swainsonine exposure leads to selection for resistant prion strains as well. The passage of these resistant prions in untreated mice produces prions that are once again susceptible to the compound. Thus, it appears that drug resistance may be a general confounding issue for anti-prion therapeutics as it is in other therapeutic areas. What is remarkable about this particular form of drug resistance is that it apparently results from “conformational mutagenesis” of PrP<sup>Sc</sup> rather than from mutations in the nucleic acid sequence of a gene.</div><div class="NLM_p">The fascinating relationship between PrP<sup>Sc</sup> conformational strains, prion species barriers, and drug resistance has been reviewed recently.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The consensus that is emerging from various studies is that strain adaptation results from the interplay between two related phenomena: (1) conformational transformation of a replicating prion to create a heterogeneous pool of novel conformations (mutation) and (2) enrichment of conformations with high proliferative capacity within this pool (selection). This “conformational drift” continuously produces pools of structurally distinct self-replicating prions that can be acted upon by natural selection. Thus, strains that are resistant to drugs can be spontaneously generated and selected upon continuous drug treatment.</div><div class="NLM_p">While the native fold of PrP<sup>C</sup> appears to be a rather poor target for small molecules, the conformational mutation of replicating prions described above may well involve the transient formation of cryptic small molecule binding sites, and these sites may well differ between strains. The first clear evidence in support of this hypothesis comes from the recently published X-ray structure of promazine bound to PrP<sup>C</sup>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Remarkably, the binding site revealed in this structure is formed in part from N-terminal residues that are unstructured in all existing X-ray and NMR structures of PrP<sup>C</sup>. Thus, promazine binding induces the formation of a new antiparallel β-strand and two tandem β-turns in the normally unstructured region PrP(117–124). The authors further demonstrate that promazine binding allosterically stabilizes more distal regions of the protein via the formation of new cation−π and hydrogen bonding interactions in the β2−α2 loop and enhanced hydrophobic interactions at the interface of the α2−α3 helices, among other changes. One can therefore propose a plausible hypothesis of small-molecule anti-prion action that involves binding to and stabilizing specific PrP<sup>C</sup> conformations. In this scenario, strain specific action can be readily understood by positing alternative misfolding pathways that avoid the conformation(s) trapped by specific therapeutic compounds.</div><div class="NLM_p">Drug discovery and development for a rare and as yet poorly understood disease like CJD are highly challenging. The studies of anti-prion AMTs described herein provide a number of valuable lessons for future discovery efforts targeting these diseases. First, it is clear that the anti-prion effects of small molecule leads can be strain-specific. Thus, compounds identified in phenotypic screens utilizing prion strains from non-human organisms (such as RML) may have limited efficacy against CJD in humans. This fact highlights the urgent need for CJD-infected cell models (as yet unknown), as these would presumably be more congruent with prion infection of differentiated neurons in the brain. Second, a more target-oriented drug discovery effort could help circumvent the problem of drug resistance. For example, targeting cellular pathways that are broadly involved in protein quality control may prove to be an effective strategy to find more widely effective compounds. Third, more sophisticated dosing regiments involving cocktails of diverse drugs and/or intermittent dosing may be required to mitigate the issue of drug resistance. Finally, as with any challenging problem in drug discovery, ultimate success will depend on the robust, sustained, and collaborative efforts of a multidisciplinary team of committed clinicians and scientists.</div><div class="NLM_p last">The insights gathered from anti-prion AMT studies not only are relevant to prion medicine but also may have important implications for related neurological conditions. A number of neurodegenerative diseases such as Alzheimer’s disease (AD), amylotrophic lateral schlerosis (ALS), and Parkinson’s disease share many features in common with prion disease.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> These prion-like diseases are associated with seeded aggregation pathways analogous to the misfolding of PrP<sup>C</sup> to PrP<sup>SC</sup>, but they lack the robust infectiousness that has enabled an expanded repertoire of in vivo and in vitro prion disease models. Thus, prions are a highly tractable prototype of protein misfolding disorders and provide an invaluable source of insight into similar diseases. Not only can successes in prion drug discovery offer research leads for these related conditions, but the challenges and lessons learned could have a broad impact as well. For example, accumulating evidence suggests that other prion-like proteins such as tau (associated with Alzheimer’s disease and other taupathies) and α-synuclein (associated with Parkinson’s disease and some forms of Alzheimer’s disease) may occur in distinct forms with different disease phenotypes.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> While it remains to be seen if these different forms behave like prion strains, the emerging similarities pose the question of whether strain specificity and drug resistance will affect treatment discovery for other neurodegenerative diseases as well.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5001425" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam R. Renslo</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Chemistry and The Small Molecule Discovery Center, University of California, San Francisco, Byers Hall 503D, 1700 4th Street, San Francisco, California 94158, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0a6b6e6b6724786f647966654a7f69796c246f6e7f"><span class="__cf_email__" data-cfemail="e485808589ca96818a97888ba491879782ca818091">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sina Ghaemmaghami</span> - <span class="hlFld-Affiliation affiliation">Department
of Biology, University of Rochester, 326 Hutchison Hall, Rochester, New York 14627, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miranda Russo</span> - <span class="hlFld-Affiliation affiliation">Department
of Biology, University of Rochester, 326 Hutchison Hall, Rochester, New York 14627, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81258" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81258" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Sina Ghaemmaghami</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=BIO-d667e1924-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sina Ghaemmaghami</b> is an Assistant Professor of Biology at the University of Rochester, NY. He received his Ph.D. from Duke University, NC, and conducted his postdoctoral studies at the University of California, San Francisco. His laborotary studies the regulation of protein folding and degradation and their role in the pathogenesis of neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Miranda Russo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=BIO-d667e1929-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Miranda Russo</b> is an undergraduate at the University of Rochester, NY, with an interest in prion biology. She is conducting research on the anti-prion mechanism of 2-aminothiazoles.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Adam R. Renslo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=BIO-d667e1934-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Adam R. Renslo</b> is an Associate Professor of Pharmaceutical Chemistry at the University of California, San Francisco. He received his Ph.D. from Massachusetts Institute of Technology, MA, and conducted postdoctoral research at The Scripps Research Institute, CA. He began his career in the pharmaceutical industry where he contributed to the discovery of multiple antibacterial drug candidates from the oxazolidinone class. His laboratory at University of California, San Francisco, applies fragment-based lead discovery to challenging drug targets and is exploring new drug delivery approaches for infectious disease and cancer.</p></figure></div><div class="ack" id="ACK-d667e1939-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge the contributions of a large team of researchers whose sustained efforts produced the results detailed in this review and in the primary publications cited herein. The work reviewed in this manuscript was funded by grants from the National Institutes of Health as well as from several private foundations. Detailed funding information is provided in the primary publications cited herein.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> Abbreviations Used</h2><tr><td class="NLM_term">CJD</td><td class="NLM_def"><p class="first last">Creutzfeldt–Jakob disease</p></td></tr><tr><td class="NLM_term">PERK</td><td class="NLM_def"><p class="first last">protein kinase RNA-like endoplasmic reticulum kinase</p></td></tr><tr><td class="NLM_term">BSE</td><td class="NLM_def"><p class="first last">bovine spongiform encephapathy</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">PrP<sup>C</sup></td><td class="NLM_def"><p class="first last">endogenous prion protein</p></td></tr><tr><td class="NLM_term">PrP<sup>Sc</sup></td><td class="NLM_def"><p class="first last">misfolded scrapie prion protein</p></td></tr><tr><td class="NLM_term">ScN2a</td><td class="NLM_def"><p class="first last">scrapie-infected murine neuroblastoma cell</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">bioluminescent imaging</p></td></tr><tr><td class="NLM_term">GFAP</td><td class="NLM_def"><p class="first last">glial fibrillary acidic protein</p></td></tr><tr><td class="NLM_term">Tg(<i>Gfap</i>-luc)</td><td class="NLM_def"><p class="first last">transgenic mice with the luciferase gene under control of the <i>gfap</i> promoter</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">AMT</td><td class="NLM_def"><p class="first last">2-aminothiazole</p></td></tr><tr><td class="NLM_term">VEGFR</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the plasma (or brain) exposure curve</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">RML</td><td class="NLM_def"><p class="first last">Rocky Mountain Laboratories</p></td></tr><tr><td class="NLM_term">CWD</td><td class="NLM_def"><p class="first last">chronic wasting disease</p></td></tr><tr><td class="NLM_term">dpi</td><td class="NLM_def"><p class="first last">days postinoculation</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Colby, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Prions</span> <span class="citation_source-journal">Cold Spring Harbor Perspect Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=a006833&author=D.+W.+Colbyauthor=S.+B.+Prusiner&title=Prions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColby%26aufirst%3DD.%2BW.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DPrions%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect%2520Biol.%26date%3D2011%26volume%3D3%26spage%3Da006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Novel proteinaceous infectious particles cause scrapie</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscience.6801762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=6801762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADyaL38XhsFyqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=136-144&author=S.+B.+Prusiner&title=Novel+proteinaceous+infectious+particles+cause+scrapie"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Novel proteinaceous infectious particles cause scrapie</span></div><div class="casAuthors">Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">4542</span>),
    <span class="NLM_cas:pages">136-44</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">After injection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats.  Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity.  Although the scrapie agent is irreversibly inactivated by alkali, 5 procedures with more specificity for modifying nucleic acids failed to cause inactivation.  The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a mol. wt. of ≤50,000.  Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term ''prion'' is proposed to denote a small proteinaceous infectious particle which is resistant to inactivation by most procedures that modify nucleic acids.  Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83jJ03vS3LLVg90H21EOLACvtfcHk0ljSB06TKh_Xtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhsFyqtro%253D&md5=a74dbfa1370646d3ea829bf34ceb03c9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.6801762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6801762%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DNovel%2520proteinaceous%2520infectious%2520particles%2520cause%2520scrapie%26jtitle%3DScience%26date%3D1982%26volume%3D216%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Shattuck lecture—neurodegenerative diseases and prions</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1056%2FNEJM200105173442006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11357156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD3M3nt1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1516-1526&author=S.+B.+Prusiner&title=Shattuck+lecture%E2%80%94neurodegenerative+diseases+and+prions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Shattuck lecture--neurodegenerative diseases and prions</span></div><div class="casAuthors">Prusiner S B</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1516-26</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIaL7FnGMqfHWEEzDrymxmfW6udTcc2eZ4Jf-JRCVF_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3nt1enuw%253D%253D&md5=3577f8f00014a9bcaa2cfe4b905525da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200105173442006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200105173442006%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DShattuck%2520lecture%25E2%2580%2594neurodegenerative%2520diseases%2520and%2520prions%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1516%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathala, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajdusek, D. C.</span><span> </span><span class="NLM_article-title">Creutzfeldt–Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1002%2Fana.410200507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=3539001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADyaL2s%252FnsVOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1986&pages=597-602&author=P.+Brownauthor=F.+Cathalaauthor=P.+Castaigneauthor=D.+C.+Gajdusek&title=Creutzfeldt%E2%80%93Jakob+disease%3A+clinical+analysis+of+a+consecutive+series+of+230+neuropathologically+verified+cases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases</span></div><div class="casAuthors">Brown P; Cathala F; Castaigne P; Gajdusek D C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-602</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">In this consecutive series of 230 patients with neuropathologically verified Creutzfeldt-Jakob disease (CJD), the disease was found to affect men and women with approximately equal frequency in a peak plateau between the ages of 55 and 75 years (mean, 61.5 years).  Familial cases accounted for 4 to 8% of the total series.  Nonspecific prodromal symptoms occurred in one third of the patients, and the neurological presentation, although usually a gradually evolving mental deterioration, was of rapid onset in 20% of patients and in 36% of patients consisted exclusively of neurological symptoms.  The great majority of these symptoms were of cerebellar or visual origin.  Extrapyramidal muscular rigidity, myoclonus, and characteristic periodic electroencephalographic (EEG) complexes were observed comparatively late in the illness, and some type of involuntary movement or periodic EEG activity was seen in over 95% of the patients.  The median duration of illness was 4 months (mean, 7.6 months); 90% of patients died within a year of onset.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2hEhUcxLtG2yYR5VtavbzfW6udTcc2eZgC-ogMk13c7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FnsVOnsA%253D%253D&md5=2567643a4adfedc23902a4fb85ec3d46</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fana.410200507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410200507%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DCathala%26aufirst%3DF.%26aulast%3DCastaigne%26aufirst%3DP.%26aulast%3DGajdusek%26aufirst%3DD.%2BC.%26atitle%3DCreutzfeldt%25E2%2580%2593Jakob%2520disease%253A%2520clinical%2520analysis%2520of%2520a%2520consecutive%2520series%2520of%2520230%2520neuropathologically%2520verified%2520cases%26jtitle%3DAnn.%2520Neurol.%26date%3D1986%26volume%3D20%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Roos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajdusek, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, C. J.,  Jr.</span><span> </span><span class="NLM_article-title">The clinical characteristics of transmissible Creutzfeldt–Jakob disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1973&pages=1-20&author=R.+Roosauthor=D.+C.+Gajdusekauthor=C.+J.+Gibbs&title=The+clinical+characteristics+of+transmissible+Creutzfeldt%E2%80%93Jakob+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DR.%26aulast%3DGajdusek%26aufirst%3DD.%2BC.%26aulast%3DGibbs%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520clinical%2520characteristics%2520of%2520transmissible%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%26jtitle%3DBrain%26date%3D1973%26volume%3D96%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Collinge, J.</span><span> </span><span class="NLM_article-title">Prion diseases of humans and animals: their causes and molecular basis</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1146%2Fannurev.neuro.24.1.519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11283320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=519-550&author=J.+Collinge&title=Prion+diseases+of+humans+and+animals%3A+their+causes+and+molecular+basis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prion diseases of humans and animals: their causes and molecular basis</span></div><div class="casAuthors">Collinge, John</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-550</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Prion diseases are transmissible neurodegenerative conditions that include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE) and scrapie in animals.  Prions appear to be composed principally or entirely of abnormal isoforms of a host-encoded glycoprotein, prion protein.  Prion propagation involves recruitment of host cellular prion protein, composed primarily of α-helical structure, into a disease specific isoform rich in β-sheet structure.  The existence of multiple prion strains was difficult to explain in terms of a protein-only infections agent, but recent studies suggest that strain specific phenotypes can be encoded by different prion protein conformations and glycosylation patterns.  The ability of a protein to encode phenotypic information has important biol. implications.  The appearance of a novel human prion disease, variant CJD, and the clear exptl. evidence that it is caused by exposure to BSE has highlighted the need to understand the mol. basis of prion propagation, pathogenesis, and the barriers limiting intermammalian transmission.  It is unclear if a large epidemic of variant CJD will occur in the years ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMiYjjuhS-v7Vg90H21EOLACvtfcHk0lgD8CxM1JuiIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7s%253D&md5=957ceb59633c634a05d02eebd2d4f761</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.519%26sid%3Dliteratum%253Aachs%26aulast%3DCollinge%26aufirst%3DJ.%26atitle%3DPrion%2520diseases%2520of%2520humans%2520and%2520animals%253A%2520their%2520causes%2520and%2520molecular%2520basis%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D519%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">The state of the prion</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnrmicro1025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=15494743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Kqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=861-871&author=C.+Weissmann&title=The+state+of+the+prion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the prion</span></div><div class="casAuthors">Weissmann, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">861-871</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is little doubt that the main component of the transmissible agent of spongiform encephalopathies - the prion - is a conformational variant of the ubiquitous host protein PrPC, and that the differing properties of various prion strains are assocd. with different abnormal conformations of this protein.  The precise structure of the prion is not yet known, nor are the mechanisms of infection, conformational conversion and pathogenesis understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4TlP6D_6ysrVg90H21EOLACvtfcHk0lgD8CxM1JuiIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Kqu78%253D&md5=58c35b75de716712178a0403c7aa6b40</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1025%26sid%3Dliteratum%253Aachs%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DThe%2520state%2520of%2520the%2520prion%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2004%26volume%3D2%26spage%3D861%26epage%3D871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zahn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luhrs, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Schroetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez Garcia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billeter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzolai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuthrich, K.</span><span> </span><span class="NLM_article-title">NMR solution structure of the human prion protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1073%2Fpnas.97.1.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=10618385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=145-150&author=R.+Zahnauthor=A.+Liuauthor=T.+Luhrsauthor=R.+Riekauthor=C.+von+Schroetterauthor=F.+Lopez+Garciaauthor=M.+Billeterauthor=L.+Calzolaiauthor=G.+Widerauthor=K.+Wuthrich&title=NMR+solution+structure+of+the+human+prion+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NMR solution structure of the human prion protein</span></div><div class="casAuthors">Zahn, Ralph; Liu, Aizhuo; Luhrs, Thorsten; Riek, Roland; von Schroetter, Christine; Garcia, Francisco Lopez; Billeter, Martin; Calzolai, Luigi; Wider, Gerhard; Wuthrich, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The NMR structures of the recombinant human prion protein, hPrP(23-230), and two C-terminal fragments, hPrP(90-230) and hPrP(121-230), include a globular domain extending from residues 125-228, for which a detailed structure was obtained, and an N-terminal flexibly disordered "tail.".  The globular domain contains three α-helixes comprising the residues 144-154, 173-194, and 200-228 and a short anti-parallel β-sheet comprising the residues 128-131 and 161-164.  Within the globular domain, three polypeptide segments show increased structural disorder: i.e., a loop of residues 167-171, the residues 187-194 at the end of helix 2, and the residues 219-228 in the C-terminal part of helix 3.  The local conformational state of the polypeptide segments 187-193 in helix 2 and 219-226 in helix 3 is measurably influenced by the length of the N-terminal tail, with the helical states being most highly populated in hPrP(23-230).  When compared with the previously reported structures of the murine and Syrian hamster prion proteins, the length of helix 3 coincides more closely with that in the Syrian hamster protein, whereas the disordered loop 167-171 is shared with murine PrP.  These species variations of local structure are in a surface area of the cellular form of PrP that has previously been implicated in intermol. interactions related both to the species barrier for infectious transmission of prion disease and to immune reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaytfjvnsOrVg90H21EOLACvtfcHk0lj1pZ25Mx4a2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVCrtg%253D%253D&md5=ec5f6231329b35ece51b950af9422ad5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.1.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.1.145%26sid%3Dliteratum%253Aachs%26aulast%3DZahn%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLuhrs%26aufirst%3DT.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3Dvon%2BSchroetter%26aufirst%3DC.%26aulast%3DLopez%2BGarcia%26aufirst%3DF.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DCalzolai%26aufirst%3DL.%26aulast%3DWider%26aufirst%3DG.%26aulast%3DWuthrich%26aufirst%3DK.%26atitle%3DNMR%2520solution%2520structure%2520of%2520the%2520human%2520prion%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sonati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baral, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaganoglu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayampakula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kav, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberski, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span> </span><span class="NLM_article-title">The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=102-106&author=T.+Sonatiauthor=R.+R.+Reimannauthor=J.+Falsigauthor=P.+K.+Baralauthor=T.+O%E2%80%99Connorauthor=S.+Hornemannauthor=S.+Yaganogluauthor=B.+Liauthor=U.+S.+Herrmannauthor=B.+Wielandauthor=M.+Swayampakulaauthor=M.+H.+Rahmanauthor=D.+Dasauthor=N.+Kavauthor=R.+Riekauthor=P.+P.+Liberskiauthor=M.+N.+Jamesauthor=A.+Aguzzi&title=The+toxicity+of+antiprion+antibodies+is+mediated+by+the+flexible+tail+of+the+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSonati%26aufirst%3DT.%26aulast%3DReimann%26aufirst%3DR.%2BR.%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3DBaral%26aufirst%3DP.%2BK.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26aulast%3DHornemann%26aufirst%3DS.%26aulast%3DYaganoglu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHerrmann%26aufirst%3DU.%2BS.%26aulast%3DWieland%26aufirst%3DB.%26aulast%3DSwayampakula%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DM.%2BH.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DKav%26aufirst%3DN.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3DLiberski%26aufirst%3DP.%2BP.%26aulast%3DJames%26aufirst%3DM.%2BN.%26aulast%3DAguzzi%26aufirst%3DA.%26atitle%3DThe%2520toxicity%2520of%2520antiprion%2520antibodies%2520is%2520mediated%2520by%2520the%2520flexible%2520tail%2520of%2520the%2520prion%2520protein%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D102%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Baral, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayampakula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rout, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kav, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spyracopoulos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Structural basis of prion inhibition by phenothiazine compounds</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=291-303&author=P.+K.+Baralauthor=M.+Swayampakulaauthor=M.+K.+Routauthor=N.+N.+Kavauthor=L.+Spyracopoulosauthor=A.+Aguzziauthor=M.+N.+James&title=Structural+basis+of+prion+inhibition+by+phenothiazine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaral%26aufirst%3DP.%2BK.%26aulast%3DSwayampakula%26aufirst%3DM.%26aulast%3DRout%26aufirst%3DM.%2BK.%26aulast%3DKav%26aufirst%3DN.%2BN.%26aulast%3DSpyracopoulos%26aufirst%3DL.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DStructural%2520basis%2520of%2520prion%2520inhibition%2520by%2520phenothiazine%2520compounds%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D291%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wasmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Melckebeke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemer, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span> </span><span class="NLM_article-title">Amyloid fibrils of the het-s(218-289) prion form a beta solenoid with a triangular hydrophobic core</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1523</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscience.1151839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=18339938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVGqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1523-1526&author=C.+Wasmerauthor=A.+Langeauthor=H.+Van+Melckebekeauthor=A.+B.+Siemerauthor=R.+Riekauthor=B.+H.+Meier&title=Amyloid+fibrils+of+the+het-s%28218-289%29+prion+form+a+beta+solenoid+with+a+triangular+hydrophobic+core"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid Fibrils of the HET-s(218-289) Prion Form a β Solenoid with a Triangular Hydrophobic Core</span></div><div class="casAuthors">Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5869</span>),
    <span class="NLM_cas:pages">1523-1526</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Prion and nonprion forms of proteins are believed to differ solely in their three-dimensional structure, which is therefore of paramount importance for the prion function.  However, no at.-resoln. structure of the fibrillar state that is likely infectious has been reported to date.  We present a structural model based on solid-state NMR restraints for amyloid fibrils from the prion-forming domain (residues 218 to 289) of the HET-s protein from the filamentous fungus Podospora anserina.  On the basis of 134 intra- and intermol. exptl. distance restraints, we find that HET-s(218-289) forms a left-handed β solenoid, with each mol. forming two helical windings, a compact hydrophobic core, at least 23 hydrogen bonds, three salt bridges, and two asparagine ladders.  The structure is likely to have broad implications for understanding the infectious amyloid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUcuGsS9yYLVg90H21EOLACvtfcHk0lhEntkNfRaz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVGqsrs%253D&md5=95fbf7331ab067166feb1d58f3a7e029</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1151839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1151839%26sid%3Dliteratum%253Aachs%26aulast%3DWasmer%26aufirst%3DC.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DVan%2BMelckebeke%26aufirst%3DH.%26aulast%3DSiemer%26aufirst%3DA.%2BB.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26atitle%3DAmyloid%2520fibrils%2520of%2520the%2520het-s%2528218-289%2529%2520prion%2520form%2520a%2520beta%2520solenoid%2520with%2520a%2520triangular%2520hydrophobic%2520core%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1523%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bueler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluethmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">Normal development and behaviour of mice lacking the neuronal cell-surface prp protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=577-582&author=H.+Buelerauthor=M.+Fischerauthor=Y.+Langauthor=H.+Bluethmannauthor=H.+P.+Lippauthor=S.+J.+DeArmondauthor=S.+B.+Prusinerauthor=M.+Aguetauthor=C.+Weissmann&title=Normal+development+and+behaviour+of+mice+lacking+the+neuronal+cell-surface+prp+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBueler%26aufirst%3DH.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DBluethmann%26aufirst%3DH.%26aulast%3DLipp%26aufirst%3DH.%2BP.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DAguet%26aufirst%3DM.%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DNormal%2520development%2520and%2520behaviour%2520of%2520mice%2520lacking%2520the%2520neuronal%2520cell-surface%2520prp%2520protein%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D577%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Richt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasinathan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamir, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathiyaseelan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathiyaseelan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroiwa, Y.</span><span> </span><span class="NLM_article-title">Production of cattle lacking prion protein</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=132-138&author=J.+A.+Richtauthor=P.+Kasinathanauthor=A.+N.+Hamirauthor=J.+Castillaauthor=T.+Sathiyaseelanauthor=F.+Vargasauthor=J.+Sathiyaseelanauthor=H.+Wuauthor=H.+Matsushitaauthor=J.+Kosterauthor=S.+Katoauthor=I.+Ishidaauthor=C.+Sotoauthor=J.+M.+Roblauthor=Y.+Kuroiwa&title=Production+of+cattle+lacking+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRicht%26aufirst%3DJ.%2BA.%26aulast%3DKasinathan%26aufirst%3DP.%26aulast%3DHamir%26aufirst%3DA.%2BN.%26aulast%3DCastilla%26aufirst%3DJ.%26aulast%3DSathiyaseelan%26aufirst%3DT.%26aulast%3DVargas%26aufirst%3DF.%26aulast%3DSathiyaseelan%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMatsushita%26aufirst%3DH.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIshida%26aufirst%3DI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DRobl%26aufirst%3DJ.%2BM.%26aulast%3DKuroiwa%26aufirst%3DY.%26atitle%3DProduction%2520of%2520cattle%2520lacking%2520prion%2520protein%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span> </span><span class="NLM_article-title">Generation of goats lacking prion protein</span> <span class="citation_source-journal">Mol. Reprod. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=3&author=G.+Yuauthor=J.+Chenauthor=Y.+Xuauthor=C.+Zhuauthor=H.+Yuauthor=S.+Liuauthor=H.+Shaauthor=J.+Chenauthor=X.+Xuauthor=Y.+Wuauthor=A.+Zhangauthor=J.+Maauthor=G.+Cheng&title=Generation+of+goats+lacking+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSha%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DGeneration%2520of%2520goats%2520lacking%2520prion%2520protein%26jtitle%3DMol.%2520Reprod.%2520Dev.%26date%3D2009%26volume%3D76%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span> </span><span class="NLM_article-title">Prion propagation, toxicity and degradation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnn.3120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=22735515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1ShsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=936-939&author=A.+Aguzziauthor=J.+Falsig&title=Prion+propagation%2C+toxicity+and+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prion propagation, toxicity and degradation</span></div><div class="casAuthors">Aguzzi, Adriano; Falsig, Jeppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">936-939</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prion science has been on a rollercoaster for two decades.  In the mid 1990s, the specter of mad cow disease (bovine spongiform encephalopathy, BSE) provoked an unprecedented public scare that was first pptd. by the realization that this animal prion disease could be transmitted to humans and then rekindled by the evidence that BSE-infected humans could pass on the infection through blood transfusions.  Along with the gradual disappearance of BSE, the interest in prions has waned with the general public, funding agencies and prospective PhD students.  In the past few years, however, a bewildering variety of diseases have been found to share features with prion infections, including cell-to-cell transmission.  Here we review these developments and summarize those open questions that we currently deem most interesting in prion biol.: how do prions damage their hosts, and how do hosts attempt to neutralize invading prions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqozXinCpzvV7Vg90H21EOLACvtfcHk0lhEntkNfRaz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1ShsLc%253D&md5=45d56b3cece6810504a95bdfcf5b32a3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.3120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3120%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DFalsig%26aufirst%3DJ.%26atitle%3DPrion%2520propagation%252C%2520toxicity%2520and%2520degradation%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D936%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hewitt, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llewelyn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, R. G.</span><span> </span><span class="NLM_article-title">Creutzfeldt–Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study</span> <span class="citation_source-journal">Vox Sang.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1111%2Fj.1423-0410.2006.00833.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=16958834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD28rjsFyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2006&pages=221-230&author=P.+E.+Hewittauthor=C.+A.+Llewelynauthor=J.+Mackenzieauthor=R.+G.+Will&title=Creutzfeldt%E2%80%93Jakob+disease+and+blood+transfusion%3A+results+of+the+UK+transfusion+medicine+epidemiological+review+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study</span></div><div class="casAuthors">Hewitt P E; Llewelyn C A; Mackenzie J; Will R G</div><div class="citationInfo"><span class="NLM_cas:title">Vox sanguinis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-30</span>
        ISSN:<span class="NLM_cas:issn">0042-9007</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  This paper reports the results to 1 March 2006 of an ongoing UK study, the Transfusion Medicine Epidemiological Review (TMER), by the National CJD Surveillance Unit (NCJDSU) and the UK Blood Services (UKBS) to determine whether there is any evidence that Creutzfeldt-Jakob disease (CJD), including sporadic CJD (sCJD), familial CJD (fCJD), and variant CJD (vCJD) is transmissible via blood transfusion.  MATERIALS AND METHODS:  Sporadic CJD and fCJD cases with a history of blood donation or transfusion are notified to UKBS.  All vCJD cases aged > 17 years are notified to UKBS on diagnosis.  A search for donation records is instigated and the fate of all donations is identified by lookback.  For cases with a history of blood transfusion, hospital and UKBS records are searched to identify blood donors.  Details of identified recipients and donors are checked against the NCJDSU register to establish if there are any matches.  RESULTS:  CJD cases with donation history: 18/31 vCJD, 3/93 sCJD, and 3/5 fCJD cases reported as blood donors were confirmed to have donated labile components transfused to 66, 20, and 11 recipients respectively.  Two vCJD recipients have appeared on the NCJDSU register as confirmed and probable vCJD cases.  The latter developed symptoms of vCJD 6.5 years and 7.8 years respectively after receiving non-leucodepleted red blood cells (RBCs) from two different donors who developed clinical symptoms approximately 40 and 21 months after donating.  A third recipient, given RBC donated by a further vCJD case approximately 18 months before onset of clinical symptoms, had abnormal prion protein in lymphoid tissue at post-mortem (5-years post-transfusion) but had no clinical symptoms of vCJD.  CJD cases with history of transfusion: Hospital records for 7/11 vCJD and 7/52 sCJD cases included a history of transfusion of labile blood components donated by 125 and 24 donors respectively.  Two recipients who developed vCJD were linked to donors who had already appeared on the NCJDSU register as vCJD cases (see above).  No further links were established.  CONCLUSION:  This study has identified three instances of probable transfusion transmission of vCJD infection, including two confirmed clinical cases and one pre- or sub-clinical infection.  This study has not provided evidence, to date, of transmission of sCJD or fCJD by blood transfusion, but data on these forms of diseases are limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcJSYx6oM0bcScOqQTSkOffW6udTcc2ebeKIifTXY35rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjsFyluw%253D%253D&md5=490a566e71d4f481e8be5c3dd52fd7f9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1423-0410.2006.00833.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1423-0410.2006.00833.x%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DP.%2BE.%26aulast%3DLlewelyn%26aufirst%3DC.%2BA.%26aulast%3DMackenzie%26aufirst%3DJ.%26aulast%3DWill%26aufirst%3DR.%2BG.%26atitle%3DCreutzfeldt%25E2%2580%2593Jakob%2520disease%2520and%2520blood%2520transfusion%253A%2520results%2520of%2520the%2520UK%2520transfusion%2520medicine%2520epidemiological%2520review%2520study%26jtitle%3DVox%2520Sang.%26date%3D2006%26volume%3D91%26spage%3D221%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Otto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratzka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehlinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekhoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergande, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellers-Lenz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H.</span><span> </span><span class="NLM_article-title">Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">714</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=714-718&author=M.+Ottoauthor=L.+Cepekauthor=P.+Ratzkaauthor=S.+Doehlingerauthor=I.+Boekhoffauthor=J.+Wiltfangauthor=E.+Irleauthor=G.+Pergandeauthor=B.+Ellers-Lenzauthor=O.+Windlauthor=H.+A.+Kretzschmarauthor=S.+Poserauthor=H.+Prange&title=Efficacy+of+flupirtine+on+cognitive+function+in+patients+with+CJD%3A+a+double-blind+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DM.%26aulast%3DCepek%26aufirst%3DL.%26aulast%3DRatzka%26aufirst%3DP.%26aulast%3DDoehlinger%26aufirst%3DS.%26aulast%3DBoekhoff%26aufirst%3DI.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DIrle%26aufirst%3DE.%26aulast%3DPergande%26aufirst%3DG.%26aulast%3DEllers-Lenz%26aufirst%3DB.%26aulast%3DWindl%26aufirst%3DO.%26aulast%3DKretzschmar%26aufirst%3DH.%2BA.%26aulast%3DPoser%26aufirst%3DS.%26aulast%3DPrange%26aufirst%3DH.%26atitle%3DEfficacy%2520of%2520flupirtine%2520on%2520cognitive%2520function%2520in%2520patients%2520with%2520CJD%253A%2520a%2520double-blind%2520study%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D714%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereux, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raudabaugh, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Chae, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thai, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possin, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span> </span><span class="NLM_article-title">Quinacrine treatment trial for sporadic Creutzfeldt–Jakob disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=2015-2023&author=M.+D.+Geschwindauthor=A.+L.+Kuoauthor=K.+S.+Wongauthor=A.+Hamanauthor=G.+Devereuxauthor=B.+J.+Raudabaughauthor=D.+Y.+Johnsonauthor=C.+C.+Torres-Chaeauthor=R.+Finleyauthor=P.+Garciaauthor=J.+N.+Thaiauthor=H.+Q.+Chengauthor=J.+M.+Neuhausauthor=S.+A.+Fornerauthor=J.+L.+Duncanauthor=K.+L.+Possinauthor=S.+J.+Dearmondauthor=S.+B.+Prusinerauthor=B.+L.+Miller&title=Quinacrine+treatment+trial+for+sporadic+Creutzfeldt%E2%80%93Jakob+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DKuo%26aufirst%3DA.%2BL.%26aulast%3DWong%26aufirst%3DK.%2BS.%26aulast%3DHaman%26aufirst%3DA.%26aulast%3DDevereux%26aufirst%3DG.%26aulast%3DRaudabaugh%26aufirst%3DB.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BY.%26aulast%3DTorres-Chae%26aufirst%3DC.%2BC.%26aulast%3DFinley%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DThai%26aufirst%3DJ.%2BN.%26aulast%3DCheng%26aufirst%3DH.%2BQ.%26aulast%3DNeuhaus%26aufirst%3DJ.%2BM.%26aulast%3DForner%26aufirst%3DS.%2BA.%26aulast%3DDuncan%26aufirst%3DJ.%2BL.%26aulast%3DPossin%26aufirst%3DK.%2BL.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26atitle%3DQuinacrine%2520treatment%2520trial%2520for%2520sporadic%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%26jtitle%3DNeurology%26date%3D2013%26volume%3D81%26spage%3D2015%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Haik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tettamanti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welaratne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguettes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperiale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aucan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucca, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckeu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranchant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houillier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vespignani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnianski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seilhean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canovi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fede, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplanche, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocchiari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forloni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, F.</span><span> </span><span class="NLM_article-title">Doxycycline in Creutzfeldt–Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1016%2FS1474-4422%2813%2970307-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24411709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Gjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=150-158&author=S.+Haikauthor=G.+Marconauthor=A.+Malletauthor=M.+Tettamantiauthor=A.+Welaratneauthor=G.+Giacconeauthor=S.+Azimiauthor=V.+Pietriniauthor=J.+R.+Fabreguettesauthor=D.+Imperialeauthor=P.+Cesaroauthor=C.+Buffaauthor=C.+Aucanauthor=U.+Luccaauthor=L.+Peckeuauthor=S.+Suardiauthor=C.+Tranchantauthor=I.+Zerrauthor=C.+Houillierauthor=V.+Redaelliauthor=H.+Vespignaniauthor=A.+Campanellaauthor=F.+Sellalauthor=A.+Krasnianskiauthor=D.+Seilheanauthor=U.+Heinemannauthor=F.+Sedelauthor=M.+Canoviauthor=M.+Gobbiauthor=G.+Di+Fedeauthor=J.+L.+Laplancheauthor=M.+Pocchiariauthor=M.+Salmonaauthor=G.+Forloniauthor=J.+P.+Brandelauthor=F.+Tagliavini&title=Doxycycline+in+Creutzfeldt%E2%80%93Jakob+disease%3A+a+phase+2%2C+randomised%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Haik, Stephane; Marcon, Gabriella; Mallet, Alain; Tettamanti, Mauro; Welaratne, Arlette; Giaccone, Giorgio; Azimi, Shohreh; Pietrini, Vladimiro; Fabreguettes, Jean-Roch; Imperiale, Daniele; Cesaro, Pierre; Buffa, Carlo; Aucan, Christophe; Lucca, Ugo; Peckeu, Laurene; Suardi, Silvia; Tranchant, Christine; Zerr, Inga; Houillier, Caroline; Redaelli, Veronica; Vespignani, Herve; Campanella, Angela; Sellal, Francois; Krasnianski, Anna; Seilhean, Danielle; Heinemann, Uta; Sedel, Frederic; Canovi, Mara; Gobbi, Marco; Di Fede, Giuseppe; Laplanche, Jean-Louis; Pocchiari, Maurizio; Salmona, Mario; Forloni, Gianluigi; Brandel, Jean-Philippe; Tagliavini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-158</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Creutzfeldt-Jakob disease (CJD) is a fatal, untreatable prion encephalopathy.  Previous studies showed that doxycycline is effective in in-vitro and in-vivo models of disease, and patients with CJD who received compassionate treatment with doxycycline showed increased survival time compared with historical series.  We therefore did a randomised, double-blind study of doxycycline vs. placebo in CJD.  We recruited patients older than 18 years old who had a diagnosis of definite or probable sporadic CJD or genetic forms of the disease via Italian ref. centers and the French national referral system.  Patients were randomly assigned (ratio 1:1) to receive oral doxycycline (100 mg daily) or placebo under double-blind conditions from the day of randomization to death.  Centralised randomization was done independently of enrolment or evaluation of patients using a minimization method in Italy and a simple randomization in France.  Participants, caregivers, and clinicians were masked to group assignment.  The primary efficacy variable was the survival time from randomization.  Interim analyses were planned to detect a significant effect of treatment as early as possible.  This trial is registered with EudraCT, 2006-001858-27 for the Italian study and 2007-005553-34 for the French study.From Apr. 12, 2007, to Aug 19, 2010, in Italy, and from Jan 30, 2009, to Jan 10, 2012, in France, 121 patients with CJD were enrolled in the study, 62 of whom were randomly assigned to the treatment group and 59 to the placebo group.  The first interim anal. showed absence of superiority of doxycycline compared with placebo, and the trial was stopped for futility.  Efficacy analyses did not show significant differences between patients treated with doxycycline and placebo with regard to survival times (HR 1·1, 95% CI 0·8-1·7, p=0·50).  Serious adverse events were judged not to be related to treatment, whereas a relation was deemed probable or possible for five non-serious adverse events that occurred in each treatment group.  Doxycycline at a dose of 100 mg per day was well tolerated but did not significantly affect the course of CJD, at variance with the results of previous observational studies.  Our experience could be useful in the design of large multinational controlled trials of potential anti-prion mols. in this rare disease.  Agenzia Italiana Farmaco, Italian Ministry of Health, AIEnP, and French Ministry of Health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY2pM-BZKmx7Vg90H21EOLACvtfcHk0lhaGMjUvJsI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Gjtw%253D%253D&md5=10674d977e3e9eda01085b964a17d64b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970307-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970307-7%26sid%3Dliteratum%253Aachs%26aulast%3DHaik%26aufirst%3DS.%26aulast%3DMarcon%26aufirst%3DG.%26aulast%3DMallet%26aufirst%3DA.%26aulast%3DTettamanti%26aufirst%3DM.%26aulast%3DWelaratne%26aufirst%3DA.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DAzimi%26aufirst%3DS.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DFabreguettes%26aufirst%3DJ.%2BR.%26aulast%3DImperiale%26aufirst%3DD.%26aulast%3DCesaro%26aufirst%3DP.%26aulast%3DBuffa%26aufirst%3DC.%26aulast%3DAucan%26aufirst%3DC.%26aulast%3DLucca%26aufirst%3DU.%26aulast%3DPeckeu%26aufirst%3DL.%26aulast%3DSuardi%26aufirst%3DS.%26aulast%3DTranchant%26aufirst%3DC.%26aulast%3DZerr%26aufirst%3DI.%26aulast%3DHouillier%26aufirst%3DC.%26aulast%3DRedaelli%26aufirst%3DV.%26aulast%3DVespignani%26aufirst%3DH.%26aulast%3DCampanella%26aufirst%3DA.%26aulast%3DSellal%26aufirst%3DF.%26aulast%3DKrasnianski%26aufirst%3DA.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DSedel%26aufirst%3DF.%26aulast%3DCanovi%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DDi%2BFede%26aufirst%3DG.%26aulast%3DLaplanche%26aufirst%3DJ.%2BL.%26aulast%3DPocchiari%26aufirst%3DM.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DBrandel%26aufirst%3DJ.%2BP.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DDoxycycline%2520in%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%253A%2520a%2520phase%25202%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Geissen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzl, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groschup, M. H.</span><span> </span><span class="NLM_article-title">From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1928</span><span class="NLM_x">–</span> <span class="NLM_lpage">1937</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1928-1937&author=M.+Geissenauthor=F.+Leidelauthor=M.+Eidenauthor=T.+Hirschbergerauthor=C.+Fastauthor=U.+Bertschauthor=P.+Tavanauthor=A.+Gieseauthor=H.+Kretzschmarauthor=H.+M.+Schatzlauthor=M.+H.+Groschup&title=From+high-throughput+cell+culture+screening+to+mouse+model%3A+identification+of+new+inhibitor+classes+against+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeissen%26aufirst%3DM.%26aulast%3DLeidel%26aufirst%3DF.%26aulast%3DEiden%26aufirst%3DM.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DFast%26aufirst%3DC.%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DKretzschmar%26aufirst%3DH.%26aulast%3DSchatzl%26aufirst%3DH.%2BM.%26aulast%3DGroschup%26aufirst%3DM.%2BH.%26atitle%3DFrom%2520high-throughput%2520cell%2520culture%2520screening%2520to%2520mouse%2520model%253A%2520identification%2520of%2520new%2520inhibitor%2520classes%2520against%2520prion%2520disease%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1928%26epage%3D1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Vilette, D.</span><span> </span><span class="NLM_article-title">Cell models of prion infection</span> <span class="citation_source-journal">Vet. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1051%2Fvetres%3A2007049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=18073097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjs1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=10&author=D.+Vilette&title=Cell+models+of+prion+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cell models of prion infection</span></div><div class="casAuthors">Vilette Didier</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">0928-4249</span>.
    </div><div class="casAbstract">Due to recent renewal of interest and concerns in prion diseases, a number of cell systems permissive to prion multiplication have been generated in the last years.  These include established cell lines, neuronal stem cells and primary neuronal cultures.  While most of these models are permissive to experimental, mouse-adapted strains of prions, the propagation of natural field isolates from sheep scrapie and chronic wasting disease has been recently achieved.  These models have improved our knowledge on the molecular and cellular events controlling the conversion of the PrP(C) protein into abnormal isoforms and on the cell-to-cell spreading of prions.  Infected cultured cells will also facilitate investigations on the molecular basis of strain identity and on the mechanisms that lead to neurodegeneration.  The ongoing development of new cell models with improved characteristics will certainly be useful for a number of unanswered critical issues in the prion field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6-eHTbo4UlJI8NvIb08rbfW6udTcc2eaThq-2dgvOkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjs1Ohug%253D%253D&md5=13c8374a2973481a964d174dd5fa61e4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fvetres%3A2007049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fvetres%253A2007049%26sid%3Dliteratum%253Aachs%26aulast%3DVilette%26aufirst%3DD.%26atitle%3DCell%2520models%2520of%2520prion%2520infection%26jtitle%3DVet.%2520Res.%26date%3D2008%26volume%3D39%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Safar, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didorenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattavat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Diagnosis of human prion disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=3501-3506&author=J.+G.+Safarauthor=M.+D.+Geschwindauthor=C.+Deeringauthor=S.+Didorenkoauthor=M.+Sattavatauthor=H.+Sanchezauthor=A.+Serbanauthor=M.+Veyauthor=H.+Baronauthor=K.+Gilesauthor=B.+L.+Millerauthor=S.+J.+Dearmondauthor=S.+B.+Prusiner&title=Diagnosis+of+human+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafar%26aufirst%3DJ.%2BG.%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DDeering%26aufirst%3DC.%26aulast%3DDidorenko%26aufirst%3DS.%26aulast%3DSattavat%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DH.%26aulast%3DSerban%26aufirst%3DA.%26aulast%3DVey%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DH.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DDiagnosis%2520of%2520human%2520prion%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D3501%26epage%3D3506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Brandner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekarik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parizek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rulicke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span> </span><span class="NLM_article-title">Neuroinvasion of prions: insights from mouse models</span> <span class="citation_source-journal">Exp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1111%2Fj.1469-445X.2000.02091.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11187965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=705-712&author=S.+Brandnerauthor=M.+A.+Kleinauthor=R.+Friggauthor=V.+Pekarikauthor=P.+Parizekauthor=A.+Raeberauthor=M.+Glatzelauthor=P.+Schwarzauthor=T.+Rulickeauthor=C.+Weissmannauthor=A.+Aguzzi&title=Neuroinvasion+of+prions%3A+insights+from+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinvasion of prions: insights from mouse models</span></div><div class="casAuthors">Brandner, Sebastian; Klein, Michael A.; Frigg, Rico; Pekarik, Valdimir; Parizek, Petra; Raeber, Alex; Glatzel, Markus; Schwarz, Petra; Rulicke, Thomas; Weissmann, Charles; Aguzzi, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-712</span>CODEN:
                <span class="NLM_cas:coden">EXPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0958-0670</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with 33 refs.  The prion was defined by Stanley B. Prusiner as the infectious agent that causes transmissible spongiform encephalopathies.  A pathol. protein accumulating in the brain of scrapie-infected hamsters was isolated in 1982 and termed prion protein (PrPSc).  Its cognate gene Prnp was identified more than a decade ago by Charles Weissmann, and shown to encode the host protein PrPC.  Since the latter discovery, transgenic mice have contributed many important insights into the field of prion biol., including the understanding of the mol. basis of the species barrier for prions.  By disrupting the Prnp gene, it was shown that an organism that lacks PrPC is resistant to infection by prions.  Introduction of mutant PrP genes into PrP-deficient mice was used to investigate the structure-activity relationship of the PrP gene with regard to scrapie susceptibility.  Ectopic expression of PrP in PrP knockout mice proved a useful tool for the identification of host cells competent for prion replication.  Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP allows selective reconstitution expts. aimed at expressing PrP in neurografts or in specific populations of hemato- and lymphopoietic cells.  The latter studies have allowed us to clarify some of the mechanisms of prion spread and disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEZ_oa4zAljbVg90H21EOLACvtfcHk0lg5d8WlpRrNEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSrtA%253D%253D&md5=1cbd8de307bb8c67bcbcbac7d2c8f600</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-445X.2000.02091.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-445X.2000.02091.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrandner%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DM.%2BA.%26aulast%3DFrigg%26aufirst%3DR.%26aulast%3DPekarik%26aufirst%3DV.%26aulast%3DParizek%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DA.%26aulast%3DGlatzel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DP.%26aulast%3DRulicke%26aufirst%3DT.%26aulast%3DWeissmann%26aufirst%3DC.%26aulast%3DAguzzi%26aufirst%3DA.%26atitle%3DNeuroinvasion%2520of%2520prions%253A%2520insights%2520from%2520mouse%2520models%26jtitle%3DExp.%2520Physiol.%26date%3D2000%26volume%3D85%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tamguney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Measuring prions by bioluminescence imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15002</span><span class="NLM_x">–</span> <span class="NLM_lpage">15006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15002-15006&author=G.+Tamguneyauthor=K.+P.+Francisauthor=K.+Gilesauthor=A.+Lemusauthor=S.+J.+DeArmondauthor=S.+B.+Prusiner&title=Measuring+prions+by+bioluminescence+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamguney%26aufirst%3DG.%26aulast%3DFrancis%26aufirst%3DK.%2BP.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLemus%26aufirst%3DA.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DMeasuring%2520prions%2520by%2520bioluminescence%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D15002%26epage%3D15006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamatari, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa-Muto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katamine, S.</span><span> </span><span class="NLM_article-title">Hot spots in prion protein for pathogenic conversion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">11921</span><span class="NLM_x">–</span> <span class="NLM_lpage">11926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11921-11926&author=K.+Kuwataauthor=N.+Nishidaauthor=T.+Matsumotoauthor=Y.+O.+Kamatariauthor=J.+Hosokawa-Mutoauthor=K.+Kodamaauthor=H.+K.+Nakamuraauthor=K.+Kimuraauthor=M.+Kawasakiauthor=Y.+Takakuraauthor=S.+Shirabeauthor=J.+Takataauthor=Y.+Kataokaauthor=S.+Katamine&title=Hot+spots+in+prion+protein+for+pathogenic+conversion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DKamatari%26aufirst%3DY.%2BO.%26aulast%3DHosokawa-Muto%26aufirst%3DJ.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%2BK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTakakura%26aufirst%3DY.%26aulast%3DShirabe%26aufirst%3DS.%26aulast%3DTakata%26aufirst%3DJ.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DKatamine%26aufirst%3DS.%26atitle%3DHot%2520spots%2520in%2520prion%2520protein%2520for%2520pathogenic%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D11921%26epage%3D11926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Trevitt, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinge, J.</span><span> </span><span class="NLM_article-title">A systematic review of prion therapeutics in experimental models</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=2241-2265&author=C.+R.+Trevittauthor=J.+Collinge&title=A+systematic+review+of+prion+therapeutics+in+experimental+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevitt%26aufirst%3DC.%2BR.%26aulast%3DCollinge%26aufirst%3DJ.%26atitle%3DA%2520systematic%2520review%2520of%2520prion%2520therapeutics%2520in%2520experimental%2520models%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D2241%26epage%3D2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sim, V. L.</span><span> </span><span class="NLM_article-title">Prion disease: chemotherapeutic strategies</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F187152612800100161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=22420513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=144-160&author=V.+L.+Sim&title=Prion+disease%3A+chemotherapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Prion disease: chemotherapeutic strategies</span></div><div class="casAuthors">Sim, Valerie L.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-160</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases, also known as transmissible spongiform encephalopathies, are invariably fatal neurodegenerative diseases for which there are no efficacious treatments.  Thousands of compds. have been screened for anti-prion effect, and yet of those that have effect in vitro, very few show effect in vivo, esp. if administered in the later stages of disease.  However, with new techniques for early diagnosis being developed, and with further insight into the pathogenesis of early disease, including the role of oligomers and the contribution of accessory mols. and signalling cascades, the chance of finding a therapeutic strategy is increasing.  Beyond clin. therapy, there is increasing need to find effective decontaminants for blood supplies, as variant Creutzfeldt Jakob Disease (vCJD) is transmissible by blood.  Non-toxic preventative therapies are also needed, with ongoing cases of Bovine Spongiform Encephalopathy (BSE) and the spread of Chronic Wasting Disease (CWD) being a growing concern.  A primary target for therapy has been the conversion of the normal form of prion protein (PrPC) to its abnormal counterpart (PrPSc).  Many of the chemotherapeutic agents with antiprion effect share structural similarities, often being polyanionic or polycyclic.  They may directly bind PrPC or PrPSc, or they may redistribute, sequester, or down-regulate PrPC, thus preventing its conversion.  There have also been some novel approaches, including trapping PrPSc in a multimeric form such that it can no longer cause conversion, increasing clearance of PrPSc, targeting accessory mols. which play a role in conversion, targeting pathways which lead to neurodegeneration, and stem cell therapy.  It may be that a combination of compds. will be necessary for maximal effect and there is evidence that synergistic responses occur with dual therapy.  This updated review focuses primarily on chemicalbased treatments in light of developments in diagnostic technologies, including results from recent clin. trials, and proposes some promising new targets for prion therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKZx035zXT9rVg90H21EOLACvtfcHk0lg5d8WlpRrNEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2is74%253D&md5=a74afce47de45b8a91223a3aeab60d38</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F187152612800100161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152612800100161%26sid%3Dliteratum%253Aachs%26aulast%3DSim%26aufirst%3DV.%2BL.%26atitle%3DPrion%2520disease%253A%2520chemotherapeutic%2520strategies%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D12%26spage%3D144%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kamatari, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa-Muto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span> </span><span class="NLM_article-title">Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1002%2Fpro.2180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVeksrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=22-34&author=Y.+O.+Kamatariauthor=Y.+Hayanoauthor=K.+Yamaguchiauthor=J.+Hosokawa-Mutoauthor=K.+Kuwata&title=Characterizing+antiprion+compounds+based+on+their+binding+properties+to+prion+proteins%3A+implications+as+medical+chaperones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing antiprion compounds based on their binding properties to prion proteins: Implications as medical chaperones</span></div><div class="casAuthors">Kamatari, Yuji O.; Hayano, Yosuke; Yamaguchi, Kei-ichi; Hosokawa-Muto, Junji; Kuwata, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A variety of antiprion compds. have been reported that are effective in ex vivo and in vivo treatment expts.  However, the mol. mechanisms for most of these compds. remain unknown.  Here we classified antiprion mechanisms into four categories: I, specific conformational stabilization; II, nonspecific stabilization; III, aggregation; and IV, interaction with mols. other than PrPC.  To characterize antiprion compds. based on this classification, we detd. their binding affinities to PrPC using surface plasmon resonance and their binding sites on PrPC using NMR spectroscopy.  GN8 and GJP49 bound specifically to the hot spot in PrPC, and acted as "medical chaperones" to stabilize the native conformation.  Thus, mechanisms I was predominant.  In contrast, quinacrine and epigallocathechin bound to PrPC rather nonspecifically; these may stabilize the PrPC conformation nonspecifically including the interference with the intermol. interaction following mechanism II.  Congo red and pentosan polysulfate bound to PrPC and caused aggregation and pptn. of PrPC, thus reducing the effective concn. of prion protein.  Thus, mechanism III was appropriate.  Finally, CP-60, an edarabone deriv., did not bind to PrPC.  Thus these were classified into mechanism IV.  However, their antiprion activities were not confirmed in the GT + FK system, whose details remain to be elucidated.  These proposed antiprion mechanisms of diverse antiprion compds. could help to elucidate their antiprion activities and facilitate effective antiprion drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG33Yz8bzeMLVg90H21EOLACvtfcHk0lg17rErD51W8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVeksrnE&md5=e0922e6dd7d2502e2ac986d699f80f8c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fpro.2180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2180%26sid%3Dliteratum%253Aachs%26aulast%3DKamatari%26aufirst%3DY.%2BO.%26aulast%3DHayano%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHosokawa-Muto%26aufirst%3DJ.%26aulast%3DKuwata%26aufirst%3DK.%26atitle%3DCharacterizing%2520antiprion%2520compounds%2520based%2520on%2520their%2520binding%2520properties%2520to%2520prion%2520proteins%253A%2520implications%2520as%2520medical%2520chaperones%26jtitle%3DProtein%2520Sci.%26date%3D2013%26volume%3D22%26spage%3D22%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Continuous quinacrine treatment results in the formation of drug-resistant prions</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000673&author=S.+Ghaemmaghamiauthor=M.+Ahnauthor=P.+Lessardauthor=K.+Gilesauthor=G.+Legnameauthor=S.+J.+DeArmondauthor=S.+B.+Prusiner&title=Continuous+quinacrine+treatment+results+in+the+formation+of+drug-resistant+prions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DLessard%26aufirst%3DP.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DContinuous%2520quinacrine%2520treatment%2520results%2520in%2520the%2520formation%2520of%2520drug-resistant%2520prions%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26spage%3De1000673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Forloni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iussich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeretti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazia Bruzzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limido, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ironside, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugiani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, F.</span><span> </span><span class="NLM_article-title">Tetracyclines affect prion infectivity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">10849</span><span class="NLM_x">–</span> <span class="NLM_lpage">10854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10849-10854&author=G.+Forloniauthor=S.+Iussichauthor=T.+Awanauthor=L.+Colomboauthor=N.+Angerettiauthor=L.+Girolaauthor=I.+Bertaniauthor=G.+Poliauthor=M.+Caramelliauthor=M.+Grazia+Bruzzoneauthor=L.+Farinaauthor=L.+Limidoauthor=G.+Rossiauthor=G.+Giacconeauthor=J.+W.+Ironsideauthor=O.+Bugianiauthor=M.+Salmonaauthor=F.+Tagliavini&title=Tetracyclines+affect+prion+infectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DIussich%26aufirst%3DS.%26aulast%3DAwan%26aufirst%3DT.%26aulast%3DColombo%26aufirst%3DL.%26aulast%3DAngeretti%26aufirst%3DN.%26aulast%3DGirola%26aufirst%3DL.%26aulast%3DBertani%26aufirst%3DI.%26aulast%3DPoli%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DM.%26aulast%3DGrazia%2BBruzzone%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DL.%26aulast%3DLimido%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DIronside%26aufirst%3DJ.%2BW.%26aulast%3DBugiani%26aufirst%3DO.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DTetracyclines%2520affect%2520prion%2520infectivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D10849%26epage%3D10854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Teruya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakasegawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doh-ura, K.</span><span> </span><span class="NLM_article-title">Amyloidophilic compounds for prion diseases</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F1871526510909010015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=19200011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=15-22&author=K.+Teruyaauthor=K.+Kawagoeauthor=T.+Kimuraauthor=C.+J.+Chenauthor=Y.+Sakasegawaauthor=K.+Doh-ura&title=Amyloidophilic+compounds+for+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloidophilic compounds for prion diseases</span></div><div class="casAuthors">Teruya, Kenta; Kawagoe, Keiichi; Kimura, Tomohiro; Chen, Chun-jen; Sakasegawa, Yuji; Doh-ura, Katsumi</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent outbreaks of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease have aroused great concern in many countries and have necessitated the development of suitable therapies.  We have demonstrated that sulfated glycans such as pentosan polysulfate and fucoidan, and amyloidophilic compds. such as amyloid dye derivs., styrylbenzoazole derivs., and phenylhydrazine derivs. have efficacies in prion-infected animals.  Amyloidophilic compds. present potentialities not only as therapeutic candidates but also as prion amyloid imaging probes for use in nuclear medicine technol. such as positron emission tomog.  A representative of styrylbenzoazole compds. has been used recently for clin. trials of brain prion amyloid imaging in patients.  On the other hand, a representative of phenylhydrazine compds., compB, displays excellent effectiveness in prolonging the incubation times of infected animals when given orally.  However, both its anti-prion effectiveness in vitro and its therapeutic efficacy in vivo are consistently dependent on the prion strain.  This prion-strain-dependency is similarly obsd. in other amyloidophilic compds.  Therefore, aside from further improvement of the safety profiles and pharmacokinetic properties of such compds., elucidation and management in the mechanism of the prion strain-dependent effectiveness is necessary.  Nevertheless, because compB studies suggest that amyloidophilic compds. are also therapeutic candidates for Alzheimer's disease, amyloidophilic compds. might be attractive as drug candidates for various conformational diseases and hasten development of therapeutic drugs for prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpQbm3jqyfbVg90H21EOLACvtfcHk0lgy6IhzR9R0Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSmtro%253D&md5=5691668e9f80ed2a9b1d59238ae7a011</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1871526510909010015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871526510909010015%26sid%3Dliteratum%253Aachs%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DKawagoe%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DSakasegawa%26aufirst%3DY.%26aulast%3DDoh-ura%26aufirst%3DK.%26atitle%3DAmyloidophilic%2520compounds%2520for%2520prion%2520diseases%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Moreno, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verity, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortori, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallucci, G. R.</span><span> </span><span class="NLM_article-title">Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">206ra138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscitranslmed.3006767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=206ra138&author=J.+A.+Morenoauthor=M.+Hallidayauthor=C.+Molloyauthor=H.+Radfordauthor=N.+Verityauthor=J.+M.+Axtenauthor=C.+A.+Ortoriauthor=A.+E.+Willisauthor=P.+M.+Fischerauthor=D.+A.+Barrettauthor=G.+R.+Mallucci&title=Oral+treatment+targeting+the+unfolded+protein+response+prevents+neurodegeneration+and+clinical+disease+in+prion-infected+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006767%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno%26aufirst%3DJ.%2BA.%26aulast%3DHalliday%26aufirst%3DM.%26aulast%3DMolloy%26aufirst%3DC.%26aulast%3DRadford%26aufirst%3DH.%26aulast%3DVerity%26aufirst%3DN.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DOrtori%26aufirst%3DC.%2BA.%26aulast%3DWillis%26aufirst%3DA.%2BE.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DMallucci%26aufirst%3DG.%2BR.%26atitle%3DOral%2520treatment%2520targeting%2520the%2520unfolded%2520protein%2520response%2520prevents%2520neurodegeneration%2520and%2520clinical%2520disease%2520in%2520prion-infected%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D206ra138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mencken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigethy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberlin, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span> </span><span class="NLM_article-title">Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7193</span><span class="NLM_x">–</span> <span class="NLM_lpage">7207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300713s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7193-7207&author=J.+M.+Axtenauthor=J.+R.+Medinaauthor=Y.+Fengauthor=A.+Shuauthor=S.+P.+Romerilauthor=S.+W.+Grantauthor=W.+H.+Liauthor=D.+A.+Heerdingauthor=E.+Minthornauthor=T.+Menckenauthor=C.+Atkinsauthor=Q.+Liuauthor=S.+Rabindranauthor=R.+Kumarauthor=X.+Hongauthor=A.+Goetzauthor=T.+Stanleyauthor=J.+D.+Taylorauthor=S.+D.+Sigethyauthor=G.+H.+Tomberlinauthor=A.+M.+Hassellauthor=K.+M.+Kahlerauthor=L.+M.+Shewchukauthor=R.+T.+Gampe&title=Discovery+of+7-methyl-5-%281-%7B%5B3-%28trifluoromethyl%29phenyl%5Dacetyl%7D-2%2C3-dihydro-1H-indol-5-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amine+%28GSK2606414%29%2C+a+potent+and+selective+first-in-class+inhibitor+of+protein+kinase+R+%28PKR%29-like+endoplasmic+reticulum+kinase+%28PERK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300713s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300713s%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DMencken%26aufirst%3DT.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DJ.%2BD.%26aulast%3DSigethy%26aufirst%3DS.%2BD.%26aulast%3DTomberlin%26aufirst%3DG.%2BH.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26atitle%3DDiscovery%2520of%25207-methyl-5-%25281-%257B%255B3-%2528trifluoromethyl%2529phenyl%255Dacetyl%257D-2%252C3-dihydro-1H-indol-5-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amine%2520%2528GSK2606414%2529%252C%2520a%2520potent%2520and%2520selective%2520first-in-class%2520inhibitor%2520of%2520protein%2520kinase%2520R%2520%2528PKR%2529-like%2520endoplasmic%2520reticulum%2520kinase%2520%2528PERK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7193%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryazanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan-Montojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitteregger-Kretzschmar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geissen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinth, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bähr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weishaupt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urlaub, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teichmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bötzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groschup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span> </span><span class="NLM_article-title">Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1007%2Fs00401-013-1114-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23604588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=795-813&author=J.+Wagnerauthor=S.+Ryazanovauthor=A.+Leonovauthor=J.+Levinauthor=S.+Shiauthor=F.+Schmidtauthor=C.+Prixauthor=F.+Pan-Montojoauthor=U.+Bertschauthor=G.+Mitteregger-Kretzschmarauthor=M.+Geissenauthor=M.+Eidenauthor=F.+Leidelauthor=T.+Hirschbergerauthor=A.+Deegauthor=J.+Krauthauthor=W.+Zinthauthor=P.+Tavanauthor=J.+Pilgerauthor=M.+Zweckstetterauthor=T.+Frankauthor=M.+B%C3%A4hrauthor=J.+Weishauptauthor=M.+Uhrauthor=H.+Urlaubauthor=U.+Teichmannauthor=M.+Samwerauthor=K.+B%C3%B6tzelauthor=M.+Groschupauthor=H.+Kretzschmarauthor=C.+Griesingerauthor=A.+Giese&title=Anle138b%3A+a+novel+oligomer+modulator+for+disease-modifying+therapy+of+neurodegenerative+diseases+such+as+prion+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease</span></div><div class="casAuthors">Wagner, Jens; Ryazanov, Sergey; Leonov, Andrei; Levin, Johannes; Shi, Song; Schmidt, Felix; Prix, Catharina; Pan-Montojo, Francisco; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Geissen, Markus; Eiden, Martin; Leidel, Fabienne; Hirschberger, Thomas; Deeg, Andreas A.; Krauth, Julian J.; Zinth, Wolfgang; Tavan, Paul; Pilger, Jens; Zweckstetter, Markus; Frank, Tobias; Baehr, Mathias; Weishaupt, Jochen H.; Uhr, Manfred; Urlaub, Henning; Teichmann, Ulrike; Samwer, Matthias; Boetzel, Kai; Groschup, Martin; Kretzschmar, Hans; Griesinger, Christian; Giese, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-813</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and prion diseases, deposits of aggregated disease-specific proteins are found.  Oligomeric aggregates are presumed to be the key neurotoxic agent.  Here we describe the novel oligomer modulator anle138b [3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole], an aggregation inhibitor we developed based on a systematic high-throughput screening campaign combined with medicinal chem. optimization.  In vitro, anle138b blocked the formation of pathol. aggregates of prion protein (PrPSc) and of α-synuclein (α-syn), which is deposited in PD and other synucleinopathies such as dementia with Lewy bodies (DLB) and multiple system atrophy (MSA).  Notably, anle138b strongly inhibited all prion strains tested including BSE-derived and human prions.  Anle138b showed structure-dependent binding to pathol. aggregates and strongly inhibited formation of pathol. oligomers in vitro and in vivo both for prion protein and α-synuclein.  Both in mouse models of prion disease and in three different PD mouse models, anle138b strongly inhibited oligomer accumulation, neuronal degeneration, and disease progression in vivo.  Anle138b had no detectable toxicity at therapeutic doses and an excellent oral bioavailability and blood-brain-barrier penetration.  Our findings indicate that oligomer modulators provide a new approach for disease-modifying therapy in these diseases, for which only symptomatic treatment is available so far.  Moreover, our findings suggest that pathol. oligomers in neurodegenerative diseases share structural features, although the main protein component is disease-specific, indicating that compds. such as anle138b that modulate oligomer formation by targeting structure-dependent epitopes can have a broad spectrum of activity in the treatment of different protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqFugFNqNrQrVg90H21EOLACvtfcHk0lhkhF5j8qPWLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWjtbk%253D&md5=a4d8b1caeddbac35bd64421cdb49b718</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1114-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1114-9%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DRyazanov%26aufirst%3DS.%26aulast%3DLeonov%26aufirst%3DA.%26aulast%3DLevin%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DPrix%26aufirst%3DC.%26aulast%3DPan-Montojo%26aufirst%3DF.%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DMitteregger-Kretzschmar%26aufirst%3DG.%26aulast%3DGeissen%26aufirst%3DM.%26aulast%3DEiden%26aufirst%3DM.%26aulast%3DLeidel%26aufirst%3DF.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DDeeg%26aufirst%3DA.%26aulast%3DKrauth%26aufirst%3DJ.%26aulast%3DZinth%26aufirst%3DW.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DPilger%26aufirst%3DJ.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DFrank%26aufirst%3DT.%26aulast%3DB%25C3%25A4hr%26aufirst%3DM.%26aulast%3DWeishaupt%26aufirst%3DJ.%26aulast%3DUhr%26aufirst%3DM.%26aulast%3DUrlaub%26aufirst%3DH.%26aulast%3DTeichmann%26aufirst%3DU.%26aulast%3DSamwer%26aufirst%3DM.%26aulast%3DB%25C3%25B6tzel%26aufirst%3DK.%26aulast%3DGroschup%26aufirst%3DM.%26aulast%3DKretzschmar%26aufirst%3DH.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DGiese%26aufirst%3DA.%26atitle%3DAnle138b%253A%2520a%2520novel%2520oligomer%2520modulator%2520for%2520disease-modifying%2520therapy%2520of%2520neurodegenerative%2520diseases%2520such%2520as%2520prion%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26spage%3D795%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Berry, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span> </span><span class="NLM_article-title">Drug resistance confounding prion therapeutics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E4160</span><span class="NLM_x">–</span> <span class="NLM_lpage">4169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E4160-4169&author=D.+B.+Berryauthor=D.+Luauthor=M.+Gevaauthor=J.+C.+Wattsauthor=S.+Bhardwajauthor=A.+Oehlerauthor=A.+R.+Rensloauthor=S.+J.+DeArmondauthor=S.+B.+Prusinerauthor=K.+Giles&title=Drug+resistance+confounding+prion+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DD.%2BB.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DGeva%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DJ.%2BC.%26aulast%3DBhardwaj%26aufirst%3DS.%26aulast%3DOehler%26aufirst%3DA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DGiles%26aufirst%3DK.%26atitle%3DDrug%2520resistance%2520confounding%2520prion%2520therapeutics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3DE4160%26epage%3D4169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kocisko, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuizon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caughey, B.</span><span> </span><span class="NLM_article-title">New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">10288</span><span class="NLM_x">–</span> <span class="NLM_lpage">10294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.77.19.10288-10294.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=12970413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFymsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=10288-10294&author=D.+A.+Kociskoauthor=G.+S.+Baronauthor=R.+Rubensteinauthor=J.+Chenauthor=S.+Kuizonauthor=B.+Caughey&title=New+inhibitors+of+scrapie-associated+prion+protein+formation+in+a+library+of+2000+drugs+and+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products</span></div><div class="casAuthors">Kocisko, David A.; Baron, Gerald S.; Rubenstein, Richard; Chen, Jiancao; Kuizon, Salomon; Caughey, Byron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10288-10294</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transmissible spongiform encephalopathies (TSEs) are fatal, untreatable neurodegenerative diseases assocd. with the accumulation of a disease-specific form of prion protein (PrP) in the brain.  One approach to TSE therapeutics is the inhibition of PrP accumulation.  Indeed, many inhibitors of the accumulation of PrP assocd. with scrapie (PrPSc) in scrapie-infected mouse neuroblastoma cells (ScN2a) also have antiscrapie activity in rodents.  To expedite the search for potential TSE therapeutic agents, we have developed a high-throughput screening assay for PrPSc inhibitors using ScN2a cells in a 96-well format.  A library of 2000 drugs and natural products was screened in ScN2a cells infected with scrapie strain RML (Chandler) or 22L.  Forty compds. were found to have concns. causing 50% inhibition (IC50s) of PrPSc accumulation of ≤10 μM against both strains.  Seventeen had IC50s of ≤1 μM against both strains.  Several classes of compds. were represented in the 17 most potent inhibitors, including naturally occurring polyphenols (e.g., tannic acid and tea exts.), phenothiazines, antihistamines, statins, and antimalarial compds.  These 17 compds. were also evaluated in a solid-phase cell-free hamster PrP conversion assay.  Only the polyphenols inhibited the cell-free reaction, and their IC50s were near 100 nM.  Several of the new PrPSc inhibitors cross the blood-brain barrier and thus have potential to be effective after TSE infection reaches the brain.  The fact that many are either approved human drugs or edible natural products should facilitate their use in animal testing and clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1vcriJCP_s7Vg90H21EOLACvtfcHk0lhkhF5j8qPWLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFymsL8%253D&md5=598d71a1e2e72514ac69124221e2204a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.19.10288-10294.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.19.10288-10294.2003%26sid%3Dliteratum%253Aachs%26aulast%3DKocisko%26aufirst%3DD.%2BA.%26aulast%3DBaron%26aufirst%3DG.%2BS.%26aulast%3DRubenstein%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuizon%26aufirst%3DS.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DNew%2520inhibitors%2520of%2520scrapie-associated%2520prion%2520protein%2520formation%2520in%2520a%2520library%2520of%25202000%2520drugs%2520and%2520natural%2520products%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D10288%26epage%3D10294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winklhofer, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatzelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span> </span><span class="NLM_article-title">Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">7785</span><span class="NLM_x">–</span> <span class="NLM_lpage">7791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.79.12.7785-7791.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=15919931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=7785-7791&author=U.+Bertschauthor=K.+F.+Winklhoferauthor=T.+Hirschbergerauthor=J.+Bieschkeauthor=P.+Weberauthor=F.+U.+Hartlauthor=P.+Tavanauthor=J.+Tatzeltauthor=H.+A.+Kretzschmarauthor=A.+Giese&title=Systematic+identification+of+antiprion+drugs+by+high-throughput+screening+based+on+scanning+for+intensely+fluorescent+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets</span></div><div class="casAuthors">Bertsch, Uwe; Winklhofer, Konstanze F.; Hirschberger, Thomas; Bieschke, Jan; Weber, Petra; Hartl, F. Ulrich; Tavan, Paul; Tatzelt, Joerg; Kretzschmar, Hans A.; Giese, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7785-7791</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Conformational changes and aggregation of specific proteins are hallmarks of a no. of diseases, like Alzheimer's disease, Parkinson's disease, and prion diseases.  In the case of prion diseases, the prion protein (PrP), a neuronal glycoprotein, undergoes a conformational change from the normal, mainly alpha-helical conformation to a disease-assocd., mainly beta-sheeted scrapie isoform (PrPSc), which forms amyloid aggregates.  This conversion, which is crucial for disease progression, depends on direct PrPC/PrPSc interaction.  The authors developed a high-throughput assay based on scanning for intensely fluorescent targets (SIFT) for the identification of drugs which interfere with this interaction at the mol. level.  Screening of a library of 10,000 drug-like compds. yielded 256 primary hits, 80 of which were confirmed by dose response curves with half-maximal inhibitory effects ranging from 0.3 to 60 μM.  Among these, six compds. displayed an inhibitory effect on PrPSc propagation in scrapie-infected N2a cells.  Four of these candidate drugs share an N'-benzylidene-benzohydrazide core structure.  Thus, the combination of high-throughput in vitro assay with the established cell culture system provides a rapid and efficient method to identify new antiprion drugs, which corroborates that interaction of PrPC and PrPSc is a crucial mol. step in the propagation of prions.  Moreover, SIFT-based screening may facilitate the search for drugs against other diseases linked to protein aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo8imCfuT6srVg90H21EOLACvtfcHk0lgEp7rNjyIDQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsb8%253D&md5=ea1bf08e5fb885976f501e97682f4d71</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.12.7785-7791.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.12.7785-7791.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DWinklhofer%26aufirst%3DK.%2BF.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DTatzelt%26aufirst%3DJ.%26aulast%3DKretzschmar%26aufirst%3DH.%2BA.%26aulast%3DGiese%26aufirst%3DA.%26atitle%3DSystematic%2520identification%2520of%2520antiprion%2520drugs%2520by%2520high-throughput%2520screening%2520based%2520on%2520scanning%2520for%2520intensely%2520fluorescent%2520targets%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D7785%26epage%3D7791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Discovery of 2-aminothiazoles as potent antiprion compounds</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.02145-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=20032192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFOgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=3408-3412&author=S.+Ghaemmaghamiauthor=B.+C.+Mayauthor=A.+R.+Rensloauthor=S.+B.+Prusiner&title=Discovery+of+2-aminothiazoles+as+potent+antiprion+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-aminothiazoles as potent antiprion compounds</span></div><div class="casAuthors">Ghaemmaghami, Sina; May, Barnaby C. H.; Renslo, Adam R.; Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3408-3412</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Prion diseases are fatal, untreatable neurodegenerative diseases caused by the accumulation of the misfolded, infectious isoform of the prion protein (PrP), termed PrPSc.  In an effort to identify novel inhibitors of prion formation, we utilized a high-throughput ELISA to evaluate PrPSc redn. in prion-infected neuroblastoma cell lines (ScN2a).  We screened a library of ∼10,000 diverse small mols. in 96-well format and identified 121 compds. that reduced PrPSc levels at a concn. of 5 μM.  Four chem. scaffolds were identified as potential candidates for chem. optimization based on the presence of preliminary structure-activity relationships (SAR) derived from the primary screening data.  A follow-up anal. of a group of com. available 2-aminothiazoles showed this class as generally active in ScN2a cells.  Our results establish 2-aminothiazoles as promising candidates for efficacy studies of animals and validate our drug discovery platform as a viable strategy for the identification of novel lead compds. with antiprion properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw0XXaqciXgLVg90H21EOLACvtfcHk0lgEp7rNjyIDQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFOgt7w%253D&md5=f65520e1f3bf9949f3f8fa42bb47495c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FJVI.02145-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02145-09%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DMay%26aufirst%3DB.%2BC.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DDiscovery%2520of%25202-aminothiazoles%2520as%2520potent%2520antiprion%2520compounds%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0lgAmuL99U07jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of <i>N</i>-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3766</span><span class="NLM_x">–</span> <span class="NLM_lpage">3769</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060347y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3766-3769&author=R.+M.+Borzilleriauthor=R.+S.+Bhideauthor=J.+C.+Barrishauthor=C.+J.+D%E2%80%99Arienzoauthor=G.+M.+Derbinauthor=J.+Fargnoliauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=D.+W.+Kukralauthor=P.+Maratheauthor=S.+Mortilloauthor=L.+Qianauthor=J.+S.+Tokarskiauthor=B.+S.+Wautletauthor=X.+Zhengauthor=L.+J.+Lombardo&title=Discovery+and+evaluation+of+N-cyclopropyl-2%2C4-difluoro-5-%28%282-%28pyridin-2-ylamino%29thiazol-5-ylmethyl%29amino%29benzamide+%28BMS-605541%29%2C+a+selective+and+orally+efficacious+inhibitor+of+vascular+endothelial+growth+factor+receptor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060347y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060347y%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DDerbin%26aufirst%3DG.%2BM.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520N-cyclopropyl-2%252C4-difluoro-5-%2528%25282-%2528pyridin-2-ylamino%2529thiazol-5-ylmethyl%2529amino%2529benzamide%2520%2528BMS-605541%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3766%26epage%3D3769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">2-Aminothiazole as a novel kinase inhibitor template. Structure–activity relationship studies toward the discovery of <i>N</i>-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6819</span><span class="NLM_x">–</span> <span class="NLM_lpage">6832</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060727j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6819-6832&author=J.+Dasauthor=P.+Chenauthor=D.+Norrisauthor=R.+Padmanabhaauthor=J.+Linauthor=R.+V.+Moquinauthor=Z.+Shenauthor=L.+S.+Cookauthor=A.+M.+Doweykoauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=Q.+Fangauthor=H.+F.+de+Fexauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+M.+Gilloolyauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+Wityakauthor=J.+C.+Barrish&title=2-Aminothiazole+as+a+novel+kinase+inhibitor+template.+Structure%E2%80%93activity+relationship+studies+toward+the+discovery+of+N-%282-chloro-6-methylphenyl%29-2-%5B%5B6-%5B4-%282-hydroxyethyl%29-1-piperazinyl%29%5D-2-methyl-4-pyrimidinyl%5Damino%29%5D-1%2C3-thiazole-5-carboxamide+%28dasatinib%2C+BMS-354825%29+as+a+potent+pan-Src+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060727j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060727j%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DPadmanabha%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DL.%2BS.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3Dde%2BFex%26aufirst%3DH.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3D2-Aminothiazole%2520as%2520a%2520novel%2520kinase%2520inhibitor%2520template.%2520Structure%25E2%2580%2593activity%2520relationship%2520studies%2520toward%2520the%2520discovery%2520of%2520N-%25282-chloro-6-methylphenyl%2529-2-%255B%255B6-%255B4-%25282-hydroxyethyl%2529-1-piperazinyl%2529%255D-2-methyl-4-pyrimidinyl%255Damino%2529%255D-1%252C3-thiazole-5-carboxamide%2520%2528dasatinib%252C%2520BMS-354825%2529%2520as%2520a%2520potent%2520pan-Src%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6819%26epage%3D6832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Press, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fullerton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberthuer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Press, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffnell, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span> </span><span class="NLM_article-title">A new orally bioavailable dual adenosine a2b/a3 receptor antagonist with therapeutic potential</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3081</span><span class="NLM_x">–</span> <span class="NLM_lpage">3085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3081-3085&author=N.+J.+Pressauthor=R.+J.+Taylorauthor=J.+D.+Fullertonauthor=P.+Tranterauthor=C.+McCarthyauthor=T.+H.+Kellerauthor=L.+Brownauthor=R.+Cheungauthor=J.+Christieauthor=S.+Haberthuerauthor=J.+D.+Hattoauthor=M.+Keenanauthor=M.+K.+Mercerauthor=N.+E.+Pressauthor=H.+Sahriauthor=A.+R.+Tuffnellauthor=M.+Tweedauthor=J.+R.+Fozard&title=A+new+orally+bioavailable+dual+adenosine+a2b%2Fa3+receptor+antagonist+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCheung%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DJ.%26aulast%3DHaberthuer%26aufirst%3DS.%26aulast%3DHatto%26aufirst%3DJ.%2BD.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DM.%2BK.%26aulast%3DPress%26aufirst%3DN.%2BE.%26aulast%3DSahri%26aufirst%3DH.%26aulast%3DTuffnell%26aufirst%3DA.%2BR.%26aulast%3DTweed%26aufirst%3DM.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26atitle%3DA%2520new%2520orally%2520bioavailable%2520dual%2520adenosine%2520a2b%252Fa3%2520receptor%2520antagonist%2520with%2520therapeutic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3081%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">van Muijlwijk-Koezen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frijtag von Drabbe Kunzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0003945" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=749-762&author=J.+E.+van+Muijlwijk-Koezenauthor=H.+Timmermanauthor=R.+C.+Vollingaauthor=J.+Frijtag+von+Drabbe+Kunzelauthor=M.+de+Grooteauthor=S.+Visserauthor=A.+P.+Ijzerman&title=Thiazole+and+thiadiazole+analogues+as+a+novel+class+of+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0003945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003945%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMuijlwijk-Koezen%26aufirst%3DJ.%2BE.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DVollinga%26aufirst%3DR.%2BC.%26aulast%3DFrijtag%2Bvon%2BDrabbe%2BKunzel%26aufirst%3DJ.%26aulast%3Dde%2BGroote%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DS.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DThiazole%2520and%2520thiadiazole%2520analogues%2520as%2520a%2520novel%2520class%2520of%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D749%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Turcotte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutphin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span> </span><span class="NLM_article-title">A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=90-102&author=S.+Turcotteauthor=D.+A.+Chanauthor=P.+D.+Sutphinauthor=M.+P.+Hayauthor=W.+A.+Dennyauthor=A.+J.+Giaccia&title=A+molecule+targeting+VHL-deficient+renal+cell+carcinoma+that+induces+autophagy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DA%2520molecule%2520targeting%2520VHL-deficient%2520renal%2520cell%2520carcinoma%2520that%2520induces%2520autophagy%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D90%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lubbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolidon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Aminothiazoles as gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6554</span><span class="NLM_x">–</span> <span class="NLM_lpage">6558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6554-6558&author=T.+Lubbersauthor=A.+Flohrauthor=S.+Jolidonauthor=P.+David-Piersonauthor=H.+Jacobsenauthor=L.+Ozmenauthor=K.+Baumann&title=Aminothiazoles+as+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLubbers%26aufirst%3DT.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DAminothiazoles%2520as%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6554%26epage%3D6558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.+M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fife, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">2-Aminothiazoles as therapeutic leads for prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101250y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1010-1021&author=A.+Gallardo-Godoyauthor=J.+Geverauthor=K.+L.+Fifeauthor=B.+M.+Silberauthor=S.+B.+Prusinerauthor=A.+R.+Renslo&title=2-Aminothiazoles+as+therapeutic+leads+for+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm101250y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101250y%26sid%3Dliteratum%253Aachs%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DGever%26aufirst%3DJ.%26aulast%3DFife%26aufirst%3DK.%2BL.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3D2-Aminothiazoles%2520as%2520therapeutic%2520leads%2520for%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1010%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolghih, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widjaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=847-857&author=Z.+Liauthor=B.+M.+Silberauthor=S.+Raoauthor=J.+R.+Geverauthor=C.+Bryantauthor=A.+Gallardo-Godoyauthor=E.+Dolghihauthor=K.+Widjajaauthor=M.+Elepanoauthor=M.+P.+Jacobsonauthor=S.+B.+Prusinerauthor=A.+R.+Renslo&title=2-Aminothiazoles+with+improved+pharmacotherapeutic+properties+for+treatment+of+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DDolghih%26aufirst%3DE.%26aulast%3DWidjaja%26aufirst%3DK.%26aulast%3DElepano%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3D2-Aminothiazoles%2520with%2520improved%2520pharmacotherapeutic%2520properties%2520for%2520treatment%2520of%2520prion%2520disease%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D847%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Chemical induction of misfolded prion protein conformers in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">10415</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10415-10423&author=S.+Ghaemmaghamiauthor=J.+Ullmanauthor=M.+Ahnauthor=S.+St+Martinauthor=S.+B.+Prusiner&title=Chemical+induction+of+misfolded+prion+protein+conformers+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DUllman%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DSt%2BMartin%26aufirst%3DS.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DChemical%2520induction%2520of%2520misfolded%2520prion%2520protein%2520conformers%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10415%26epage%3D10423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fife, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=932-950&author=B.+M.+Silberauthor=S.+Raoauthor=K.+L.+Fifeauthor=A.+Gallardo-Godoyauthor=A.+R.+Rensloauthor=D.+K.+Dalvieauthor=K.+Gilesauthor=Y.+Freymanauthor=M.+Elepanoauthor=J.+R.+Geverauthor=Z.+Liauthor=M.+P.+Jacobsonauthor=Y.+Huangauthor=L.+Z.+Benetauthor=S.+B.+Prusiner&title=Pharmacokinetics+and+metabolism+of+2-aminothiazoles+with+antiprion+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DFife%26aufirst%3DK.%2BL.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DFreyman%26aufirst%3DY.%26aulast%3DElepano%26aufirst%3DM.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%25202-aminothiazoles%2520with%2520antiprion%2520activity%2520in%2520mice%26jtitle%3DPharm.%2520Res.%26date%3D2013%26volume%3D30%26spage%3D932%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolghih, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1124%2Fjpet.113.205799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23965382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=325-338&author=D.+Luauthor=K.+Gilesauthor=Z.+Liauthor=S.+Raoauthor=E.+Dolghihauthor=J.+R.+Geverauthor=M.+Gevaauthor=M.+L.+Elepanoauthor=A.+Oehlerauthor=C.+Bryantauthor=A.+R.+Rensloauthor=M.+P.+Jacobsonauthor=S.+J.+Dearmondauthor=B.+M.+Silberauthor=S.+B.+Prusiner&title=Biaryl+amides+and+hydrazones+as+therapeutics+for+prion+disease+in+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice</span></div><div class="casAuthors">Lu, Duo; Giles, Kurt; Li, Zhe; Rao, Satish; Dolghih, Elena; Gever, Joel R.; Geva, Michal; Elepano, Manuel L.; Oehler, Abby; Bryant, Clifford; Renslo, Adam R.; Jacobson, Matthew P.; DeArmond, Stephen J.; Silber, B. Michael; Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-338</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The only small-mol. compd. demonstrated to substantially extend survival in prion-infected mice is a biaryl hydrazone termed "Compd B" (4-pyridinecarboxaldehyde,2-[4-(5-oxazolyl)phenyl]hydrazone).  However, the hydrazone moiety of Compd B results in toxic metabolites, making it a poor candidate for further drug development.  We developed a pharmacophore model based on diverse antiprion compds. identified by high-throughput screening; based on this model, we generated biaryl amide analogs of Compd B.  Medicinal chem. optimization led to multiple compds. with increased potency, increased brain concns., and greater metabolic stability, indicating that they could be promising candidates for antiprion therapy.  Replacing the pyridyl ring of Compd B with a Ph group contg. an electron-donating substituent increased potency, while adding an aryl group to the oxazole moiety increased metabolic stability.  To test the efficacy of Compd B, we applied bioluminescence imaging (BLI), which was previously shown to detect prion disease onset in live mice earlier than clin. signs.  In our studies, Compd B showed good efficacy in two lines of transgenic mice infected with the mouse-adapted Rocky Mountain Lab. (RML) strain of prions, but not in transgenic mice infected with human prions.  The BLI system successfully predicted the efficacies in all cases long before extension in survival could be obsd.  Our studies suggest that this BLI system has good potential to be applied in future antiprion drug efficacy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pfysI0-wIbVg90H21EOLACvtfcHk0lhwMv9XP6IVjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsL3P&md5=9fedbf2b5876b9e2551797714a69c90b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.205799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.205799%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DD.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DDolghih%26aufirst%3DE.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DGeva%26aufirst%3DM.%26aulast%3DElepano%26aufirst%3DM.%2BL.%26aulast%3DOehler%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DBiaryl%2520amides%2520and%2520hydrazones%2520as%2520therapeutics%2520for%2520prion%2520disease%2520in%2520transgenic%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D325%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelschlegel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">Darwinian evolution of prions in cell culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=869-872&author=J.+Liauthor=S.+Browningauthor=S.+P.+Mahalauthor=A.+M.+Oelschlegelauthor=C.+Weissmann&title=Darwinian+evolution+of+prions+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBrowning%26aufirst%3DS.%26aulast%3DMahal%26aufirst%3DS.%2BP.%26aulast%3DOelschlegel%26aufirst%3DA.%2BM.%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DDarwinian%2520evolution%2520of%2520prions%2520in%2520cell%2520culture%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D869%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Miller-Vedam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span> </span><span class="NLM_article-title">Strain specificity and drug resistance in anti-prion therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F15680266113136660168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24059341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWhu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2397-2406&author=L.+Miller-Vedamauthor=S.+Ghaemmaghami&title=Strain+specificity+and+drug+resistance+in+anti-prion+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Strain Specificity and Drug Resistance in Anti-Prion Therapy</span></div><div class="casAuthors">Miller-Vedam, Lakshmi; Ghaemmaghami, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2397-2406</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases are a group of fatal neurodegenerative diseases caused by the misfolding of cellular prion protein (PrPC) into pathogenic conformers (PrPSc).  Although no effective therapies for prion diseases are currently available, a no. of small mol. inhibitors have been identified that are capable of reducing or eliminating PrPSc in prion infected cells.  However, recent expts. have shown that upon sustained treatment, prions have the capacity to evolve into drug resistant conformations.  These studies suggest that the mechanism of prion strain adaptation involves rare conformational conversions followed by competitive selection among the heterogeneous pool of PrPSc conformers.  The plasticity of prion conformers makes PrPSc a particularly challenging drug target and suggests that combination drug therapies or targeting of PrPC may be required for effective therapy.  In this review, we highlight recent literature that demonstrate the phenomenon of prion drug resistance and strain specificity, and discuss potential ramifications for therapeutic efforts against prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_PpzUIKI0E7Vg90H21EOLACvtfcHk0lhwMv9XP6IVjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWhu7jM&md5=4ff4a30725315b4680cfa0d657f7bf7e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F15680266113136660168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113136660168%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Vedam%26aufirst%3DL.%26aulast%3DGhaemmaghami%26aufirst%3DS.%26atitle%3DStrain%2520specificity%2520and%2520drug%2520resistance%2520in%2520anti-prion%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D2397%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Cell biology. A unifying role for prions in neurodegenerative diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=1511-1513&author=S.+B.+Prusiner&title=Cell+biology.+A+unifying+role+for+prions+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DCell%2520biology.%2520A%2520unifying%2520role%2520for%2520prions%2520in%2520neurodegenerative%2520diseases%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D1511%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span> </span><span class="NLM_article-title">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnature12481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24005412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=45-51&author=M.+Juckerauthor=L.+C.+Walker&title=Self-propagation+of+pathogenic+protein+aggregates+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias; Walker, Lary C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7465</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biol. of the prion diseases.  Recently, owing largely to the advent of new disease models, this hypothesis has gained exptl. momentum.  In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid.  Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease.  Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin.  However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function.  As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZxraDJnKbbVg90H21EOLACvtfcHk0lgS42ZFSeiFxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP&md5=6e10e4c3d25f9a907b7af8944cb1ba69</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature12481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12481%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26atitle%3DSelf-propagation%2520of%2520pathogenic%2520protein%2520aggregates%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Guo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Distinct alpha-synuclein strains differentially promote tau inclusions in neurons</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1016%2Fj.cell.2013.05.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23827677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=103-117&author=J.+L.+Guoauthor=D.+J.+Covellauthor=J.+P.+Danielsauthor=M.+Ibaauthor=A.+Stieberauthor=B.+Zhangauthor=D.+M.+Riddleauthor=L.+K.+Kwongauthor=Y.+Xuauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Distinct+alpha-synuclein+strains+differentially+promote+tau+inclusions+in+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct α-synuclein strains differentially promote Tau inclusions in neurons</span></div><div class="casAuthors">Guo, Jing L.; Covell, Dustin J.; Daniels, Joshua P.; Iba, Michiyo; Stieber, Anna; Zhang, Bin; Riddle, Dawn M.; Kwong, Linda K.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-117</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many neurodegenerative diseases are characterized by the accumulation of insol. protein aggregates, including neurofibrillary tangles comprised of tau in Alzheimer's disease and Lewy bodies composed of α-synuclein in Parkinson's disease.  Moreover, different pathol. proteins frequently codeposit in disease brains.  To test whether aggregated α-synuclein can directly cross-seed tau fibrillization, we administered preformed α-synuclein fibrils assembled from recombinant protein to primary neurons and transgenic mice.  Remarkably, we discovered two distinct strains of synthetic α-synuclein fibrils that demonstrated striking differences in the efficiency of cross-seeding tau aggregation, both in neuron cultures and in vivo.  Proteinase K digestion revealed conformational differences between the two synthetic α-synuclein strains and also between sarkosyl-insol. α-synuclein extd. from two subgroups of Parkinson's disease brains.  We speculate that distinct strains of pathol. α-synuclein likely exist in neurodegenerative disease brains and may underlie the tremendous heterogeneity of synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob08jmoYbLqbVg90H21EOLACvtfcHk0lgS42ZFSeiFxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGktbzE&md5=02b6b2f5f06b5b44a8e751636591359f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%2BL.%26aulast%3DCovell%26aufirst%3DD.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BP.%26aulast%3DIba%26aufirst%3DM.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRiddle%26aufirst%3DD.%2BM.%26aulast%3DKwong%26aufirst%3DL.%2BK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DDistinct%2520alpha-synuclein%2520strains%2520differentially%2520promote%2520tau%2520inclusions%2520in%2520neurons%26jtitle%3DCell%26date%3D2013%26volume%3D154%26spage%3D103%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Clavaguera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hench, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichwald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span> </span><span class="NLM_article-title">Brain homogenates from human tauopathies induce tau inclusions in mouse brain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">9535</span><span class="NLM_x">–</span> <span class="NLM_lpage">9540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=9535-9540&author=F.+Clavagueraauthor=H.+Akatsuauthor=G.+Fraserauthor=R.+A.+Crowtherauthor=S.+Frankauthor=J.+Henchauthor=A.+Probstauthor=D.+T.+Winklerauthor=J.+Reichwaldauthor=M.+Staufenbielauthor=B.+Ghettiauthor=M.+Goedertauthor=M.+Tolnay&title=Brain+homogenates+from+human+tauopathies+induce+tau+inclusions+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClavaguera%26aufirst%3DF.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DHench%26aufirst%3DJ.%26aulast%3DProbst%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DD.%2BT.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DTolnay%26aufirst%3DM.%26atitle%3DBrain%2520homogenates%2520from%2520human%2520tauopathies%2520induce%2520tau%2520inclusions%2520in%2520mouse%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D9535%26epage%3D9540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4383-4438. <a href="https://doi.org/10.1021/jm501853m" title="DOI URL">https://doi.org/10.1021/jm501853m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501853m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSurvey%252Bof%252Bthe%252BRole%252Bof%252BNoncovalent%252BSulfur%252BInteractions%252Bin%252BDrug%252BDesign%26aulast%3DBeno%26aufirst%3DBrett%2BR.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01122014%26date%3D03032015%26date%3D11062015%26volume%3D58%26issue%3D11%26spage%3D4383%26epage%3D4438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satish K.  Nemani</span>, <span class="hlFld-ContribAuthor ">Xiangzhu  Xiao</span>, <span class="hlFld-ContribAuthor ">Ignazio  Cali</span>, <span class="hlFld-ContribAuthor ">Laura  Cracco</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Puoti</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Nigro</span>, <span class="hlFld-ContribAuthor ">Jody  Lavrich</span>, <span class="hlFld-ContribAuthor ">Anuradha  Bharara Singh</span>, <span class="hlFld-ContribAuthor ">Brian S.  Appleby</span>, <span class="hlFld-ContribAuthor ">Valerie L.  Sim</span>, <span class="hlFld-ContribAuthor ">Silvio  Notari</span>, <span class="hlFld-ContribAuthor ">Witold K.  Surewicz</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Gambetti</span>. </span><span class="cited-content_cbyCitation_article-title">A novel mechanism of phenotypic heterogeneity in Creutzfeldt-Jakob disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-020-00966-x" title="DOI URL">https://doi.org/10.1186/s40478-020-00966-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-020-00966-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-020-00966-x%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DA%252Bnovel%252Bmechanism%252Bof%252Bphenotypic%252Bheterogeneity%252Bin%252BCreutzfeldt-Jakob%252Bdisease%26aulast%3DNemani%26aufirst%3DSatish%2BK.%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Altieri</span>, <span class="hlFld-ContribAuthor ">Evgeny A.  Spiridonov</span>, <span class="hlFld-ContribAuthor ">Semen I.  Sivtzev</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ishibashi</span>, <span class="hlFld-ContribAuthor ">Silvia  Biggi</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Nishida</span>, <span class="hlFld-ContribAuthor ">Emiliano  Biasini</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Kurkin</span>. </span><span class="cited-content_cbyCitation_article-title">Generation, optimization and characterization of novel anti-prion compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (21)
                                     , 115717. <a href="https://doi.org/10.1016/j.bmc.2020.115717" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115717%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DGeneration%25252C%252Boptimization%252Band%252Bcharacterization%252Bof%252Bnovel%252Banti-prion%252Bcompounds%26aulast%3DAltieri%26aufirst%3DAndrea%26date%3D2020%26volume%3D28%26issue%3D21%26spage%3D115717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raissa A.  Conceição</span>, <span class="hlFld-ContribAuthor ">Lucas M.  Ascari</span>, <span class="hlFld-ContribAuthor ">Natália C.  Ferreira</span>, <span class="hlFld-ContribAuthor ">Carolina F.  Goes</span>, <span class="hlFld-ContribAuthor ">Carolina O.  Matos</span>, <span class="hlFld-ContribAuthor ">Anderson S.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Marina A.  Alves</span>, <span class="hlFld-ContribAuthor ">Alessandra M. T.  Souza</span>, <span class="hlFld-ContribAuthor ">Rodolfo C.  Maia</span>, <span class="hlFld-ContribAuthor ">Byron  Caughey</span>, <span class="hlFld-ContribAuthor ">Yraima  Cordeiro</span>, <span class="hlFld-ContribAuthor ">Maria Letícia C.  Barbosa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in silico and in vitro evaluation of trimethoxy-benzamides designed as anti-prion derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (12)
                                     , 2128-2141. <a href="https://doi.org/10.1007/s00044-019-02441-2" title="DOI URL">https://doi.org/10.1007/s00044-019-02441-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02441-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02441-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bin%252Bsilico%252Band%252Bin%252Bvitro%252Bevaluation%252Bof%252Btrimethoxy-benzamides%252Bdesigned%252Bas%252Banti-prion%252Bderivatives%26aulast%3DConcei%25C3%25A7%25C3%25A3o%26aufirst%3DRaissa%2BA.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D12%26spage%3D2128%26epage%3D2141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio  Moda</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Legname</span>. </span><span class="cited-content_cbyCitation_article-title">Novel screening approaches for human prion diseases drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 983-993. <a href="https://doi.org/10.1080/17460441.2019.1637851" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637851%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bscreening%252Bapproaches%252Bfor%252Bhuman%252Bprion%252Bdiseases%252Bdrug%252Bdiscovery%26aulast%3DModa%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carol L.  Ladner-Keay</span>, <span class="hlFld-ContribAuthor ">Li  Ross</span>, <span class="hlFld-ContribAuthor ">Rolando  Perez-Pineiro</span>, <span class="hlFld-ContribAuthor ">Lun  Zhang</span>, <span class="hlFld-ContribAuthor ">Trent C.  Bjorndahl</span>, <span class="hlFld-ContribAuthor ">Neil  Cashman</span>, <span class="hlFld-ContribAuthor ">David S.  Wishart</span>. </span><span class="cited-content_cbyCitation_article-title">A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds. </span><span class="cited-content_cbyCitation_journal-name">Prion</span><span> <strong>2018,</strong> <em>12 </em>
                                    (5-6)
                                     , 280-300. <a href="https://doi.org/10.1080/19336896.2018.1525254" title="DOI URL">https://doi.org/10.1080/19336896.2018.1525254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/19336896.2018.1525254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F19336896.2018.1525254%26sid%3Dliteratum%253Aachs%26jtitle%3DPrion%26atitle%3DA%252Bsimple%252Bin%252Bvitro%252Bassay%252Bfor%252Bassessing%252Bthe%252Befficacy%25252C%252Bmechanisms%252Band%252Bkinetics%252Bof%252Banti-prion%252Bfibril%252Bcompounds%26aulast%3DLadner-Keay%26aufirst%3DCarol%2BL.%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3D5-6%26spage%3D280%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanlan  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Wen-Juan  Jia</span>, <span class="hlFld-ContribAuthor ">Yongchang  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiang-Huai  Chen</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Tian</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Yong-Xing  He</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2017,</strong> <em>31 </em>
                                    (12)
                                     , 1053-1062. <a href="https://doi.org/10.1007/s10822-017-0086-6" title="DOI URL">https://doi.org/10.1007/s10822-017-0086-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-017-0086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-017-0086-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bbinding%252Bto%252Bthe%252Bnormal%252Bconformation%252Bof%252Bprion%252Bby%252Bcombining%252Bvirtual%252Bscreening%252Band%252Bmultiple%252Bbiological%252Bactivity%252Bevaluation%252Bmethods%26aulast%3DLi%26aufirst%3DLanlan%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D12%26spage%3D1053%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María  Blázquez-Sánchez</span>, <span class="hlFld-ContribAuthor ">Ana  de Matos</span>, <span class="hlFld-ContribAuthor ">Amélia  Rauter</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (6)
                                     , 864. <a href="https://doi.org/10.3390/molecules22060864" title="DOI URL">https://doi.org/10.3390/molecules22060864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22060864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22060864%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DExploring%252BAnti-Prion%252BGlyco-Based%252Band%252BAromatic%252BScaffolds%25253A%252BA%252BChemical%252BStrategy%252Bfor%252Bthe%252BQuality%252Bof%252BLife%26aulast%3DBl%25C3%25A1zquez-S%25C3%25A1nchez%26aufirst%3DMar%25C3%25ADa%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D6%26spage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenta  Teruya</span>, <span class="hlFld-ContribAuthor ">Katsumi  Doh-ura</span>. </span><span class="cited-content_cbyCitation_article-title">Insights from Therapeutic Studies for PrP Prion Disease. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Medicine</span><span> <strong>2017,</strong> <em>7 </em>
                                    (3)
                                     , a024430. <a href="https://doi.org/10.1101/cshperspect.a024430" title="DOI URL">https://doi.org/10.1101/cshperspect.a024430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a024430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a024430%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Medicine%26atitle%3DInsights%252Bfrom%252BTherapeutic%252BStudies%252Bfor%252BPrP%252BPrion%252BDisease%26aulast%3DTeruya%26aufirst%3DKenta%26date%3D2017%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3Da024430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margit  Pissarek</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule-Assisted PET: Approaches to Imaging of Conformational Diseases of the Brain. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Neuroscience</span><span> <strong>2017,</strong> <em>07 </em>
                                    (01)
                                     , 106-139. <a href="https://doi.org/10.4236/wjns.2017.71010" title="DOI URL">https://doi.org/10.4236/wjns.2017.71010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/wjns.2017.71010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fwjns.2017.71010%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Neuroscience%26atitle%3DSmall%252BMolecule-Assisted%252BPET%25253A%252BApproaches%252Bto%252BImaging%252Bof%252BConformational%252BDiseases%252Bof%252Bthe%252BBrain%26aulast%3DPissarek%26aufirst%3DMargit%26date%3D2017%26volume%3D07%26issue%3D01%26spage%3D106%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenta  Teruya</span>, <span class="hlFld-ContribAuthor ">Ayumi  Oguma</span>, <span class="hlFld-ContribAuthor ">Keiko  Nishizawa</span>, <span class="hlFld-ContribAuthor ">Maki  Kawata</span>, <span class="hlFld-ContribAuthor ">Yuji  Sakasegawa</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kamitakahara</span>, <span class="hlFld-ContribAuthor ">Katsumi  Doh-ura</span>, . </span><span class="cited-content_cbyCitation_article-title">A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2016,</strong> <em>12 </em>
                                    (12)
                                     , e1006045. <a href="https://doi.org/10.1371/journal.ppat.1006045" title="DOI URL">https://doi.org/10.1371/journal.ppat.1006045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1006045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1006045%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DA%252BSingle%252BSubcutaneous%252BInjection%252Bof%252BCellulose%252BEthers%252BAdministered%252BLong%252Bbefore%252BInfection%252BConfers%252BSustained%252BProtection%252Bagainst%252BPrion%252BDiseases%252Bin%252BRodents%26aulast%3DTeruya%26aufirst%3DKenta%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D12%26spage%3De1006045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Cheng</span>, <span class="hlFld-ContribAuthor ">Srinivasa Rao  Avula</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Dinesh  Addla</span>, <span class="hlFld-ContribAuthor ">Vijai Kumar Reddy  Tangadanchu</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian-Mei  Lin</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-targeting exploration of new 2-aminothiazolyl quinolones: Synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 935-945. <a href="https://doi.org/10.1016/j.ejmech.2016.10.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMulti-targeting%252Bexploration%252Bof%252Bnew%252B2-aminothiazolyl%252Bquinolones%25253A%252BSynthesis%25252C%252Bantimicrobial%252Bevaluation%25252C%252Binteraction%252Bwith%252BDNA%25252C%252Bcombination%252Bwith%252Btopoisomerase%252BIV%252Band%252Bpenetrability%252Binto%252Bcells%26aulast%3DCheng%26aufirst%3DYu%26date%3D2016%26volume%3D124%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tania  Massignan</span>, <span class="hlFld-ContribAuthor ">Sara  Cimini</span>, <span class="hlFld-ContribAuthor ">Claudia  Stincardini</span>, <span class="hlFld-ContribAuthor ">Milica  Cerovic</span>, <span class="hlFld-ContribAuthor ">Ilaria  Vanni</span>, <span class="hlFld-ContribAuthor ">Saioa R.  Elezgarai</span>, <span class="hlFld-ContribAuthor ">Jorge  Moreno</span>, <span class="hlFld-ContribAuthor ">Matteo  Stravalaci</span>, <span class="hlFld-ContribAuthor ">Alessandro  Negro</span>, <span class="hlFld-ContribAuthor ">Valeria  Sangiovanni</span>, <span class="hlFld-ContribAuthor ">Elena  Restelli</span>, <span class="hlFld-ContribAuthor ">Geraldina  Riccardi</span>, <span class="hlFld-ContribAuthor ">Marco  Gobbi</span>, <span class="hlFld-ContribAuthor ">Joaquín  Castilla</span>, <span class="hlFld-ContribAuthor ">Tiziana  Borsello</span>, <span class="hlFld-ContribAuthor ">Romolo  Nonno</span>, <span class="hlFld-ContribAuthor ">Emiliano  Biasini</span>. </span><span class="cited-content_cbyCitation_article-title">A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep23180" title="DOI URL">https://doi.org/10.1038/srep23180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep23180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep23180%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bcationic%252Btetrapyrrole%252Binhibits%252Btoxic%252Bactivities%252Bof%252Bthe%252Bcellular%252Bprion%252Bprotein%26aulast%3DMassignan%26aufirst%3DTania%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Heather  West Greenlee</span>, <span class="hlFld-ContribAuthor ">Melissa  Lind</span>, <span class="hlFld-ContribAuthor ">Robyn  Kokemuller</span>, <span class="hlFld-ContribAuthor ">Najiba  Mammadova</span>, <span class="hlFld-ContribAuthor ">Naveen  Kondru</span>, <span class="hlFld-ContribAuthor ">Sireesha  Manne</span>, <span class="hlFld-ContribAuthor ">Jodi  Smith</span>, <span class="hlFld-ContribAuthor ">Anumantha  Kanthasamy</span>, <span class="hlFld-ContribAuthor ">Justin  Greenlee</span>. </span><span class="cited-content_cbyCitation_article-title">Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie. </span><span class="cited-content_cbyCitation_journal-name">The American Journal of Pathology</span><span> <strong>2016,</strong> <em>186 </em>
                                    (9)
                                     , 2302-2309. <a href="https://doi.org/10.1016/j.ajpath.2016.05.018" title="DOI URL">https://doi.org/10.1016/j.ajpath.2016.05.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ajpath.2016.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ajpath.2016.05.018%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520American%2520Journal%2520of%2520Pathology%26atitle%3DTemporal%252BResolution%252Bof%252BMisfolded%252BPrion%252BProtein%252BTransport%25252C%252BAccumulation%25252C%252BGlial%252BActivation%25252C%252Band%252BNeuronal%252BDeath%252Bin%252Bthe%252BRetinas%252Bof%252BMice%252BInoculated%252Bwith%252BScrapie%26aulast%3DWest%2BGreenlee%26aufirst%3DM.%2BHeather%26date%3D2016%26volume%3D186%26issue%3D9%26spage%3D2302%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Legname</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches for discovering anti-prion compounds: lessons learned and challenges ahead. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 389-397. <a href="https://doi.org/10.1517/17460441.2015.1016498" title="DOI URL">https://doi.org/10.1517/17460441.2015.1016498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1016498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1016498%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bfor%252Bdiscovering%252Banti-prion%252Bcompounds%25253A%252Blessons%252Blearned%252Band%252Bchallenges%252Bahead%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vito  Vetrugno</span>, <span class="hlFld-ContribAuthor ">Maria  Puopolo</span>, <span class="hlFld-ContribAuthor ">Franco  Cardone</span>, <span class="hlFld-ContribAuthor ">Fiorentino  Capozzoli</span>, <span class="hlFld-ContribAuthor ">Anna  Ladogana</span>, <span class="hlFld-ContribAuthor ">Maurizio  Pocchiari</span>. </span><span class="cited-content_cbyCitation_article-title">The future for treating Creutzfeldt–Jakob disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Orphan Drugs</span><span> <strong>2015,</strong> <em>3 </em>
                                    (1)
                                     , 57-74. <a href="https://doi.org/10.1517/21678707.2015.994605" title="DOI URL">https://doi.org/10.1517/21678707.2015.994605</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/21678707.2015.994605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F21678707.2015.994605%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Orphan%2520Drugs%26atitle%3DThe%252Bfuture%252Bfor%252Btreating%252BCreutzfeldt%2525E2%252580%252593Jakob%252Bdisease%26aulast%3DVetrugno%26aufirst%3DVito%26date%3D2015%26date%3D2014%26volume%3D3%26issue%3D1%26spage%3D57%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0006.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of prion propagation and potential points of therapeutic intervention. (A) The NMR structure of the folded domain of human PrP<sup>C</sup> is shown. (B) PrP<sup>Sc</sup> forms fibrillar aggregates as shown in the electron micrograph (bar indicates 1000 Å). The β solenoid structure of the fungal Het-S prion provides one possible model of the pathogenic fold. (C) A simplified model for the propagation of PrP<sup>Sc</sup> suggests several potential sites for therapeutic intervention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Approved drugs studied in human clinical trials for CJD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell-based assay for identification of anti-prion compounds. (A) Neuroblastoma cell lines are exposed to PrP<sup>Sc</sup> to initiate the infection process. Once infected, cells continuously transmit PrP<sup>Sc</sup> to daughter cells upon passage. (B) Infected cells are exposed to test compounds at various concentrations and time durations. The effect of a compound on PrP<sup>Sc</sup> levels is quantified by treating cell lysates with proteinase K and quantifying the level of remaining PrP<sup>Sc</sup> by ELISA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0008.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Selected Small Molecules with Anti-Prion Activity<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Compound <b>1</b> and <b>4</b>–<b>8</b> have demonstrated efficacy in animal models of prion disease.</p></p></figure><figure data-id="cht2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0009.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Pharmacologic Agents Bearing the 2-Aminothiazole Ring System</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of anti-prion SAR for aminothiazole analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0010.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Select Early AMT Analogues Evaluated for Brain Exposure in Mice<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>The EC<sub>50</sub> values shown are for the ScN2a-cl3 assay, while brain AUC values reflect analysis of total brain homogenate following a single oral dose of 40 mg/kg in mice.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></p></figure><figure data-id="cht4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0011.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 4. Anti-Prion Activities (ScN2a-cl3 Assay) for Structural Analogues of <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Chart a</span>Additional PK data for some of these analogues is provided in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/medium/jm-2014-001425_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Kaplan–Meier survival curves for mice infected with ME7 (top) and RML prions (bottom) . The vehicle-treated cohort is shown as a solid black line. Treated cohorts received compound <b>7</b> from day 1 postinoculation (solid gray line) or from day 60 postinoculation (dashed gray line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm5001425/20150424/images/large/jm-2014-001425_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001425&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Colby, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Prions</span> <span class="citation_source-journal">Cold Spring Harbor Perspect Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=a006833&author=D.+W.+Colbyauthor=S.+B.+Prusiner&title=Prions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColby%26aufirst%3DD.%2BW.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DPrions%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect%2520Biol.%26date%3D2011%26volume%3D3%26spage%3Da006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Novel proteinaceous infectious particles cause scrapie</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscience.6801762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=6801762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADyaL38XhsFyqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=136-144&author=S.+B.+Prusiner&title=Novel+proteinaceous+infectious+particles+cause+scrapie"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Novel proteinaceous infectious particles cause scrapie</span></div><div class="casAuthors">Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">4542</span>),
    <span class="NLM_cas:pages">136-44</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">After injection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats.  Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity.  Although the scrapie agent is irreversibly inactivated by alkali, 5 procedures with more specificity for modifying nucleic acids failed to cause inactivation.  The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a mol. wt. of ≤50,000.  Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term ''prion'' is proposed to denote a small proteinaceous infectious particle which is resistant to inactivation by most procedures that modify nucleic acids.  Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83jJ03vS3LLVg90H21EOLACvtfcHk0lhagW4O9gDkvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhsFyqtro%253D&md5=a74dbfa1370646d3ea829bf34ceb03c9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.6801762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6801762%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DNovel%2520proteinaceous%2520infectious%2520particles%2520cause%2520scrapie%26jtitle%3DScience%26date%3D1982%26volume%3D216%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Shattuck lecture—neurodegenerative diseases and prions</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">1516</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1056%2FNEJM200105173442006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11357156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD3M3nt1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2001&pages=1516-1526&author=S.+B.+Prusiner&title=Shattuck+lecture%E2%80%94neurodegenerative+diseases+and+prions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Shattuck lecture--neurodegenerative diseases and prions</span></div><div class="casAuthors">Prusiner S B</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1516-26</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIaL7FnGMqfHWEEzDrymxmfW6udTcc2eb5EggH93HH17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3nt1enuw%253D%253D&md5=3577f8f00014a9bcaa2cfe4b905525da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM200105173442006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200105173442006%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DShattuck%2520lecture%25E2%2580%2594neurodegenerative%2520diseases%2520and%2520prions%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2001%26volume%3D344%26spage%3D1516%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brown, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cathala, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajdusek, D. C.</span><span> </span><span class="NLM_article-title">Creutzfeldt–Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1002%2Fana.410200507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=3539001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADyaL2s%252FnsVOnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1986&pages=597-602&author=P.+Brownauthor=F.+Cathalaauthor=P.+Castaigneauthor=D.+C.+Gajdusek&title=Creutzfeldt%E2%80%93Jakob+disease%3A+clinical+analysis+of+a+consecutive+series+of+230+neuropathologically+verified+cases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases</span></div><div class="casAuthors">Brown P; Cathala F; Castaigne P; Gajdusek D C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-602</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">In this consecutive series of 230 patients with neuropathologically verified Creutzfeldt-Jakob disease (CJD), the disease was found to affect men and women with approximately equal frequency in a peak plateau between the ages of 55 and 75 years (mean, 61.5 years).  Familial cases accounted for 4 to 8% of the total series.  Nonspecific prodromal symptoms occurred in one third of the patients, and the neurological presentation, although usually a gradually evolving mental deterioration, was of rapid onset in 20% of patients and in 36% of patients consisted exclusively of neurological symptoms.  The great majority of these symptoms were of cerebellar or visual origin.  Extrapyramidal muscular rigidity, myoclonus, and characteristic periodic electroencephalographic (EEG) complexes were observed comparatively late in the illness, and some type of involuntary movement or periodic EEG activity was seen in over 95% of the patients.  The median duration of illness was 4 months (mean, 7.6 months); 90% of patients died within a year of onset.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2hEhUcxLtG2yYR5VtavbzfW6udTcc2eb5EggH93HH17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FnsVOnsA%253D%253D&md5=2567643a4adfedc23902a4fb85ec3d46</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fana.410200507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410200507%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DCathala%26aufirst%3DF.%26aulast%3DCastaigne%26aufirst%3DP.%26aulast%3DGajdusek%26aufirst%3DD.%2BC.%26atitle%3DCreutzfeldt%25E2%2580%2593Jakob%2520disease%253A%2520clinical%2520analysis%2520of%2520a%2520consecutive%2520series%2520of%2520230%2520neuropathologically%2520verified%2520cases%26jtitle%3DAnn.%2520Neurol.%26date%3D1986%26volume%3D20%26spage%3D597%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Roos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajdusek, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, C. J.,  Jr.</span><span> </span><span class="NLM_article-title">The clinical characteristics of transmissible Creutzfeldt–Jakob disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1973&pages=1-20&author=R.+Roosauthor=D.+C.+Gajdusekauthor=C.+J.+Gibbs&title=The+clinical+characteristics+of+transmissible+Creutzfeldt%E2%80%93Jakob+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DR.%26aulast%3DGajdusek%26aufirst%3DD.%2BC.%26aulast%3DGibbs%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520clinical%2520characteristics%2520of%2520transmissible%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%26jtitle%3DBrain%26date%3D1973%26volume%3D96%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Collinge, J.</span><span> </span><span class="NLM_article-title">Prion diseases of humans and animals: their causes and molecular basis</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1146%2Fannurev.neuro.24.1.519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11283320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=519-550&author=J.+Collinge&title=Prion+diseases+of+humans+and+animals%3A+their+causes+and+molecular+basis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prion diseases of humans and animals: their causes and molecular basis</span></div><div class="casAuthors">Collinge, John</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">519-550</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  Prion diseases are transmissible neurodegenerative conditions that include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE) and scrapie in animals.  Prions appear to be composed principally or entirely of abnormal isoforms of a host-encoded glycoprotein, prion protein.  Prion propagation involves recruitment of host cellular prion protein, composed primarily of α-helical structure, into a disease specific isoform rich in β-sheet structure.  The existence of multiple prion strains was difficult to explain in terms of a protein-only infections agent, but recent studies suggest that strain specific phenotypes can be encoded by different prion protein conformations and glycosylation patterns.  The ability of a protein to encode phenotypic information has important biol. implications.  The appearance of a novel human prion disease, variant CJD, and the clear exptl. evidence that it is caused by exposure to BSE has highlighted the need to understand the mol. basis of prion propagation, pathogenesis, and the barriers limiting intermammalian transmission.  It is unclear if a large epidemic of variant CJD will occur in the years ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMiYjjuhS-v7Vg90H21EOLACvtfcHk0li1vegYnTSk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7s%253D&md5=957ceb59633c634a05d02eebd2d4f761</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.519%26sid%3Dliteratum%253Aachs%26aulast%3DCollinge%26aufirst%3DJ.%26atitle%3DPrion%2520diseases%2520of%2520humans%2520and%2520animals%253A%2520their%2520causes%2520and%2520molecular%2520basis%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D519%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">The state of the prion</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnrmicro1025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=15494743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Kqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=861-871&author=C.+Weissmann&title=The+state+of+the+prion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The state of the prion</span></div><div class="casAuthors">Weissmann, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">861-871</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is little doubt that the main component of the transmissible agent of spongiform encephalopathies - the prion - is a conformational variant of the ubiquitous host protein PrPC, and that the differing properties of various prion strains are assocd. with different abnormal conformations of this protein.  The precise structure of the prion is not yet known, nor are the mechanisms of infection, conformational conversion and pathogenesis understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4TlP6D_6ysrVg90H21EOLACvtfcHk0li1vegYnTSk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Kqu78%253D&md5=58c35b75de716712178a0403c7aa6b40</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1025%26sid%3Dliteratum%253Aachs%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DThe%2520state%2520of%2520the%2520prion%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2004%26volume%3D2%26spage%3D861%26epage%3D871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zahn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luhrs, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Schroetter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez Garcia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billeter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzolai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuthrich, K.</span><span> </span><span class="NLM_article-title">NMR solution structure of the human prion protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1073%2Fpnas.97.1.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=10618385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=145-150&author=R.+Zahnauthor=A.+Liuauthor=T.+Luhrsauthor=R.+Riekauthor=C.+von+Schroetterauthor=F.+Lopez+Garciaauthor=M.+Billeterauthor=L.+Calzolaiauthor=G.+Widerauthor=K.+Wuthrich&title=NMR+solution+structure+of+the+human+prion+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">NMR solution structure of the human prion protein</span></div><div class="casAuthors">Zahn, Ralph; Liu, Aizhuo; Luhrs, Thorsten; Riek, Roland; von Schroetter, Christine; Garcia, Francisco Lopez; Billeter, Martin; Calzolai, Luigi; Wider, Gerhard; Wuthrich, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The NMR structures of the recombinant human prion protein, hPrP(23-230), and two C-terminal fragments, hPrP(90-230) and hPrP(121-230), include a globular domain extending from residues 125-228, for which a detailed structure was obtained, and an N-terminal flexibly disordered "tail.".  The globular domain contains three α-helixes comprising the residues 144-154, 173-194, and 200-228 and a short anti-parallel β-sheet comprising the residues 128-131 and 161-164.  Within the globular domain, three polypeptide segments show increased structural disorder: i.e., a loop of residues 167-171, the residues 187-194 at the end of helix 2, and the residues 219-228 in the C-terminal part of helix 3.  The local conformational state of the polypeptide segments 187-193 in helix 2 and 219-226 in helix 3 is measurably influenced by the length of the N-terminal tail, with the helical states being most highly populated in hPrP(23-230).  When compared with the previously reported structures of the murine and Syrian hamster prion proteins, the length of helix 3 coincides more closely with that in the Syrian hamster protein, whereas the disordered loop 167-171 is shared with murine PrP.  These species variations of local structure are in a surface area of the cellular form of PrP that has previously been implicated in intermol. interactions related both to the species barrier for infectious transmission of prion disease and to immune reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaytfjvnsOrVg90H21EOLACvtfcHk0li1vegYnTSk0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVCrtg%253D%253D&md5=ec5f6231329b35ece51b950af9422ad5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.1.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.1.145%26sid%3Dliteratum%253Aachs%26aulast%3DZahn%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DA.%26aulast%3DLuhrs%26aufirst%3DT.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3Dvon%2BSchroetter%26aufirst%3DC.%26aulast%3DLopez%2BGarcia%26aufirst%3DF.%26aulast%3DBilleter%26aufirst%3DM.%26aulast%3DCalzolai%26aufirst%3DL.%26aulast%3DWider%26aufirst%3DG.%26aulast%3DWuthrich%26aufirst%3DK.%26atitle%3DNMR%2520solution%2520structure%2520of%2520the%2520human%2520prion%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sonati, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baral, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaganoglu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayampakula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kav, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liberski, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span> </span><span class="NLM_article-title">The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=102-106&author=T.+Sonatiauthor=R.+R.+Reimannauthor=J.+Falsigauthor=P.+K.+Baralauthor=T.+O%E2%80%99Connorauthor=S.+Hornemannauthor=S.+Yaganogluauthor=B.+Liauthor=U.+S.+Herrmannauthor=B.+Wielandauthor=M.+Swayampakulaauthor=M.+H.+Rahmanauthor=D.+Dasauthor=N.+Kavauthor=R.+Riekauthor=P.+P.+Liberskiauthor=M.+N.+Jamesauthor=A.+Aguzzi&title=The+toxicity+of+antiprion+antibodies+is+mediated+by+the+flexible+tail+of+the+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSonati%26aufirst%3DT.%26aulast%3DReimann%26aufirst%3DR.%2BR.%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3DBaral%26aufirst%3DP.%2BK.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DT.%26aulast%3DHornemann%26aufirst%3DS.%26aulast%3DYaganoglu%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DHerrmann%26aufirst%3DU.%2BS.%26aulast%3DWieland%26aufirst%3DB.%26aulast%3DSwayampakula%26aufirst%3DM.%26aulast%3DRahman%26aufirst%3DM.%2BH.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DKav%26aufirst%3DN.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3DLiberski%26aufirst%3DP.%2BP.%26aulast%3DJames%26aufirst%3DM.%2BN.%26aulast%3DAguzzi%26aufirst%3DA.%26atitle%3DThe%2520toxicity%2520of%2520antiprion%2520antibodies%2520is%2520mediated%2520by%2520the%2520flexible%2520tail%2520of%2520the%2520prion%2520protein%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D102%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Baral, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayampakula, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rout, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kav, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spyracopoulos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Structural basis of prion inhibition by phenothiazine compounds</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=291-303&author=P.+K.+Baralauthor=M.+Swayampakulaauthor=M.+K.+Routauthor=N.+N.+Kavauthor=L.+Spyracopoulosauthor=A.+Aguzziauthor=M.+N.+James&title=Structural+basis+of+prion+inhibition+by+phenothiazine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaral%26aufirst%3DP.%2BK.%26aulast%3DSwayampakula%26aufirst%3DM.%26aulast%3DRout%26aufirst%3DM.%2BK.%26aulast%3DKav%26aufirst%3DN.%2BN.%26aulast%3DSpyracopoulos%26aufirst%3DL.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DStructural%2520basis%2520of%2520prion%2520inhibition%2520by%2520phenothiazine%2520compounds%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D291%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wasmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Melckebeke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemer, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span> </span><span class="NLM_article-title">Amyloid fibrils of the het-s(218-289) prion form a beta solenoid with a triangular hydrophobic core</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1523</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscience.1151839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=18339938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVGqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1523-1526&author=C.+Wasmerauthor=A.+Langeauthor=H.+Van+Melckebekeauthor=A.+B.+Siemerauthor=R.+Riekauthor=B.+H.+Meier&title=Amyloid+fibrils+of+the+het-s%28218-289%29+prion+form+a+beta+solenoid+with+a+triangular+hydrophobic+core"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid Fibrils of the HET-s(218-289) Prion Form a β Solenoid with a Triangular Hydrophobic Core</span></div><div class="casAuthors">Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5869</span>),
    <span class="NLM_cas:pages">1523-1526</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Prion and nonprion forms of proteins are believed to differ solely in their three-dimensional structure, which is therefore of paramount importance for the prion function.  However, no at.-resoln. structure of the fibrillar state that is likely infectious has been reported to date.  We present a structural model based on solid-state NMR restraints for amyloid fibrils from the prion-forming domain (residues 218 to 289) of the HET-s protein from the filamentous fungus Podospora anserina.  On the basis of 134 intra- and intermol. exptl. distance restraints, we find that HET-s(218-289) forms a left-handed β solenoid, with each mol. forming two helical windings, a compact hydrophobic core, at least 23 hydrogen bonds, three salt bridges, and two asparagine ladders.  The structure is likely to have broad implications for understanding the infectious amyloid state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUcuGsS9yYLVg90H21EOLACvtfcHk0lhXRte6U6tIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVGqsrs%253D&md5=95fbf7331ab067166feb1d58f3a7e029</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1151839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1151839%26sid%3Dliteratum%253Aachs%26aulast%3DWasmer%26aufirst%3DC.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DVan%2BMelckebeke%26aufirst%3DH.%26aulast%3DSiemer%26aufirst%3DA.%2BB.%26aulast%3DRiek%26aufirst%3DR.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26atitle%3DAmyloid%2520fibrils%2520of%2520the%2520het-s%2528218-289%2529%2520prion%2520form%2520a%2520beta%2520solenoid%2520with%2520a%2520triangular%2520hydrophobic%2520core%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1523%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bueler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bluethmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipp, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">Normal development and behaviour of mice lacking the neuronal cell-surface prp protein</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=577-582&author=H.+Buelerauthor=M.+Fischerauthor=Y.+Langauthor=H.+Bluethmannauthor=H.+P.+Lippauthor=S.+J.+DeArmondauthor=S.+B.+Prusinerauthor=M.+Aguetauthor=C.+Weissmann&title=Normal+development+and+behaviour+of+mice+lacking+the+neuronal+cell-surface+prp+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBueler%26aufirst%3DH.%26aulast%3DFischer%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DBluethmann%26aufirst%3DH.%26aulast%3DLipp%26aufirst%3DH.%2BP.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DAguet%26aufirst%3DM.%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DNormal%2520development%2520and%2520behaviour%2520of%2520mice%2520lacking%2520the%2520neuronal%2520cell-surface%2520prp%2520protein%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D577%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Richt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasinathan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamir, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathiyaseelan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathiyaseelan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroiwa, Y.</span><span> </span><span class="NLM_article-title">Production of cattle lacking prion protein</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=132-138&author=J.+A.+Richtauthor=P.+Kasinathanauthor=A.+N.+Hamirauthor=J.+Castillaauthor=T.+Sathiyaseelanauthor=F.+Vargasauthor=J.+Sathiyaseelanauthor=H.+Wuauthor=H.+Matsushitaauthor=J.+Kosterauthor=S.+Katoauthor=I.+Ishidaauthor=C.+Sotoauthor=J.+M.+Roblauthor=Y.+Kuroiwa&title=Production+of+cattle+lacking+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRicht%26aufirst%3DJ.%2BA.%26aulast%3DKasinathan%26aufirst%3DP.%26aulast%3DHamir%26aufirst%3DA.%2BN.%26aulast%3DCastilla%26aufirst%3DJ.%26aulast%3DSathiyaseelan%26aufirst%3DT.%26aulast%3DVargas%26aufirst%3DF.%26aulast%3DSathiyaseelan%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMatsushita%26aufirst%3DH.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DIshida%26aufirst%3DI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DRobl%26aufirst%3DJ.%2BM.%26aulast%3DKuroiwa%26aufirst%3DY.%26atitle%3DProduction%2520of%2520cattle%2520lacking%2520prion%2520protein%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, G.</span><span> </span><span class="NLM_article-title">Generation of goats lacking prion protein</span> <span class="citation_source-journal">Mol. Reprod. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2009&pages=3&author=G.+Yuauthor=J.+Chenauthor=Y.+Xuauthor=C.+Zhuauthor=H.+Yuauthor=S.+Liuauthor=H.+Shaauthor=J.+Chenauthor=X.+Xuauthor=Y.+Wuauthor=A.+Zhangauthor=J.+Maauthor=G.+Cheng&title=Generation+of+goats+lacking+prion+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSha%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26atitle%3DGeneration%2520of%2520goats%2520lacking%2520prion%2520protein%26jtitle%3DMol.%2520Reprod.%2520Dev.%26date%3D2009%26volume%3D76%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span> </span><span class="NLM_article-title">Prion propagation, toxicity and degradation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnn.3120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=22735515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38Xpt1ShsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=936-939&author=A.+Aguzziauthor=J.+Falsig&title=Prion+propagation%2C+toxicity+and+degradation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prion propagation, toxicity and degradation</span></div><div class="casAuthors">Aguzzi, Adriano; Falsig, Jeppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">936-939</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Prion science has been on a rollercoaster for two decades.  In the mid 1990s, the specter of mad cow disease (bovine spongiform encephalopathy, BSE) provoked an unprecedented public scare that was first pptd. by the realization that this animal prion disease could be transmitted to humans and then rekindled by the evidence that BSE-infected humans could pass on the infection through blood transfusions.  Along with the gradual disappearance of BSE, the interest in prions has waned with the general public, funding agencies and prospective PhD students.  In the past few years, however, a bewildering variety of diseases have been found to share features with prion infections, including cell-to-cell transmission.  Here we review these developments and summarize those open questions that we currently deem most interesting in prion biol.: how do prions damage their hosts, and how do hosts attempt to neutralize invading prions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqozXinCpzvV7Vg90H21EOLACvtfcHk0liyXqyYgl1mgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xpt1ShsLc%253D&md5=45d56b3cece6810504a95bdfcf5b32a3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.3120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3120%26sid%3Dliteratum%253Aachs%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DFalsig%26aufirst%3DJ.%26atitle%3DPrion%2520propagation%252C%2520toxicity%2520and%2520degradation%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D936%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hewitt, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llewelyn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, R. G.</span><span> </span><span class="NLM_article-title">Creutzfeldt–Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study</span> <span class="citation_source-journal">Vox Sang.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1111%2Fj.1423-0410.2006.00833.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=16958834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD28rjsFyluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2006&pages=221-230&author=P.+E.+Hewittauthor=C.+A.+Llewelynauthor=J.+Mackenzieauthor=R.+G.+Will&title=Creutzfeldt%E2%80%93Jakob+disease+and+blood+transfusion%3A+results+of+the+UK+transfusion+medicine+epidemiological+review+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study</span></div><div class="casAuthors">Hewitt P E; Llewelyn C A; Mackenzie J; Will R G</div><div class="citationInfo"><span class="NLM_cas:title">Vox sanguinis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-30</span>
        ISSN:<span class="NLM_cas:issn">0042-9007</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  This paper reports the results to 1 March 2006 of an ongoing UK study, the Transfusion Medicine Epidemiological Review (TMER), by the National CJD Surveillance Unit (NCJDSU) and the UK Blood Services (UKBS) to determine whether there is any evidence that Creutzfeldt-Jakob disease (CJD), including sporadic CJD (sCJD), familial CJD (fCJD), and variant CJD (vCJD) is transmissible via blood transfusion.  MATERIALS AND METHODS:  Sporadic CJD and fCJD cases with a history of blood donation or transfusion are notified to UKBS.  All vCJD cases aged > 17 years are notified to UKBS on diagnosis.  A search for donation records is instigated and the fate of all donations is identified by lookback.  For cases with a history of blood transfusion, hospital and UKBS records are searched to identify blood donors.  Details of identified recipients and donors are checked against the NCJDSU register to establish if there are any matches.  RESULTS:  CJD cases with donation history: 18/31 vCJD, 3/93 sCJD, and 3/5 fCJD cases reported as blood donors were confirmed to have donated labile components transfused to 66, 20, and 11 recipients respectively.  Two vCJD recipients have appeared on the NCJDSU register as confirmed and probable vCJD cases.  The latter developed symptoms of vCJD 6.5 years and 7.8 years respectively after receiving non-leucodepleted red blood cells (RBCs) from two different donors who developed clinical symptoms approximately 40 and 21 months after donating.  A third recipient, given RBC donated by a further vCJD case approximately 18 months before onset of clinical symptoms, had abnormal prion protein in lymphoid tissue at post-mortem (5-years post-transfusion) but had no clinical symptoms of vCJD.  CJD cases with history of transfusion: Hospital records for 7/11 vCJD and 7/52 sCJD cases included a history of transfusion of labile blood components donated by 125 and 24 donors respectively.  Two recipients who developed vCJD were linked to donors who had already appeared on the NCJDSU register as vCJD cases (see above).  No further links were established.  CONCLUSION:  This study has identified three instances of probable transfusion transmission of vCJD infection, including two confirmed clinical cases and one pre- or sub-clinical infection.  This study has not provided evidence, to date, of transmission of sCJD or fCJD by blood transfusion, but data on these forms of diseases are limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcJSYx6oM0bcScOqQTSkOffW6udTcc2eZT5naT6QqvQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rjsFyluw%253D%253D&md5=490a566e71d4f481e8be5c3dd52fd7f9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1423-0410.2006.00833.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1423-0410.2006.00833.x%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DP.%2BE.%26aulast%3DLlewelyn%26aufirst%3DC.%2BA.%26aulast%3DMackenzie%26aufirst%3DJ.%26aulast%3DWill%26aufirst%3DR.%2BG.%26atitle%3DCreutzfeldt%25E2%2580%2593Jakob%2520disease%2520and%2520blood%2520transfusion%253A%2520results%2520of%2520the%2520UK%2520transfusion%2520medicine%2520epidemiological%2520review%2520study%26jtitle%3DVox%2520Sang.%26date%3D2006%26volume%3D91%26spage%3D221%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Otto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratzka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehlinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekhoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiltfang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergande, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellers-Lenz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prange, H.</span><span> </span><span class="NLM_article-title">Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">714</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2004&pages=714-718&author=M.+Ottoauthor=L.+Cepekauthor=P.+Ratzkaauthor=S.+Doehlingerauthor=I.+Boekhoffauthor=J.+Wiltfangauthor=E.+Irleauthor=G.+Pergandeauthor=B.+Ellers-Lenzauthor=O.+Windlauthor=H.+A.+Kretzschmarauthor=S.+Poserauthor=H.+Prange&title=Efficacy+of+flupirtine+on+cognitive+function+in+patients+with+CJD%3A+a+double-blind+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DM.%26aulast%3DCepek%26aufirst%3DL.%26aulast%3DRatzka%26aufirst%3DP.%26aulast%3DDoehlinger%26aufirst%3DS.%26aulast%3DBoekhoff%26aufirst%3DI.%26aulast%3DWiltfang%26aufirst%3DJ.%26aulast%3DIrle%26aufirst%3DE.%26aulast%3DPergande%26aufirst%3DG.%26aulast%3DEllers-Lenz%26aufirst%3DB.%26aulast%3DWindl%26aufirst%3DO.%26aulast%3DKretzschmar%26aufirst%3DH.%2BA.%26aulast%3DPoser%26aufirst%3DS.%26aulast%3DPrange%26aufirst%3DH.%26atitle%3DEfficacy%2520of%2520flupirtine%2520on%2520cognitive%2520function%2520in%2520patients%2520with%2520CJD%253A%2520a%2520double-blind%2520study%26jtitle%3DNeurology%26date%3D2004%26volume%3D62%26spage%3D714%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devereux, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raudabaugh, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Chae, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thai, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhaus, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forner, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Possin, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span> </span><span class="NLM_article-title">Quinacrine treatment trial for sporadic Creutzfeldt–Jakob disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=2015-2023&author=M.+D.+Geschwindauthor=A.+L.+Kuoauthor=K.+S.+Wongauthor=A.+Hamanauthor=G.+Devereuxauthor=B.+J.+Raudabaughauthor=D.+Y.+Johnsonauthor=C.+C.+Torres-Chaeauthor=R.+Finleyauthor=P.+Garciaauthor=J.+N.+Thaiauthor=H.+Q.+Chengauthor=J.+M.+Neuhausauthor=S.+A.+Fornerauthor=J.+L.+Duncanauthor=K.+L.+Possinauthor=S.+J.+Dearmondauthor=S.+B.+Prusinerauthor=B.+L.+Miller&title=Quinacrine+treatment+trial+for+sporadic+Creutzfeldt%E2%80%93Jakob+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DKuo%26aufirst%3DA.%2BL.%26aulast%3DWong%26aufirst%3DK.%2BS.%26aulast%3DHaman%26aufirst%3DA.%26aulast%3DDevereux%26aufirst%3DG.%26aulast%3DRaudabaugh%26aufirst%3DB.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%2BY.%26aulast%3DTorres-Chae%26aufirst%3DC.%2BC.%26aulast%3DFinley%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DP.%26aulast%3DThai%26aufirst%3DJ.%2BN.%26aulast%3DCheng%26aufirst%3DH.%2BQ.%26aulast%3DNeuhaus%26aufirst%3DJ.%2BM.%26aulast%3DForner%26aufirst%3DS.%2BA.%26aulast%3DDuncan%26aufirst%3DJ.%2BL.%26aulast%3DPossin%26aufirst%3DK.%2BL.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26atitle%3DQuinacrine%2520treatment%2520trial%2520for%2520sporadic%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%26jtitle%3DNeurology%26date%3D2013%26volume%3D81%26spage%3D2015%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Haik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tettamanti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welaratne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabreguettes, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imperiale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesaro, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aucan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucca, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckeu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranchant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerr, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houillier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redaelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vespignani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnianski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seilhean, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinemann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canovi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fede, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplanche, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocchiari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forloni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, F.</span><span> </span><span class="NLM_article-title">Doxycycline in Creutzfeldt–Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1016%2FS1474-4422%2813%2970307-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24411709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1Gjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=150-158&author=S.+Haikauthor=G.+Marconauthor=A.+Malletauthor=M.+Tettamantiauthor=A.+Welaratneauthor=G.+Giacconeauthor=S.+Azimiauthor=V.+Pietriniauthor=J.+R.+Fabreguettesauthor=D.+Imperialeauthor=P.+Cesaroauthor=C.+Buffaauthor=C.+Aucanauthor=U.+Luccaauthor=L.+Peckeuauthor=S.+Suardiauthor=C.+Tranchantauthor=I.+Zerrauthor=C.+Houillierauthor=V.+Redaelliauthor=H.+Vespignaniauthor=A.+Campanellaauthor=F.+Sellalauthor=A.+Krasnianskiauthor=D.+Seilheanauthor=U.+Heinemannauthor=F.+Sedelauthor=M.+Canoviauthor=M.+Gobbiauthor=G.+Di+Fedeauthor=J.+L.+Laplancheauthor=M.+Pocchiariauthor=M.+Salmonaauthor=G.+Forloniauthor=J.+P.+Brandelauthor=F.+Tagliavini&title=Doxycycline+in+Creutzfeldt%E2%80%93Jakob+disease%3A+a+phase+2%2C+randomised%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial</span></div><div class="casAuthors">Haik, Stephane; Marcon, Gabriella; Mallet, Alain; Tettamanti, Mauro; Welaratne, Arlette; Giaccone, Giorgio; Azimi, Shohreh; Pietrini, Vladimiro; Fabreguettes, Jean-Roch; Imperiale, Daniele; Cesaro, Pierre; Buffa, Carlo; Aucan, Christophe; Lucca, Ugo; Peckeu, Laurene; Suardi, Silvia; Tranchant, Christine; Zerr, Inga; Houillier, Caroline; Redaelli, Veronica; Vespignani, Herve; Campanella, Angela; Sellal, Francois; Krasnianski, Anna; Seilhean, Danielle; Heinemann, Uta; Sedel, Frederic; Canovi, Mara; Gobbi, Marco; Di Fede, Giuseppe; Laplanche, Jean-Louis; Pocchiari, Maurizio; Salmona, Mario; Forloni, Gianluigi; Brandel, Jean-Philippe; Tagliavini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">150-158</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Creutzfeldt-Jakob disease (CJD) is a fatal, untreatable prion encephalopathy.  Previous studies showed that doxycycline is effective in in-vitro and in-vivo models of disease, and patients with CJD who received compassionate treatment with doxycycline showed increased survival time compared with historical series.  We therefore did a randomised, double-blind study of doxycycline vs. placebo in CJD.  We recruited patients older than 18 years old who had a diagnosis of definite or probable sporadic CJD or genetic forms of the disease via Italian ref. centers and the French national referral system.  Patients were randomly assigned (ratio 1:1) to receive oral doxycycline (100 mg daily) or placebo under double-blind conditions from the day of randomization to death.  Centralised randomization was done independently of enrolment or evaluation of patients using a minimization method in Italy and a simple randomization in France.  Participants, caregivers, and clinicians were masked to group assignment.  The primary efficacy variable was the survival time from randomization.  Interim analyses were planned to detect a significant effect of treatment as early as possible.  This trial is registered with EudraCT, 2006-001858-27 for the Italian study and 2007-005553-34 for the French study.From Apr. 12, 2007, to Aug 19, 2010, in Italy, and from Jan 30, 2009, to Jan 10, 2012, in France, 121 patients with CJD were enrolled in the study, 62 of whom were randomly assigned to the treatment group and 59 to the placebo group.  The first interim anal. showed absence of superiority of doxycycline compared with placebo, and the trial was stopped for futility.  Efficacy analyses did not show significant differences between patients treated with doxycycline and placebo with regard to survival times (HR 1·1, 95% CI 0·8-1·7, p=0·50).  Serious adverse events were judged not to be related to treatment, whereas a relation was deemed probable or possible for five non-serious adverse events that occurred in each treatment group.  Doxycycline at a dose of 100 mg per day was well tolerated but did not significantly affect the course of CJD, at variance with the results of previous observational studies.  Our experience could be useful in the design of large multinational controlled trials of potential anti-prion mols. in this rare disease.  Agenzia Italiana Farmaco, Italian Ministry of Health, AIEnP, and French Ministry of Health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY2pM-BZKmx7Vg90H21EOLACvtfcHk0liKOi1POZEMtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1Gjtw%253D%253D&md5=10674d977e3e9eda01085b964a17d64b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970307-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970307-7%26sid%3Dliteratum%253Aachs%26aulast%3DHaik%26aufirst%3DS.%26aulast%3DMarcon%26aufirst%3DG.%26aulast%3DMallet%26aufirst%3DA.%26aulast%3DTettamanti%26aufirst%3DM.%26aulast%3DWelaratne%26aufirst%3DA.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DAzimi%26aufirst%3DS.%26aulast%3DPietrini%26aufirst%3DV.%26aulast%3DFabreguettes%26aufirst%3DJ.%2BR.%26aulast%3DImperiale%26aufirst%3DD.%26aulast%3DCesaro%26aufirst%3DP.%26aulast%3DBuffa%26aufirst%3DC.%26aulast%3DAucan%26aufirst%3DC.%26aulast%3DLucca%26aufirst%3DU.%26aulast%3DPeckeu%26aufirst%3DL.%26aulast%3DSuardi%26aufirst%3DS.%26aulast%3DTranchant%26aufirst%3DC.%26aulast%3DZerr%26aufirst%3DI.%26aulast%3DHouillier%26aufirst%3DC.%26aulast%3DRedaelli%26aufirst%3DV.%26aulast%3DVespignani%26aufirst%3DH.%26aulast%3DCampanella%26aufirst%3DA.%26aulast%3DSellal%26aufirst%3DF.%26aulast%3DKrasnianski%26aufirst%3DA.%26aulast%3DSeilhean%26aufirst%3DD.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DSedel%26aufirst%3DF.%26aulast%3DCanovi%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DDi%2BFede%26aufirst%3DG.%26aulast%3DLaplanche%26aufirst%3DJ.%2BL.%26aulast%3DPocchiari%26aufirst%3DM.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DBrandel%26aufirst%3DJ.%2BP.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DDoxycycline%2520in%2520Creutzfeldt%25E2%2580%2593Jakob%2520disease%253A%2520a%2520phase%25202%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Geissen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzl, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groschup, M. H.</span><span> </span><span class="NLM_article-title">From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1928</span><span class="NLM_x">–</span> <span class="NLM_lpage">1937</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1928-1937&author=M.+Geissenauthor=F.+Leidelauthor=M.+Eidenauthor=T.+Hirschbergerauthor=C.+Fastauthor=U.+Bertschauthor=P.+Tavanauthor=A.+Gieseauthor=H.+Kretzschmarauthor=H.+M.+Schatzlauthor=M.+H.+Groschup&title=From+high-throughput+cell+culture+screening+to+mouse+model%3A+identification+of+new+inhibitor+classes+against+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeissen%26aufirst%3DM.%26aulast%3DLeidel%26aufirst%3DF.%26aulast%3DEiden%26aufirst%3DM.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DFast%26aufirst%3DC.%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DA.%26aulast%3DKretzschmar%26aufirst%3DH.%26aulast%3DSchatzl%26aufirst%3DH.%2BM.%26aulast%3DGroschup%26aufirst%3DM.%2BH.%26atitle%3DFrom%2520high-throughput%2520cell%2520culture%2520screening%2520to%2520mouse%2520model%253A%2520identification%2520of%2520new%2520inhibitor%2520classes%2520against%2520prion%2520disease%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1928%26epage%3D1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Vilette, D.</span><span> </span><span class="NLM_article-title">Cell models of prion infection</span> <span class="citation_source-journal">Vet. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1051%2Fvetres%3A2007049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=18073097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A280%3ADC%252BD2sjjs1Ohug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2008&pages=10&author=D.+Vilette&title=Cell+models+of+prion+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cell models of prion infection</span></div><div class="casAuthors">Vilette Didier</div><div class="citationInfo"><span class="NLM_cas:title">Veterinary research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn">0928-4249</span>.
    </div><div class="casAbstract">Due to recent renewal of interest and concerns in prion diseases, a number of cell systems permissive to prion multiplication have been generated in the last years.  These include established cell lines, neuronal stem cells and primary neuronal cultures.  While most of these models are permissive to experimental, mouse-adapted strains of prions, the propagation of natural field isolates from sheep scrapie and chronic wasting disease has been recently achieved.  These models have improved our knowledge on the molecular and cellular events controlling the conversion of the PrP(C) protein into abnormal isoforms and on the cell-to-cell spreading of prions.  Infected cultured cells will also facilitate investigations on the molecular basis of strain identity and on the mechanisms that lead to neurodegeneration.  The ongoing development of new cell models with improved characteristics will certainly be useful for a number of unanswered critical issues in the prion field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6-eHTbo4UlJI8NvIb08rbfW6udTcc2eabyxp4trXaYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjjs1Ohug%253D%253D&md5=13c8374a2973481a964d174dd5fa61e4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fvetres%3A2007049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fvetres%253A2007049%26sid%3Dliteratum%253Aachs%26aulast%3DVilette%26aufirst%3DD.%26atitle%3DCell%2520models%2520of%2520prion%2520infection%26jtitle%3DVet.%2520Res.%26date%3D2008%26volume%3D39%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Safar, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didorenko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattavat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Diagnosis of human prion disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=3501-3506&author=J.+G.+Safarauthor=M.+D.+Geschwindauthor=C.+Deeringauthor=S.+Didorenkoauthor=M.+Sattavatauthor=H.+Sanchezauthor=A.+Serbanauthor=M.+Veyauthor=H.+Baronauthor=K.+Gilesauthor=B.+L.+Millerauthor=S.+J.+Dearmondauthor=S.+B.+Prusiner&title=Diagnosis+of+human+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSafar%26aufirst%3DJ.%2BG.%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DDeering%26aufirst%3DC.%26aulast%3DDidorenko%26aufirst%3DS.%26aulast%3DSattavat%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DH.%26aulast%3DSerban%26aufirst%3DA.%26aulast%3DVey%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DH.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DDiagnosis%2520of%2520human%2520prion%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D3501%26epage%3D3506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Brandner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekarik, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parizek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raeber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rulicke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span> </span><span class="NLM_article-title">Neuroinvasion of prions: insights from mouse models</span> <span class="citation_source-journal">Exp. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1111%2Fj.1469-445X.2000.02091.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=11187965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=705-712&author=S.+Brandnerauthor=M.+A.+Kleinauthor=R.+Friggauthor=V.+Pekarikauthor=P.+Parizekauthor=A.+Raeberauthor=M.+Glatzelauthor=P.+Schwarzauthor=T.+Rulickeauthor=C.+Weissmannauthor=A.+Aguzzi&title=Neuroinvasion+of+prions%3A+insights+from+mouse+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroinvasion of prions: insights from mouse models</span></div><div class="casAuthors">Brandner, Sebastian; Klein, Michael A.; Frigg, Rico; Pekarik, Valdimir; Parizek, Petra; Raeber, Alex; Glatzel, Markus; Schwarz, Petra; Rulicke, Thomas; Weissmann, Charles; Aguzzi, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Physiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-712</span>CODEN:
                <span class="NLM_cas:coden">EXPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0958-0670</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with 33 refs.  The prion was defined by Stanley B. Prusiner as the infectious agent that causes transmissible spongiform encephalopathies.  A pathol. protein accumulating in the brain of scrapie-infected hamsters was isolated in 1982 and termed prion protein (PrPSc).  Its cognate gene Prnp was identified more than a decade ago by Charles Weissmann, and shown to encode the host protein PrPC.  Since the latter discovery, transgenic mice have contributed many important insights into the field of prion biol., including the understanding of the mol. basis of the species barrier for prions.  By disrupting the Prnp gene, it was shown that an organism that lacks PrPC is resistant to infection by prions.  Introduction of mutant PrP genes into PrP-deficient mice was used to investigate the structure-activity relationship of the PrP gene with regard to scrapie susceptibility.  Ectopic expression of PrP in PrP knockout mice proved a useful tool for the identification of host cells competent for prion replication.  Finally, the availability of PrP knockout mice and transgenic mice overexpressing PrP allows selective reconstitution expts. aimed at expressing PrP in neurografts or in specific populations of hemato- and lymphopoietic cells.  The latter studies have allowed us to clarify some of the mechanisms of prion spread and disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEZ_oa4zAljbVg90H21EOLACvtfcHk0ligHaeyPaJPLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSrtA%253D%253D&md5=1cbd8de307bb8c67bcbcbac7d2c8f600</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-445X.2000.02091.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-445X.2000.02091.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrandner%26aufirst%3DS.%26aulast%3DKlein%26aufirst%3DM.%2BA.%26aulast%3DFrigg%26aufirst%3DR.%26aulast%3DPekarik%26aufirst%3DV.%26aulast%3DParizek%26aufirst%3DP.%26aulast%3DRaeber%26aufirst%3DA.%26aulast%3DGlatzel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DP.%26aulast%3DRulicke%26aufirst%3DT.%26aulast%3DWeissmann%26aufirst%3DC.%26aulast%3DAguzzi%26aufirst%3DA.%26atitle%3DNeuroinvasion%2520of%2520prions%253A%2520insights%2520from%2520mouse%2520models%26jtitle%3DExp.%2520Physiol.%26date%3D2000%26volume%3D85%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tamguney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Measuring prions by bioluminescence imaging</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15002</span><span class="NLM_x">–</span> <span class="NLM_lpage">15006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15002-15006&author=G.+Tamguneyauthor=K.+P.+Francisauthor=K.+Gilesauthor=A.+Lemusauthor=S.+J.+DeArmondauthor=S.+B.+Prusiner&title=Measuring+prions+by+bioluminescence+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamguney%26aufirst%3DG.%26aulast%3DFrancis%26aufirst%3DK.%2BP.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLemus%26aufirst%3DA.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DMeasuring%2520prions%2520by%2520bioluminescence%2520imaging%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D15002%26epage%3D15006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamatari, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa-Muto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katamine, S.</span><span> </span><span class="NLM_article-title">Hot spots in prion protein for pathogenic conversion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">11921</span><span class="NLM_x">–</span> <span class="NLM_lpage">11926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11921-11926&author=K.+Kuwataauthor=N.+Nishidaauthor=T.+Matsumotoauthor=Y.+O.+Kamatariauthor=J.+Hosokawa-Mutoauthor=K.+Kodamaauthor=H.+K.+Nakamuraauthor=K.+Kimuraauthor=M.+Kawasakiauthor=Y.+Takakuraauthor=S.+Shirabeauthor=J.+Takataauthor=Y.+Kataokaauthor=S.+Katamine&title=Hot+spots+in+prion+protein+for+pathogenic+conversion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DN.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DKamatari%26aufirst%3DY.%2BO.%26aulast%3DHosokawa-Muto%26aufirst%3DJ.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%2BK.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DTakakura%26aufirst%3DY.%26aulast%3DShirabe%26aufirst%3DS.%26aulast%3DTakata%26aufirst%3DJ.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DKatamine%26aufirst%3DS.%26atitle%3DHot%2520spots%2520in%2520prion%2520protein%2520for%2520pathogenic%2520conversion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D11921%26epage%3D11926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Trevitt, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinge, J.</span><span> </span><span class="NLM_article-title">A systematic review of prion therapeutics in experimental models</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2265</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2006&pages=2241-2265&author=C.+R.+Trevittauthor=J.+Collinge&title=A+systematic+review+of+prion+therapeutics+in+experimental+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevitt%26aufirst%3DC.%2BR.%26aulast%3DCollinge%26aufirst%3DJ.%26atitle%3DA%2520systematic%2520review%2520of%2520prion%2520therapeutics%2520in%2520experimental%2520models%26jtitle%3DBrain%26date%3D2006%26volume%3D129%26spage%3D2241%26epage%3D2265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sim, V. L.</span><span> </span><span class="NLM_article-title">Prion disease: chemotherapeutic strategies</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F187152612800100161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=22420513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=144-160&author=V.+L.+Sim&title=Prion+disease%3A+chemotherapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Prion disease: chemotherapeutic strategies</span></div><div class="casAuthors">Sim, Valerie L.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-160</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases, also known as transmissible spongiform encephalopathies, are invariably fatal neurodegenerative diseases for which there are no efficacious treatments.  Thousands of compds. have been screened for anti-prion effect, and yet of those that have effect in vitro, very few show effect in vivo, esp. if administered in the later stages of disease.  However, with new techniques for early diagnosis being developed, and with further insight into the pathogenesis of early disease, including the role of oligomers and the contribution of accessory mols. and signalling cascades, the chance of finding a therapeutic strategy is increasing.  Beyond clin. therapy, there is increasing need to find effective decontaminants for blood supplies, as variant Creutzfeldt Jakob Disease (vCJD) is transmissible by blood.  Non-toxic preventative therapies are also needed, with ongoing cases of Bovine Spongiform Encephalopathy (BSE) and the spread of Chronic Wasting Disease (CWD) being a growing concern.  A primary target for therapy has been the conversion of the normal form of prion protein (PrPC) to its abnormal counterpart (PrPSc).  Many of the chemotherapeutic agents with antiprion effect share structural similarities, often being polyanionic or polycyclic.  They may directly bind PrPC or PrPSc, or they may redistribute, sequester, or down-regulate PrPC, thus preventing its conversion.  There have also been some novel approaches, including trapping PrPSc in a multimeric form such that it can no longer cause conversion, increasing clearance of PrPSc, targeting accessory mols. which play a role in conversion, targeting pathways which lead to neurodegeneration, and stem cell therapy.  It may be that a combination of compds. will be necessary for maximal effect and there is evidence that synergistic responses occur with dual therapy.  This updated review focuses primarily on chemicalbased treatments in light of developments in diagnostic technologies, including results from recent clin. trials, and proposes some promising new targets for prion therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKZx035zXT9rVg90H21EOLACvtfcHk0ligHaeyPaJPLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2is74%253D&md5=a74afce47de45b8a91223a3aeab60d38</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F187152612800100161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152612800100161%26sid%3Dliteratum%253Aachs%26aulast%3DSim%26aufirst%3DV.%2BL.%26atitle%3DPrion%2520disease%253A%2520chemotherapeutic%2520strategies%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2012%26volume%3D12%26spage%3D144%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kamatari, Y. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosokawa-Muto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span> </span><span class="NLM_article-title">Characterizing antiprion compounds based on their binding properties to prion proteins: implications as medical chaperones</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1002%2Fpro.2180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVeksrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=22-34&author=Y.+O.+Kamatariauthor=Y.+Hayanoauthor=K.+Yamaguchiauthor=J.+Hosokawa-Mutoauthor=K.+Kuwata&title=Characterizing+antiprion+compounds+based+on+their+binding+properties+to+prion+proteins%3A+implications+as+medical+chaperones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterizing antiprion compounds based on their binding properties to prion proteins: Implications as medical chaperones</span></div><div class="casAuthors">Kamatari, Yuji O.; Hayano, Yosuke; Yamaguchi, Kei-ichi; Hosokawa-Muto, Junji; Kuwata, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-34</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A variety of antiprion compds. have been reported that are effective in ex vivo and in vivo treatment expts.  However, the mol. mechanisms for most of these compds. remain unknown.  Here we classified antiprion mechanisms into four categories: I, specific conformational stabilization; II, nonspecific stabilization; III, aggregation; and IV, interaction with mols. other than PrPC.  To characterize antiprion compds. based on this classification, we detd. their binding affinities to PrPC using surface plasmon resonance and their binding sites on PrPC using NMR spectroscopy.  GN8 and GJP49 bound specifically to the hot spot in PrPC, and acted as "medical chaperones" to stabilize the native conformation.  Thus, mechanisms I was predominant.  In contrast, quinacrine and epigallocathechin bound to PrPC rather nonspecifically; these may stabilize the PrPC conformation nonspecifically including the interference with the intermol. interaction following mechanism II.  Congo red and pentosan polysulfate bound to PrPC and caused aggregation and pptn. of PrPC, thus reducing the effective concn. of prion protein.  Thus, mechanism III was appropriate.  Finally, CP-60, an edarabone deriv., did not bind to PrPC.  Thus these were classified into mechanism IV.  However, their antiprion activities were not confirmed in the GT + FK system, whose details remain to be elucidated.  These proposed antiprion mechanisms of diverse antiprion compds. could help to elucidate their antiprion activities and facilitate effective antiprion drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG33Yz8bzeMLVg90H21EOLACvtfcHk0lgQ-791DnNYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVeksrnE&md5=e0922e6dd7d2502e2ac986d699f80f8c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fpro.2180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2180%26sid%3Dliteratum%253Aachs%26aulast%3DKamatari%26aufirst%3DY.%2BO.%26aulast%3DHayano%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DHosokawa-Muto%26aufirst%3DJ.%26aulast%3DKuwata%26aufirst%3DK.%26atitle%3DCharacterizing%2520antiprion%2520compounds%2520based%2520on%2520their%2520binding%2520properties%2520to%2520prion%2520proteins%253A%2520implications%2520as%2520medical%2520chaperones%26jtitle%3DProtein%2520Sci.%26date%3D2013%26volume%3D22%26spage%3D22%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legname, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Continuous quinacrine treatment results in the formation of drug-resistant prions</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000673&author=S.+Ghaemmaghamiauthor=M.+Ahnauthor=P.+Lessardauthor=K.+Gilesauthor=G.+Legnameauthor=S.+J.+DeArmondauthor=S.+B.+Prusiner&title=Continuous+quinacrine+treatment+results+in+the+formation+of+drug-resistant+prions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DLessard%26aufirst%3DP.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DContinuous%2520quinacrine%2520treatment%2520results%2520in%2520the%2520formation%2520of%2520drug-resistant%2520prions%26jtitle%3DPLoS%2520Pathog.%26date%3D2009%26volume%3D5%26spage%3De1000673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Forloni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iussich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeretti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caramelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazia Bruzzone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limido, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ironside, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugiani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, F.</span><span> </span><span class="NLM_article-title">Tetracyclines affect prion infectivity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">10849</span><span class="NLM_x">–</span> <span class="NLM_lpage">10854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10849-10854&author=G.+Forloniauthor=S.+Iussichauthor=T.+Awanauthor=L.+Colomboauthor=N.+Angerettiauthor=L.+Girolaauthor=I.+Bertaniauthor=G.+Poliauthor=M.+Caramelliauthor=M.+Grazia+Bruzzoneauthor=L.+Farinaauthor=L.+Limidoauthor=G.+Rossiauthor=G.+Giacconeauthor=J.+W.+Ironsideauthor=O.+Bugianiauthor=M.+Salmonaauthor=F.+Tagliavini&title=Tetracyclines+affect+prion+infectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DForloni%26aufirst%3DG.%26aulast%3DIussich%26aufirst%3DS.%26aulast%3DAwan%26aufirst%3DT.%26aulast%3DColombo%26aufirst%3DL.%26aulast%3DAngeretti%26aufirst%3DN.%26aulast%3DGirola%26aufirst%3DL.%26aulast%3DBertani%26aufirst%3DI.%26aulast%3DPoli%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DM.%26aulast%3DGrazia%2BBruzzone%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DL.%26aulast%3DLimido%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DIronside%26aufirst%3DJ.%2BW.%26aulast%3DBugiani%26aufirst%3DO.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DTagliavini%26aufirst%3DF.%26atitle%3DTetracyclines%2520affect%2520prion%2520infectivity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D10849%26epage%3D10854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Teruya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawagoe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakasegawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doh-ura, K.</span><span> </span><span class="NLM_article-title">Amyloidophilic compounds for prion diseases</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F1871526510909010015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=19200011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=15-22&author=K.+Teruyaauthor=K.+Kawagoeauthor=T.+Kimuraauthor=C.+J.+Chenauthor=Y.+Sakasegawaauthor=K.+Doh-ura&title=Amyloidophilic+compounds+for+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloidophilic compounds for prion diseases</span></div><div class="casAuthors">Teruya, Kenta; Kawagoe, Keiichi; Kimura, Tomohiro; Chen, Chun-jen; Sakasegawa, Yuji; Doh-ura, Katsumi</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent outbreaks of variant Creutzfeldt-Jakob disease and iatrogenic Creutzfeldt-Jakob disease have aroused great concern in many countries and have necessitated the development of suitable therapies.  We have demonstrated that sulfated glycans such as pentosan polysulfate and fucoidan, and amyloidophilic compds. such as amyloid dye derivs., styrylbenzoazole derivs., and phenylhydrazine derivs. have efficacies in prion-infected animals.  Amyloidophilic compds. present potentialities not only as therapeutic candidates but also as prion amyloid imaging probes for use in nuclear medicine technol. such as positron emission tomog.  A representative of styrylbenzoazole compds. has been used recently for clin. trials of brain prion amyloid imaging in patients.  On the other hand, a representative of phenylhydrazine compds., compB, displays excellent effectiveness in prolonging the incubation times of infected animals when given orally.  However, both its anti-prion effectiveness in vitro and its therapeutic efficacy in vivo are consistently dependent on the prion strain.  This prion-strain-dependency is similarly obsd. in other amyloidophilic compds.  Therefore, aside from further improvement of the safety profiles and pharmacokinetic properties of such compds., elucidation and management in the mechanism of the prion strain-dependent effectiveness is necessary.  Nevertheless, because compB studies suggest that amyloidophilic compds. are also therapeutic candidates for Alzheimer's disease, amyloidophilic compds. might be attractive as drug candidates for various conformational diseases and hasten development of therapeutic drugs for prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCpQbm3jqyfbVg90H21EOLACvtfcHk0lgQ-791DnNYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSmtro%253D&md5=5691668e9f80ed2a9b1d59238ae7a011</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F1871526510909010015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871526510909010015%26sid%3Dliteratum%253Aachs%26aulast%3DTeruya%26aufirst%3DK.%26aulast%3DKawagoe%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.%2BJ.%26aulast%3DSakasegawa%26aufirst%3DY.%26aulast%3DDoh-ura%26aufirst%3DK.%26atitle%3DAmyloidophilic%2520compounds%2520for%2520prion%2520diseases%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Moreno, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molloy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verity, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortori, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallucci, G. R.</span><span> </span><span class="NLM_article-title">Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">206ra138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1126%2Fscitranslmed.3006767" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=206ra138&author=J.+A.+Morenoauthor=M.+Hallidayauthor=C.+Molloyauthor=H.+Radfordauthor=N.+Verityauthor=J.+M.+Axtenauthor=C.+A.+Ortoriauthor=A.+E.+Willisauthor=P.+M.+Fischerauthor=D.+A.+Barrettauthor=G.+R.+Mallucci&title=Oral+treatment+targeting+the+unfolded+protein+response+prevents+neurodegeneration+and+clinical+disease+in+prion-infected+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3006767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3006767%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno%26aufirst%3DJ.%2BA.%26aulast%3DHalliday%26aufirst%3DM.%26aulast%3DMolloy%26aufirst%3DC.%26aulast%3DRadford%26aufirst%3DH.%26aulast%3DVerity%26aufirst%3DN.%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DOrtori%26aufirst%3DC.%2BA.%26aulast%3DWillis%26aufirst%3DA.%2BE.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DBarrett%26aufirst%3DD.%2BA.%26aulast%3DMallucci%26aufirst%3DG.%2BR.%26atitle%3DOral%2520treatment%2520targeting%2520the%2520unfolded%2520protein%2520response%2520prevents%2520neurodegeneration%2520and%2520clinical%2520disease%2520in%2520prion-infected%2520mice%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D206ra138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Axten, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeril, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mencken, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabindran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigethy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberlin, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span> </span><span class="NLM_article-title">Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7193</span><span class="NLM_x">–</span> <span class="NLM_lpage">7207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300713s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7193-7207&author=J.+M.+Axtenauthor=J.+R.+Medinaauthor=Y.+Fengauthor=A.+Shuauthor=S.+P.+Romerilauthor=S.+W.+Grantauthor=W.+H.+Liauthor=D.+A.+Heerdingauthor=E.+Minthornauthor=T.+Menckenauthor=C.+Atkinsauthor=Q.+Liuauthor=S.+Rabindranauthor=R.+Kumarauthor=X.+Hongauthor=A.+Goetzauthor=T.+Stanleyauthor=J.+D.+Taylorauthor=S.+D.+Sigethyauthor=G.+H.+Tomberlinauthor=A.+M.+Hassellauthor=K.+M.+Kahlerauthor=L.+M.+Shewchukauthor=R.+T.+Gampe&title=Discovery+of+7-methyl-5-%281-%7B%5B3-%28trifluoromethyl%29phenyl%5Dacetyl%7D-2%2C3-dihydro-1H-indol-5-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-amine+%28GSK2606414%29%2C+a+potent+and+selective+first-in-class+inhibitor+of+protein+kinase+R+%28PKR%29-like+endoplasmic+reticulum+kinase+%28PERK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300713s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300713s%26sid%3Dliteratum%253Aachs%26aulast%3DAxten%26aufirst%3DJ.%2BM.%26aulast%3DMedina%26aufirst%3DJ.%2BR.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DA.%26aulast%3DRomeril%26aufirst%3DS.%2BP.%26aulast%3DGrant%26aufirst%3DS.%2BW.%26aulast%3DLi%26aufirst%3DW.%2BH.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DMencken%26aufirst%3DT.%26aulast%3DAtkins%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DRabindran%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DX.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DStanley%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DJ.%2BD.%26aulast%3DSigethy%26aufirst%3DS.%2BD.%26aulast%3DTomberlin%26aufirst%3DG.%2BH.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DKahler%26aufirst%3DK.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26atitle%3DDiscovery%2520of%25207-methyl-5-%25281-%257B%255B3-%2528trifluoromethyl%2529phenyl%255Dacetyl%257D-2%252C3-dihydro-1H-indol-5-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-amine%2520%2528GSK2606414%2529%252C%2520a%2520potent%2520and%2520selective%2520first-in-class%2520inhibitor%2520of%2520protein%2520kinase%2520R%2520%2528PKR%2529-like%2520endoplasmic%2520reticulum%2520kinase%2520%2528PERK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7193%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryazanov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prix, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan-Montojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitteregger-Kretzschmar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geissen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leidel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinth, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bähr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weishaupt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urlaub, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teichmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bötzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groschup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span> </span><span class="NLM_article-title">Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1007%2Fs00401-013-1114-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23604588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXoslWjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=795-813&author=J.+Wagnerauthor=S.+Ryazanovauthor=A.+Leonovauthor=J.+Levinauthor=S.+Shiauthor=F.+Schmidtauthor=C.+Prixauthor=F.+Pan-Montojoauthor=U.+Bertschauthor=G.+Mitteregger-Kretzschmarauthor=M.+Geissenauthor=M.+Eidenauthor=F.+Leidelauthor=T.+Hirschbergerauthor=A.+Deegauthor=J.+Krauthauthor=W.+Zinthauthor=P.+Tavanauthor=J.+Pilgerauthor=M.+Zweckstetterauthor=T.+Frankauthor=M.+B%C3%A4hrauthor=J.+Weishauptauthor=M.+Uhrauthor=H.+Urlaubauthor=U.+Teichmannauthor=M.+Samwerauthor=K.+B%C3%B6tzelauthor=M.+Groschupauthor=H.+Kretzschmarauthor=C.+Griesingerauthor=A.+Giese&title=Anle138b%3A+a+novel+oligomer+modulator+for+disease-modifying+therapy+of+neurodegenerative+diseases+such+as+prion+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease</span></div><div class="casAuthors">Wagner, Jens; Ryazanov, Sergey; Leonov, Andrei; Levin, Johannes; Shi, Song; Schmidt, Felix; Prix, Catharina; Pan-Montojo, Francisco; Bertsch, Uwe; Mitteregger-Kretzschmar, Gerda; Geissen, Markus; Eiden, Martin; Leidel, Fabienne; Hirschberger, Thomas; Deeg, Andreas A.; Krauth, Julian J.; Zinth, Wolfgang; Tavan, Paul; Pilger, Jens; Zweckstetter, Markus; Frank, Tobias; Baehr, Mathias; Weishaupt, Jochen H.; Uhr, Manfred; Urlaub, Henning; Teichmann, Ulrike; Samwer, Matthias; Boetzel, Kai; Groschup, Martin; Kretzschmar, Hans; Griesinger, Christian; Giese, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-813</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and prion diseases, deposits of aggregated disease-specific proteins are found.  Oligomeric aggregates are presumed to be the key neurotoxic agent.  Here we describe the novel oligomer modulator anle138b [3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole], an aggregation inhibitor we developed based on a systematic high-throughput screening campaign combined with medicinal chem. optimization.  In vitro, anle138b blocked the formation of pathol. aggregates of prion protein (PrPSc) and of α-synuclein (α-syn), which is deposited in PD and other synucleinopathies such as dementia with Lewy bodies (DLB) and multiple system atrophy (MSA).  Notably, anle138b strongly inhibited all prion strains tested including BSE-derived and human prions.  Anle138b showed structure-dependent binding to pathol. aggregates and strongly inhibited formation of pathol. oligomers in vitro and in vivo both for prion protein and α-synuclein.  Both in mouse models of prion disease and in three different PD mouse models, anle138b strongly inhibited oligomer accumulation, neuronal degeneration, and disease progression in vivo.  Anle138b had no detectable toxicity at therapeutic doses and an excellent oral bioavailability and blood-brain-barrier penetration.  Our findings indicate that oligomer modulators provide a new approach for disease-modifying therapy in these diseases, for which only symptomatic treatment is available so far.  Moreover, our findings suggest that pathol. oligomers in neurodegenerative diseases share structural features, although the main protein component is disease-specific, indicating that compds. such as anle138b that modulate oligomer formation by targeting structure-dependent epitopes can have a broad spectrum of activity in the treatment of different protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqFugFNqNrQrVg90H21EOLACvtfcHk0lh-bHkZ8kHHbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXoslWjtbk%253D&md5=a4d8b1caeddbac35bd64421cdb49b718</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1114-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1114-9%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DRyazanov%26aufirst%3DS.%26aulast%3DLeonov%26aufirst%3DA.%26aulast%3DLevin%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DF.%26aulast%3DPrix%26aufirst%3DC.%26aulast%3DPan-Montojo%26aufirst%3DF.%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DMitteregger-Kretzschmar%26aufirst%3DG.%26aulast%3DGeissen%26aufirst%3DM.%26aulast%3DEiden%26aufirst%3DM.%26aulast%3DLeidel%26aufirst%3DF.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DDeeg%26aufirst%3DA.%26aulast%3DKrauth%26aufirst%3DJ.%26aulast%3DZinth%26aufirst%3DW.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DPilger%26aufirst%3DJ.%26aulast%3DZweckstetter%26aufirst%3DM.%26aulast%3DFrank%26aufirst%3DT.%26aulast%3DB%25C3%25A4hr%26aufirst%3DM.%26aulast%3DWeishaupt%26aufirst%3DJ.%26aulast%3DUhr%26aufirst%3DM.%26aulast%3DUrlaub%26aufirst%3DH.%26aulast%3DTeichmann%26aufirst%3DU.%26aulast%3DSamwer%26aufirst%3DM.%26aulast%3DB%25C3%25B6tzel%26aufirst%3DK.%26aulast%3DGroschup%26aufirst%3DM.%26aulast%3DKretzschmar%26aufirst%3DH.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DGiese%26aufirst%3DA.%26atitle%3DAnle138b%253A%2520a%2520novel%2520oligomer%2520modulator%2520for%2520disease-modifying%2520therapy%2520of%2520neurodegenerative%2520diseases%2520such%2520as%2520prion%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26spage%3D795%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Berry, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeArmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span> </span><span class="NLM_article-title">Drug resistance confounding prion therapeutics</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E4160</span><span class="NLM_x">–</span> <span class="NLM_lpage">4169</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E4160-4169&author=D.+B.+Berryauthor=D.+Luauthor=M.+Gevaauthor=J.+C.+Wattsauthor=S.+Bhardwajauthor=A.+Oehlerauthor=A.+R.+Rensloauthor=S.+J.+DeArmondauthor=S.+B.+Prusinerauthor=K.+Giles&title=Drug+resistance+confounding+prion+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DD.%2BB.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DGeva%26aufirst%3DM.%26aulast%3DWatts%26aufirst%3DJ.%2BC.%26aulast%3DBhardwaj%26aufirst%3DS.%26aulast%3DOehler%26aufirst%3DA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DDeArmond%26aufirst%3DS.%2BJ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DGiles%26aufirst%3DK.%26atitle%3DDrug%2520resistance%2520confounding%2520prion%2520therapeutics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3DE4160%26epage%3D4169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kocisko, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuizon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caughey, B.</span><span> </span><span class="NLM_article-title">New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">10288</span><span class="NLM_x">–</span> <span class="NLM_lpage">10294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.77.19.10288-10294.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=12970413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFymsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=10288-10294&author=D.+A.+Kociskoauthor=G.+S.+Baronauthor=R.+Rubensteinauthor=J.+Chenauthor=S.+Kuizonauthor=B.+Caughey&title=New+inhibitors+of+scrapie-associated+prion+protein+formation+in+a+library+of+2000+drugs+and+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products</span></div><div class="casAuthors">Kocisko, David A.; Baron, Gerald S.; Rubenstein, Richard; Chen, Jiancao; Kuizon, Salomon; Caughey, Byron</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10288-10294</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Transmissible spongiform encephalopathies (TSEs) are fatal, untreatable neurodegenerative diseases assocd. with the accumulation of a disease-specific form of prion protein (PrP) in the brain.  One approach to TSE therapeutics is the inhibition of PrP accumulation.  Indeed, many inhibitors of the accumulation of PrP assocd. with scrapie (PrPSc) in scrapie-infected mouse neuroblastoma cells (ScN2a) also have antiscrapie activity in rodents.  To expedite the search for potential TSE therapeutic agents, we have developed a high-throughput screening assay for PrPSc inhibitors using ScN2a cells in a 96-well format.  A library of 2000 drugs and natural products was screened in ScN2a cells infected with scrapie strain RML (Chandler) or 22L.  Forty compds. were found to have concns. causing 50% inhibition (IC50s) of PrPSc accumulation of ≤10 μM against both strains.  Seventeen had IC50s of ≤1 μM against both strains.  Several classes of compds. were represented in the 17 most potent inhibitors, including naturally occurring polyphenols (e.g., tannic acid and tea exts.), phenothiazines, antihistamines, statins, and antimalarial compds.  These 17 compds. were also evaluated in a solid-phase cell-free hamster PrP conversion assay.  Only the polyphenols inhibited the cell-free reaction, and their IC50s were near 100 nM.  Several of the new PrPSc inhibitors cross the blood-brain barrier and thus have potential to be effective after TSE infection reaches the brain.  The fact that many are either approved human drugs or edible natural products should facilitate their use in animal testing and clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1vcriJCP_s7Vg90H21EOLACvtfcHk0li_TlJbxMvnwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFymsL8%253D&md5=598d71a1e2e72514ac69124221e2204a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.19.10288-10294.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.19.10288-10294.2003%26sid%3Dliteratum%253Aachs%26aulast%3DKocisko%26aufirst%3DD.%2BA.%26aulast%3DBaron%26aufirst%3DG.%2BS.%26aulast%3DRubenstein%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DKuizon%26aufirst%3DS.%26aulast%3DCaughey%26aufirst%3DB.%26atitle%3DNew%2520inhibitors%2520of%2520scrapie-associated%2520prion%2520protein%2520formation%2520in%2520a%2520library%2520of%25202000%2520drugs%2520and%2520natural%2520products%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D10288%26epage%3D10294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bertsch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winklhofer, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieschke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatzelt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretzschmar, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, A.</span><span> </span><span class="NLM_article-title">Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">7785</span><span class="NLM_x">–</span> <span class="NLM_lpage">7791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.79.12.7785-7791.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=15919931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=7785-7791&author=U.+Bertschauthor=K.+F.+Winklhoferauthor=T.+Hirschbergerauthor=J.+Bieschkeauthor=P.+Weberauthor=F.+U.+Hartlauthor=P.+Tavanauthor=J.+Tatzeltauthor=H.+A.+Kretzschmarauthor=A.+Giese&title=Systematic+identification+of+antiprion+drugs+by+high-throughput+screening+based+on+scanning+for+intensely+fluorescent+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets</span></div><div class="casAuthors">Bertsch, Uwe; Winklhofer, Konstanze F.; Hirschberger, Thomas; Bieschke, Jan; Weber, Petra; Hartl, F. Ulrich; Tavan, Paul; Tatzelt, Joerg; Kretzschmar, Hans A.; Giese, Armin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7785-7791</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Conformational changes and aggregation of specific proteins are hallmarks of a no. of diseases, like Alzheimer's disease, Parkinson's disease, and prion diseases.  In the case of prion diseases, the prion protein (PrP), a neuronal glycoprotein, undergoes a conformational change from the normal, mainly alpha-helical conformation to a disease-assocd., mainly beta-sheeted scrapie isoform (PrPSc), which forms amyloid aggregates.  This conversion, which is crucial for disease progression, depends on direct PrPC/PrPSc interaction.  The authors developed a high-throughput assay based on scanning for intensely fluorescent targets (SIFT) for the identification of drugs which interfere with this interaction at the mol. level.  Screening of a library of 10,000 drug-like compds. yielded 256 primary hits, 80 of which were confirmed by dose response curves with half-maximal inhibitory effects ranging from 0.3 to 60 μM.  Among these, six compds. displayed an inhibitory effect on PrPSc propagation in scrapie-infected N2a cells.  Four of these candidate drugs share an N'-benzylidene-benzohydrazide core structure.  Thus, the combination of high-throughput in vitro assay with the established cell culture system provides a rapid and efficient method to identify new antiprion drugs, which corroborates that interaction of PrPC and PrPSc is a crucial mol. step in the propagation of prions.  Moreover, SIFT-based screening may facilitate the search for drugs against other diseases linked to protein aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo8imCfuT6srVg90H21EOLACvtfcHk0li_TlJbxMvnwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFCmsb8%253D&md5=ea1bf08e5fb885976f501e97682f4d71</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.12.7785-7791.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.12.7785-7791.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBertsch%26aufirst%3DU.%26aulast%3DWinklhofer%26aufirst%3DK.%2BF.%26aulast%3DHirschberger%26aufirst%3DT.%26aulast%3DBieschke%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DTavan%26aufirst%3DP.%26aulast%3DTatzelt%26aufirst%3DJ.%26aulast%3DKretzschmar%26aufirst%3DH.%2BA.%26aulast%3DGiese%26aufirst%3DA.%26atitle%3DSystematic%2520identification%2520of%2520antiprion%2520drugs%2520by%2520high-throughput%2520screening%2520based%2520on%2520scanning%2520for%2520intensely%2520fluorescent%2520targets%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D7785%26epage%3D7791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Discovery of 2-aminothiazoles as potent antiprion compounds</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">3408</span><span class="NLM_x">–</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1128%2FJVI.02145-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=20032192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFOgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=3408-3412&author=S.+Ghaemmaghamiauthor=B.+C.+Mayauthor=A.+R.+Rensloauthor=S.+B.+Prusiner&title=Discovery+of+2-aminothiazoles+as+potent+antiprion+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-aminothiazoles as potent antiprion compounds</span></div><div class="casAuthors">Ghaemmaghami, Sina; May, Barnaby C. H.; Renslo, Adam R.; Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3408-3412</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Prion diseases are fatal, untreatable neurodegenerative diseases caused by the accumulation of the misfolded, infectious isoform of the prion protein (PrP), termed PrPSc.  In an effort to identify novel inhibitors of prion formation, we utilized a high-throughput ELISA to evaluate PrPSc redn. in prion-infected neuroblastoma cell lines (ScN2a).  We screened a library of ∼10,000 diverse small mols. in 96-well format and identified 121 compds. that reduced PrPSc levels at a concn. of 5 μM.  Four chem. scaffolds were identified as potential candidates for chem. optimization based on the presence of preliminary structure-activity relationships (SAR) derived from the primary screening data.  A follow-up anal. of a group of com. available 2-aminothiazoles showed this class as generally active in ScN2a cells.  Our results establish 2-aminothiazoles as promising candidates for efficacy studies of animals and validate our drug discovery platform as a viable strategy for the identification of novel lead compds. with antiprion properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw0XXaqciXgLVg90H21EOLACvtfcHk0ljl7e5j1iya2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFOgt7w%253D&md5=f65520e1f3bf9949f3f8fa42bb47495c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1128%2FJVI.02145-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02145-09%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DMay%26aufirst%3DB.%2BC.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DDiscovery%2520of%25202-aminothiazoles%2520as%2520potent%2520antiprion%2520compounds%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0ljl7e5j1iya2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of <i>N</i>-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3766</span><span class="NLM_x">–</span> <span class="NLM_lpage">3769</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060347y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3766-3769&author=R.+M.+Borzilleriauthor=R.+S.+Bhideauthor=J.+C.+Barrishauthor=C.+J.+D%E2%80%99Arienzoauthor=G.+M.+Derbinauthor=J.+Fargnoliauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=D.+W.+Kukralauthor=P.+Maratheauthor=S.+Mortilloauthor=L.+Qianauthor=J.+S.+Tokarskiauthor=B.+S.+Wautletauthor=X.+Zhengauthor=L.+J.+Lombardo&title=Discovery+and+evaluation+of+N-cyclopropyl-2%2C4-difluoro-5-%28%282-%28pyridin-2-ylamino%29thiazol-5-ylmethyl%29amino%29benzamide+%28BMS-605541%29%2C+a+selective+and+orally+efficacious+inhibitor+of+vascular+endothelial+growth+factor+receptor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060347y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060347y%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DDerbin%26aufirst%3DG.%2BM.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520N-cyclopropyl-2%252C4-difluoro-5-%2528%25282-%2528pyridin-2-ylamino%2529thiazol-5-ylmethyl%2529amino%2529benzamide%2520%2528BMS-605541%2529%252C%2520a%2520selective%2520and%2520orally%2520efficacious%2520inhibitor%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3766%26epage%3D3769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">2-Aminothiazole as a novel kinase inhibitor template. Structure–activity relationship studies toward the discovery of <i>N</i>-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6819</span><span class="NLM_x">–</span> <span class="NLM_lpage">6832</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060727j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6819-6832&author=J.+Dasauthor=P.+Chenauthor=D.+Norrisauthor=R.+Padmanabhaauthor=J.+Linauthor=R.+V.+Moquinauthor=Z.+Shenauthor=L.+S.+Cookauthor=A.+M.+Doweykoauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=Q.+Fangauthor=H.+F.+de+Fexauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+M.+Gilloolyauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+Wityakauthor=J.+C.+Barrish&title=2-Aminothiazole+as+a+novel+kinase+inhibitor+template.+Structure%E2%80%93activity+relationship+studies+toward+the+discovery+of+N-%282-chloro-6-methylphenyl%29-2-%5B%5B6-%5B4-%282-hydroxyethyl%29-1-piperazinyl%29%5D-2-methyl-4-pyrimidinyl%5Damino%29%5D-1%2C3-thiazole-5-carboxamide+%28dasatinib%2C+BMS-354825%29+as+a+potent+pan-Src+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm060727j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060727j%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DPadmanabha%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DCook%26aufirst%3DL.%2BS.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3Dde%2BFex%26aufirst%3DH.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3D2-Aminothiazole%2520as%2520a%2520novel%2520kinase%2520inhibitor%2520template.%2520Structure%25E2%2580%2593activity%2520relationship%2520studies%2520toward%2520the%2520discovery%2520of%2520N-%25282-chloro-6-methylphenyl%2529-2-%255B%255B6-%255B4-%25282-hydroxyethyl%2529-1-piperazinyl%2529%255D-2-methyl-4-pyrimidinyl%255Damino%2529%255D-1%252C3-thiazole-5-carboxamide%2520%2528dasatinib%252C%2520BMS-354825%2529%2520as%2520a%2520potent%2520pan-Src%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6819%26epage%3D6832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Press, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fullerton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberthuer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatto, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Press, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffnell, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span> </span><span class="NLM_article-title">A new orally bioavailable dual adenosine a2b/a3 receptor antagonist with therapeutic potential</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3081</span><span class="NLM_x">–</span> <span class="NLM_lpage">3085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3081-3085&author=N.+J.+Pressauthor=R.+J.+Taylorauthor=J.+D.+Fullertonauthor=P.+Tranterauthor=C.+McCarthyauthor=T.+H.+Kellerauthor=L.+Brownauthor=R.+Cheungauthor=J.+Christieauthor=S.+Haberthuerauthor=J.+D.+Hattoauthor=M.+Keenanauthor=M.+K.+Mercerauthor=N.+E.+Pressauthor=H.+Sahriauthor=A.+R.+Tuffnellauthor=M.+Tweedauthor=J.+R.+Fozard&title=A+new+orally+bioavailable+dual+adenosine+a2b%2Fa3+receptor+antagonist+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCheung%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DJ.%26aulast%3DHaberthuer%26aufirst%3DS.%26aulast%3DHatto%26aufirst%3DJ.%2BD.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DM.%2BK.%26aulast%3DPress%26aufirst%3DN.%2BE.%26aulast%3DSahri%26aufirst%3DH.%26aulast%3DTuffnell%26aufirst%3DA.%2BR.%26aulast%3DTweed%26aufirst%3DM.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26atitle%3DA%2520new%2520orally%2520bioavailable%2520dual%2520adenosine%2520a2b%252Fa3%2520receptor%2520antagonist%2520with%2520therapeutic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3081%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">van Muijlwijk-Koezen, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frijtag von Drabbe Kunzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0003945" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=749-762&author=J.+E.+van+Muijlwijk-Koezenauthor=H.+Timmermanauthor=R.+C.+Vollingaauthor=J.+Frijtag+von+Drabbe+Kunzelauthor=M.+de+Grooteauthor=S.+Visserauthor=A.+P.+Ijzerman&title=Thiazole+and+thiadiazole+analogues+as+a+novel+class+of+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0003945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0003945%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMuijlwijk-Koezen%26aufirst%3DJ.%2BE.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DVollinga%26aufirst%3DR.%2BC.%26aulast%3DFrijtag%2Bvon%2BDrabbe%2BKunzel%26aufirst%3DJ.%26aulast%3Dde%2BGroote%26aufirst%3DM.%26aulast%3DVisser%26aufirst%3DS.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DThiazole%2520and%2520thiadiazole%2520analogues%2520as%2520a%2520novel%2520class%2520of%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D749%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Turcotte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutphin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccia, A. J.</span><span> </span><span class="NLM_article-title">A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=90-102&author=S.+Turcotteauthor=D.+A.+Chanauthor=P.+D.+Sutphinauthor=M.+P.+Hayauthor=W.+A.+Dennyauthor=A.+J.+Giaccia&title=A+molecule+targeting+VHL-deficient+renal+cell+carcinoma+that+induces+autophagy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurcotte%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DD.%2BA.%26aulast%3DSutphin%26aufirst%3DP.%2BD.%26aulast%3DHay%26aufirst%3DM.%2BP.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DA%2520molecule%2520targeting%2520VHL-deficient%2520renal%2520cell%2520carcinoma%2520that%2520induces%2520autophagy%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D90%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lubbers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolidon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Aminothiazoles as gamma-secretase modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6554</span><span class="NLM_x">–</span> <span class="NLM_lpage">6558</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6554-6558&author=T.+Lubbersauthor=A.+Flohrauthor=S.+Jolidonauthor=P.+David-Piersonauthor=H.+Jacobsenauthor=L.+Ozmenauthor=K.+Baumann&title=Aminothiazoles+as+gamma-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLubbers%26aufirst%3DT.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DAminothiazoles%2520as%2520gamma-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6554%26epage%3D6558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.+M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fife, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">2-Aminothiazoles as therapeutic leads for prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101250y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1010-1021&author=A.+Gallardo-Godoyauthor=J.+Geverauthor=K.+L.+Fifeauthor=B.+M.+Silberauthor=S.+B.+Prusinerauthor=A.+R.+Renslo&title=2-Aminothiazoles+as+therapeutic+leads+for+prion+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm101250y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101250y%26sid%3Dliteratum%253Aachs%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DGever%26aufirst%3DJ.%26aulast%3DFife%26aufirst%3DK.%2BL.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3D2-Aminothiazoles%2520as%2520therapeutic%2520leads%2520for%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1010%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolghih, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widjaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span> </span><span class="NLM_article-title">2-Aminothiazoles with improved pharmacotherapeutic properties for treatment of prion disease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=847-857&author=Z.+Liauthor=B.+M.+Silberauthor=S.+Raoauthor=J.+R.+Geverauthor=C.+Bryantauthor=A.+Gallardo-Godoyauthor=E.+Dolghihauthor=K.+Widjajaauthor=M.+Elepanoauthor=M.+P.+Jacobsonauthor=S.+B.+Prusinerauthor=A.+R.+Renslo&title=2-Aminothiazoles+with+improved+pharmacotherapeutic+properties+for+treatment+of+prion+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DDolghih%26aufirst%3DE.%26aulast%3DWidjaja%26aufirst%3DK.%26aulast%3DElepano%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26atitle%3D2-Aminothiazoles%2520with%2520improved%2520pharmacotherapeutic%2520properties%2520for%2520treatment%2520of%2520prion%2520disease%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D847%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Chemical induction of misfolded prion protein conformers in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">10415</span><span class="NLM_x">–</span> <span class="NLM_lpage">10423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10415-10423&author=S.+Ghaemmaghamiauthor=J.+Ullmanauthor=M.+Ahnauthor=S.+St+Martinauthor=S.+B.+Prusiner&title=Chemical+induction+of+misfolded+prion+protein+conformers+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhaemmaghami%26aufirst%3DS.%26aulast%3DUllman%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DSt%2BMartin%26aufirst%3DS.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DChemical%2520induction%2520of%2520misfolded%2520prion%2520protein%2520conformers%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10415%26epage%3D10423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fife, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo-Godoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freyman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benet, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and metabolism of 2-aminothiazoles with antiprion activity in mice</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=932-950&author=B.+M.+Silberauthor=S.+Raoauthor=K.+L.+Fifeauthor=A.+Gallardo-Godoyauthor=A.+R.+Rensloauthor=D.+K.+Dalvieauthor=K.+Gilesauthor=Y.+Freymanauthor=M.+Elepanoauthor=J.+R.+Geverauthor=Z.+Liauthor=M.+P.+Jacobsonauthor=Y.+Huangauthor=L.+Z.+Benetauthor=S.+B.+Prusiner&title=Pharmacokinetics+and+metabolism+of+2-aminothiazoles+with+antiprion+activity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DFife%26aufirst%3DK.%2BL.%26aulast%3DGallardo-Godoy%26aufirst%3DA.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DFreyman%26aufirst%3DY.%26aulast%3DElepano%26aufirst%3DM.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DPharmacokinetics%2520and%2520metabolism%2520of%25202-aminothiazoles%2520with%2520antiprion%2520activity%2520in%2520mice%26jtitle%3DPharm.%2520Res.%26date%3D2013%26volume%3D30%26spage%3D932%26epage%3D950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Lu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolghih, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gever, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elepano, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renslo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dearmond, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1124%2Fjpet.113.205799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23965382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=325-338&author=D.+Luauthor=K.+Gilesauthor=Z.+Liauthor=S.+Raoauthor=E.+Dolghihauthor=J.+R.+Geverauthor=M.+Gevaauthor=M.+L.+Elepanoauthor=A.+Oehlerauthor=C.+Bryantauthor=A.+R.+Rensloauthor=M.+P.+Jacobsonauthor=S.+J.+Dearmondauthor=B.+M.+Silberauthor=S.+B.+Prusiner&title=Biaryl+amides+and+hydrazones+as+therapeutics+for+prion+disease+in+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice</span></div><div class="casAuthors">Lu, Duo; Giles, Kurt; Li, Zhe; Rao, Satish; Dolghih, Elena; Gever, Joel R.; Geva, Michal; Elepano, Manuel L.; Oehler, Abby; Bryant, Clifford; Renslo, Adam R.; Jacobson, Matthew P.; DeArmond, Stephen J.; Silber, B. Michael; Prusiner, Stanley B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-338</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The only small-mol. compd. demonstrated to substantially extend survival in prion-infected mice is a biaryl hydrazone termed "Compd B" (4-pyridinecarboxaldehyde,2-[4-(5-oxazolyl)phenyl]hydrazone).  However, the hydrazone moiety of Compd B results in toxic metabolites, making it a poor candidate for further drug development.  We developed a pharmacophore model based on diverse antiprion compds. identified by high-throughput screening; based on this model, we generated biaryl amide analogs of Compd B.  Medicinal chem. optimization led to multiple compds. with increased potency, increased brain concns., and greater metabolic stability, indicating that they could be promising candidates for antiprion therapy.  Replacing the pyridyl ring of Compd B with a Ph group contg. an electron-donating substituent increased potency, while adding an aryl group to the oxazole moiety increased metabolic stability.  To test the efficacy of Compd B, we applied bioluminescence imaging (BLI), which was previously shown to detect prion disease onset in live mice earlier than clin. signs.  In our studies, Compd B showed good efficacy in two lines of transgenic mice infected with the mouse-adapted Rocky Mountain Lab. (RML) strain of prions, but not in transgenic mice infected with human prions.  The BLI system successfully predicted the efficacies in all cases long before extension in survival could be obsd.  Our studies suggest that this BLI system has good potential to be applied in future antiprion drug efficacy studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pfysI0-wIbVg90H21EOLACvtfcHk0lgd5gPmb6LrXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsL3P&md5=9fedbf2b5876b9e2551797714a69c90b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.205799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.205799%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DD.%26aulast%3DGiles%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DDolghih%26aufirst%3DE.%26aulast%3DGever%26aufirst%3DJ.%2BR.%26aulast%3DGeva%26aufirst%3DM.%26aulast%3DElepano%26aufirst%3DM.%2BL.%26aulast%3DOehler%26aufirst%3DA.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DDearmond%26aufirst%3DS.%2BJ.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DBiaryl%2520amides%2520and%2520hydrazones%2520as%2520therapeutics%2520for%2520prion%2520disease%2520in%2520transgenic%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D325%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oelschlegel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissmann, C.</span><span> </span><span class="NLM_article-title">Darwinian evolution of prions in cell culture</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=869-872&author=J.+Liauthor=S.+Browningauthor=S.+P.+Mahalauthor=A.+M.+Oelschlegelauthor=C.+Weissmann&title=Darwinian+evolution+of+prions+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBrowning%26aufirst%3DS.%26aulast%3DMahal%26aufirst%3DS.%2BP.%26aulast%3DOelschlegel%26aufirst%3DA.%2BM.%26aulast%3DWeissmann%26aufirst%3DC.%26atitle%3DDarwinian%2520evolution%2520of%2520prions%2520in%2520cell%2520culture%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D869%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Miller-Vedam, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghaemmaghami, S.</span><span> </span><span class="NLM_article-title">Strain specificity and drug resistance in anti-prion therapy</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.2174%2F15680266113136660168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24059341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWhu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=2397-2406&author=L.+Miller-Vedamauthor=S.+Ghaemmaghami&title=Strain+specificity+and+drug+resistance+in+anti-prion+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Strain Specificity and Drug Resistance in Anti-Prion Therapy</span></div><div class="casAuthors">Miller-Vedam, Lakshmi; Ghaemmaghami, Sina</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2397-2406</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prion diseases are a group of fatal neurodegenerative diseases caused by the misfolding of cellular prion protein (PrPC) into pathogenic conformers (PrPSc).  Although no effective therapies for prion diseases are currently available, a no. of small mol. inhibitors have been identified that are capable of reducing or eliminating PrPSc in prion infected cells.  However, recent expts. have shown that upon sustained treatment, prions have the capacity to evolve into drug resistant conformations.  These studies suggest that the mechanism of prion strain adaptation involves rare conformational conversions followed by competitive selection among the heterogeneous pool of PrPSc conformers.  The plasticity of prion conformers makes PrPSc a particularly challenging drug target and suggests that combination drug therapies or targeting of PrPC may be required for effective therapy.  In this review, we highlight recent literature that demonstrate the phenomenon of prion drug resistance and strain specificity, and discuss potential ramifications for therapeutic efforts against prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_PpzUIKI0E7Vg90H21EOLACvtfcHk0ljH5z2Jyn9I5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWhu7jM&md5=4ff4a30725315b4680cfa0d657f7bf7e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F15680266113136660168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113136660168%26sid%3Dliteratum%253Aachs%26aulast%3DMiller-Vedam%26aufirst%3DL.%26aulast%3DGhaemmaghami%26aufirst%3DS.%26atitle%3DStrain%2520specificity%2520and%2520drug%2520resistance%2520in%2520anti-prion%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D2397%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Prusiner, S. B.</span><span> </span><span class="NLM_article-title">Cell biology. A unifying role for prions in neurodegenerative diseases</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=1511-1513&author=S.+B.+Prusiner&title=Cell+biology.+A+unifying+role+for+prions+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrusiner%26aufirst%3DS.%2BB.%26atitle%3DCell%2520biology.%2520A%2520unifying%2520role%2520for%2520prions%2520in%2520neurodegenerative%2520diseases%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D1511%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, L. C.</span><span> </span><span class="NLM_article-title">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">501</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1038%2Fnature12481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=24005412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2013&pages=45-51&author=M.+Juckerauthor=L.+C.+Walker&title=Self-propagation+of+pathogenic+protein+aggregates+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Self-propagation of pathogenic protein aggregates in neurodegenerative diseases</span></div><div class="casAuthors">Jucker, Mathias; Walker, Lary C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">7465</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biol. of the prion diseases.  Recently, owing largely to the advent of new disease models, this hypothesis has gained exptl. momentum.  In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid.  Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease.  Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin.  However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function.  As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCZxraDJnKbbVg90H21EOLACvtfcHk0ljH5z2Jyn9I5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtLzP&md5=6e10e4c3d25f9a907b7af8944cb1ba69</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature12481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12481%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%2BC.%26atitle%3DSelf-propagation%2520of%2520pathogenic%2520protein%2520aggregates%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2013%26volume%3D501%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Guo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stieber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Distinct alpha-synuclein strains differentially promote tau inclusions in neurons</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm5001425&amp;key=10.1016%2Fj.cell.2013.05.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm5001425&amp;key=23827677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm5001425&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVGktbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=103-117&author=J.+L.+Guoauthor=D.+J.+Covellauthor=J.+P.+Danielsauthor=M.+Ibaauthor=A.+Stieberauthor=B.+Zhangauthor=D.+M.+Riddleauthor=L.+K.+Kwongauthor=Y.+Xuauthor=J.+Q.+Trojanowskiauthor=V.+M.+Lee&title=Distinct+alpha-synuclein+strains+differentially+promote+tau+inclusions+in+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct α-synuclein strains differentially promote Tau inclusions in neurons</span></div><div class="casAuthors">Guo, Jing L.; Covell, Dustin J.; Daniels, Joshua P.; Iba, Michiyo; Stieber, Anna; Zhang, Bin; Riddle, Dawn M.; Kwong, Linda K.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-117</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Many neurodegenerative diseases are characterized by the accumulation of insol. protein aggregates, including neurofibrillary tangles comprised of tau in Alzheimer's disease and Lewy bodies composed of α-synuclein in Parkinson's disease.  Moreover, different pathol. proteins frequently codeposit in disease brains.  To test whether aggregated α-synuclein can directly cross-seed tau fibrillization, we administered preformed α-synuclein fibrils assembled from recombinant protein to primary neurons and transgenic mice.  Remarkably, we discovered two distinct strains of synthetic α-synuclein fibrils that demonstrated striking differences in the efficiency of cross-seeding tau aggregation, both in neuron cultures and in vivo.  Proteinase K digestion revealed conformational differences between the two synthetic α-synuclein strains and also between sarkosyl-insol. α-synuclein extd. from two subgroups of Parkinson's disease brains.  We speculate that distinct strains of pathol. α-synuclein likely exist in neurodegenerative disease brains and may underlie the tremendous heterogeneity of synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob08jmoYbLqbVg90H21EOLACvtfcHk0ljH5z2Jyn9I5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVGktbzE&md5=02b6b2f5f06b5b44a8e751636591359f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.05.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.05.057%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%2BL.%26aulast%3DCovell%26aufirst%3DD.%2BJ.%26aulast%3DDaniels%26aufirst%3DJ.%2BP.%26aulast%3DIba%26aufirst%3DM.%26aulast%3DStieber%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRiddle%26aufirst%3DD.%2BM.%26aulast%3DKwong%26aufirst%3DL.%2BK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DDistinct%2520alpha-synuclein%2520strains%2520differentially%2520promote%2520tau%2520inclusions%2520in%2520neurons%26jtitle%3DCell%26date%3D2013%26volume%3D154%26spage%3D103%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Clavaguera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hench, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichwald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span> </span><span class="NLM_article-title">Brain homogenates from human tauopathies induce tau inclusions in mouse brain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">9535</span><span class="NLM_x">–</span> <span class="NLM_lpage">9540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=9535-9540&author=F.+Clavagueraauthor=H.+Akatsuauthor=G.+Fraserauthor=R.+A.+Crowtherauthor=S.+Frankauthor=J.+Henchauthor=A.+Probstauthor=D.+T.+Winklerauthor=J.+Reichwaldauthor=M.+Staufenbielauthor=B.+Ghettiauthor=M.+Goedertauthor=M.+Tolnay&title=Brain+homogenates+from+human+tauopathies+induce+tau+inclusions+in+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClavaguera%26aufirst%3DF.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DFraser%26aufirst%3DG.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DHench%26aufirst%3DJ.%26aulast%3DProbst%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DD.%2BT.%26aulast%3DReichwald%26aufirst%3DJ.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DTolnay%26aufirst%3DM.%26atitle%3DBrain%2520homogenates%2520from%2520human%2520tauopathies%2520induce%2520tau%2520inclusions%2520in%2520mouse%2520brain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D9535%26epage%3D9540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5001425&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-16%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm5001425" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5001425" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a94a33ff5d96a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
